"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtWith_AU_IN_FIRST","meanArtWith_AU_IN_LAST","meanArtWith_AU_IN_CORR","mean_articles_per_internal_author","mean_articles_per_internal_first_author","mean_articles_per_internal_last_author","mean_articles_per_internal_corresponding_author","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","meanCitationTrend","InternCoauthorship","AffCoauthorship","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"AOUSSN_FEDERICOII",2000,199,6.7035175879397,3.44723618090452,0.733668341708543,0.49748743718593,0.743718592964824,1.29245283018868,1.20661157024793,1.26923076923077,1.20325203252033,0.231155778894472,12,99,42,22,18,0.5,0.21,0.11,0.09,36.76,0.810897887034298,NA,0.21105527638191,0.512562814070352,0.364,0.312,0.365,0.308,"LUCIO SANTORO;SALVATORE PANICO;FRANCO CONTALDO;CLAUDIO PIGNATA;ROBERTO GRASSI;OLGA VACCARO;LUIGI SACCÀ;LUIGI TROJANO;BRUNO TRIMARCO;EGIDIO CELENTANO;ROCCO GALASSO;F. RENGO;FABRIZIO PASANISI;FAUSTO J. PINTO;MARIANO SCAGLIONE;C IOVINE;A. PERRETTI;ANTÓNIO PINTO;ANGELA A. RIVELLESE;GENEROSO ANDRIA","9;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","BRUNO TRIMARCO;L FERRARA;G BUDILLON;ROSARIO CUOMO;GERARDO NARDONE;LUCIO SANTORO;ALFREDO GUARINO;ROBERTO GRASSI;MASSIMO IMBRIACO;FRANCO CONTALDO;ANNA GIUNTA;TERESA CIRILLO;GENOVEFFA D’ANIELLO;MASSIMO ROMANÒ;RAFFAELE SCARPA;ANGELA A. RIVELLESE;FABRIZIO PASANISI;GIORGIO İACONETTA;F MAIURI;CLAUDIO PIGNATA","1.6;1.45;1.33;1.33;1.33;1.26;1.25;1.17;1.12;1.11;1;1;1;1;1;0.89;0.84;0.83;0.83;0.8","LUCIO SANTORO;SALVATORE PANICO;FRANCO CONTALDO;CLAUDIO PIGNATA;ROBERTO GRASSI;OLGA VACCARO;LUIGI SACCÀ;BRUNO TRIMARCO;EGIDIO CELENTANO;ROCCO GALASSO;F. RENGO;FABRIZIO PASANISI;C IOVINE;A. PERRETTI;ANGELA A. RIVELLESE;GENEROSO ANDRIA;GABRIELE RICCARDI;MARIACAROLINA SALERNO;SALVATORE CUCCHIARA;G. MAZZACCA","9;6;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","BRUNO TRIMARCO;L FERRARA;G BUDILLON;ROSARIO CUOMO;GERARDO NARDONE;LUCIO SANTORO;ALFREDO GUARINO;ROBERTO GRASSI;MASSIMO IMBRIACO;FRANCO CONTALDO;ANNA GIUNTA;TERESA CIRILLO;GENOVEFFA D’ANIELLO;MASSIMO ROMANÒ;RAFFAELE SCARPA;ANGELA A. RIVELLESE;FABRIZIO PASANISI;GIORGIO İACONETTA;F MAIURI;CLAUDIO PIGNATA","1.6;1.45;1.33;1.33;1.33;1.26;1.25;1.17;1.12;1.11;1;1;1;1;1;0.89;0.84;0.83;0.83;0.8","LUIGI SACCÀ;JENS OTTO LUNDE JØRGENSEN;NICOLA KEAY;JENNIFER WALLACE;ANTONIO CITTADINI;JENS SANDAHL CHRISTIANSEN;PETER H. SÖNKSEN;ROSS C. CUNEO;S. LONGOBARDI;CHRISTER EHRNBORG;M BOROUJERDI;ROLF DALL;T. ROSÉN;LUIGI MAIURI;ANNAMARIA COLAO;ALBERTO GOBBI;ANDREA BIANCHINI;CLARA NERVI;CRISTIAN MATTEUCCI;EMANUELA COLOMBO","632;539;539;431;405;336;336;336;326;311;311;311;311;306;295;286;286;286;286;286","LUIGI SACCÀ;ANTONIO CITTADINI;S. LONGOBARDI;PASQUALE DE LUCA;CAROLINA CIACCI;FRANCO CONTALDO;CIRO INDOLFI;EMILIO DI LORENZO;EUGENIO STABILE;MASSIMO CHIARIELLO;EZIO RICCA;LOREDANA BACCIGALUPI;SALVATORE LONGOBARDI;LUCIO SANTORO;ANGELA MARIA STINGONE;ANTONIO LECCIA;MARIO DE MICHELE;F RINALDI;GIOVANNI MUSCETTOLA;GIUSEPPE BARBATO","539;326;326;286;260;253;252;252;252;252;248;236;228;212;202;202;201;197;197;197","LUCIO SANTORO;SALVATORE PANICO;FRANCO CONTALDO;A. PERRETTI;BRUNO TRIMARCO;GABRIELE RICCARDI;GABRIELLA DE JOANNA;OLGA VACCARO;SALVATORE CUCCHIARA;ADA MAFFETTONE;ANGELA A. RIVELLESE;ANNAMARIA COLAO;CIRO INDOLFI;CLAUDIO PIGNATA;DIEGO FERONE;EMILIO DI LORENZO;EUGENIO STABILE;G. MAZZACCA;L FERRARA;LUIGI SACCÀ","9;6;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;ENGINEERING;MATHEMATICS;BUSINESS;MATERIALS SCIENCE;SOCIOLOGY;ART;PHILOSOPHY;GEOGRAPHY;GEOLOGY;POLITICAL SCIENCE;ECONOMICS;ENVIRONMENTAL SCIENCE","168;63;40;18;12;10;7;7;4;4;4;3;3;2;2;2;1;1","INTERNAL MEDICINE;ENDOCRINOLOGY;PATHOLOGY;BIOCHEMISTRY;SURGERY;CARDIOLOGY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;RADIOLOGY;ANESTHESIA;PSYCHIATRY;NEUROSCIENCE;ANATOMY;ORGANIC CHEMISTRY;PEDIATRICS;PHARMACOLOGY;BIOTECHNOLOGY;MOLECULAR BIOLOGY;FOOD SCIENCE;NUCLEAR MEDICINE;ONCOLOGY;PALEONTOLOGY;UROLOGY","126;48;44;36;35;28;26;26;24;21;15;15;10;9;9;9;9;7;7;6;6;6;6;6","BLOOD PRESSURE;GENE;DISEASE;ALTERNATIVE MEDICINE;RECEPTOR;CANCER;ENZYME;DIABETES MELLITUS;HORMONE;INSULIN;HEART FAILURE;IN VIVO;ANTIBODY;BODY MASS INDEX;LESION;MAGNETIC RESONANCE IMAGING;AMINO ACID;IMMUNE SYSTEM;IMMUNOHISTOCHEMISTRY;ASYMPTOMATIC;BIOPSY;MYOCARDIAL INFARCTION;POPULATION;PREGNANCY","22;22;18;16;16;14;13;11;11;11;9;8;7;7;7;7;6;6;6;5;5;5;5;5","PLACEBO;DIASTOLE;GENOTYPE;MUTATION;ALKALINE PHOSPHATASE;CARDIAC FUNCTION CURVE;HEART RATE;BASAL (MEDICINE);BREAST CANCER;COLORECTAL CANCER;GROWTH HORMONE;IMMUNOSTAINING;TYPE 2 DIABETES;ALLELE;CROHN'S DISEASE;EJECTION FRACTION;ERYTHROCYTE MEMBRANE;HAEMATOPOIESIS;INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;INTIMA-MEDIA THICKNESS;POLYUNSATURATED FATTY ACID;PROLACTIN;RESTENOSIS;SOMATOSTATIN RECEPTOR;T CELL;WHITE MATTER","10;9;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","DOPPLER ECHOCARDIOGRAPHY;ACROMEGALY;COLONOSCOPY;DIASTOLIC FUNCTION;NEOINTIMA;ASPARTATE TRANSAMINASE;DOUBLE BLIND;METHACHOLINE;METHYLENETETRAHYDROFOLATE REDUCTASE;MISSENSE MUTATION;NEOINTIMAL HYPERPLASIA;OSTEOCALCIN;5-HT RECEPTOR;ABDUCENS NERVE;AEROMONAS CAVIAE;AMINE OXIDASE (COPPER-CONTAINING);ANDROGEN RECEPTOR;ANDROSTENEDIONE;ANEUPLOIDY;APGAR SCORE;AROMATASE;AUTONOMIC NERVOUS SYSTEM;BONE MARROW TRANSPLANT;BRONCHIAL HYPERRESPONSIVENESS;BRONCHUS;CARDIAC INDEX;CD28;CD3;CD40;CD86;CENTRAL PRECOCIOUS PUBERTY;CERIC AMMONIUM NITRATE;CHROMATID;CHRONIC GASTRITIS;CONTIG;CROSSOVER STUDY;CYSTATHIONINE BETA SYNTHASE;DIAGNOSTIC PERITONEAL LAVAGE;DIESEL CYCLE;DOPPLER IMAGING;EATING DISORDER INVENTORY;EDMAN DEGRADATION;ENALAPRIL;ENTEROPATHOGENIC ESCHERICHIA COLI;ENTEROTOXIN;ESTROGEN RECEPTOR;FATAL FAMILIAL INSOMNIA;FOLLICLE-STIMULATING HORMONE;FUSION PROTEIN;FYN;GALLOPAMIL;GASTRO-;GENETIC HETEROGENEITY;GENETIC VARIANTS;GERD;GERMLINE MUTATION;GLYCEMIC INDEX;GONADOTROPIN-RELEASING HORMONE;GREY MATTER;HAPLOTYPE;HEART RATE VARIABILITY;HEARTBURN;HEPATIC LIPASE;HEREDITARY SPASTIC PARAPLEGIA;HERPESVIRIDAE;HETEROPLASMY;HISTONE DEACETYLASE;HMG-COA REDUCTASE;HYPERINSULINEMIA;INFLAMMATORY BOWEL DISEASES;INSULIN-LIKE GROWTH FACTOR;INTERATRIAL SEPTUM;INTERCELLULAR ADHESION MOLECULE;ISCHEMIC CARDIOMYOPATHY;ISRADIPINE;LACIDIPINE;LAMINOPLASTY;LEIGH DISEASE;LEISHMANIA INFANTUM;LEYDIG CELL;LIPOPROTEIN(A);MEGAKARYOCYTE;MOLECULAR EPIDEMIOLOGY;MOLECULAR MEDICINE;MORBID OBESITY;MYOTOMY;NASAL PROVOCATION TEST;NUCLEAR PROTEIN;OLIGOARTHRITIS;OPIOID RECEPTOR;ORNITHINE;OSSIFICATION OF THE POSTERIOR LONGITUDINAL LIGAMENT;OSTEOPENIA;PANCREATIC HORMONE;PERCEPTUAL DISORDERS;PLASMA PARAMETER;POLYMORPHISM (COMPUTER SCIENCE);PRIMARY TUMOR;PROTEIN LOSING ENTEROPATHY;PROTEIN-TYROSINE KINASES;PSYCHOLOGICAL REPRESSION;PULSED-FIELD GEL ELECTROPHORESIS;REPRESSOR;RESPIRATORY RATE;RILMENIDINE;SCRAPIE;SHELLFISH;SILENT PERIOD;SINGLE-NUCLEOTIDE POLYMORPHISM;SINGLE-STRAND CONFORMATION POLYMORPHISM;SPHEROCYTOSIS;SPINAL CANAL STENOSIS;SRC FAMILY KINASE;STAPHYLOCOCCAL INFECTIONS;STAPHYLOCOCCUS EPIDERMIDIS;STREPTOCOCCUS THERMOPHILUS;STRUCTURAL GENE;SYSTOLE;T-CELL RECEPTOR;THIORPHAN;THYMIC INVOLUTION;TRANSSPHENOIDAL SURGERY;TROCHLEAR NERVE;UTERINE ARTERY;VARICOCELE;VERY LOW-DENSITY LIPOPROTEIN;VILLOUS ATROPHY","6;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;;AGED;ADOLESCENT;HUMAN GROWTH HORMONE;ANIMALS;ITALY;CHILD;BLOOD PRESSURE;INSULIN;DIABETES MELLITUS, TYPE 1;BREAST NEOPLASMS;CHILD, PRESCHOOL;HYPERTENSION;IMMUNOSUPPRESSIVE AGENTS;TUNICA INTIMA","133;98;88;66;58;50;34;26;20;19;19;18;16;16;14;13;13;13;13;13","ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;CHOLESTEROL-LOWERING TREATMENT;AMINO ACID TRANSPORT AND METABOLISM IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF NEUROENDOCRINE TUMORS;GENETIC AND CLINICAL ASPECTS OF HEMOGLOBIN DISORDERS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MITOCHONDRIAL DYNAMICS AND REACTIVE OXYGEN SPECIES REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME;ADVANCES IN METABOLOMICS RESEARCH;ANALYSIS AND APPLICATIONS OF HEART RATE VARIABILITY;BLOOD RHEOLOGY AND COAGULATION MECHANISMS;CHOLESTEROL METABOLISM AND ATHEROSCLEROSIS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION","5;5;5;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","HYPERTENSION;DIABETES;INSULIN RESISTANCE;LEFT VENTRICULAR FUNCTION;GROWTH HORMONE;BASAL (MEDICINE);CARDIAC IMAGING;DIAGNOSIS;IMMUNOSTAINING;ISOVOLUMIC RELAXATION TIME;CREATINE KINASE;ECHOCARDIOGRAPHY;HOMOCYSTEINE;INTIMA-MEDIA THICKNESS;NEOINTIMA;OUTPATIENT CLINIC;PATHOGENESIS;SOMATOSTATIN RECEPTOR;ACROMEGALY;ASPARTATE TRANSAMINASE","8;6;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2","GROWTH HORMONE;LEFT VENTRICULAR;CHEMINFORM ABSTRACT;HEART DISEASE;CELL PROLIFERATION;ERYTHROCYTE MEMBRANE;MEMBRANE FATTY;VENTRICULAR DIASTOLIC;CORONARY HEART;CROHNS DISEASE;SOMATOSTATIN RECEPTOR;TYPE DIABETES;ABSTRACT SYNTHESIS;ACID COMPOSITION;ACIDS EFFECTS;AUTOIMMUNE DISEASES;AUTOMATED SEGMENTATION;BLOOD PRESSURE;CARDIAC STATUS;CENTRAL PRECOCIOUS;CLINICAL QUIZ;COELIAC DISEASE;COLLAGEN TURNOVER;D-ASPARTIC ACID;DELAYED PRESENTATION;DIABETES MELLITUS;DIAPHRAGMATIC AVULSION;DIASTOLIC FUNCTION;DIFFERENTIATING RAT;ECHOCARDIOGRAPHIC EVALUATION","7;7;6;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","SECONDARY CFC;BLOOD PRESSURE;LEFT VENTRICULAR;GH TREATMENT;HYPERTENSIVE PATIENTS;TUMOR CELLS;EA RATIO;NERVOUS SYSTEM;THYROID VOLUME;AGE YR;AMINO ACID;CULTURED TUMOR;EXPRESSED SST;BODY MASS;CELIAC DISEASE;CONTROL SUBJECTS;DIASTOLIC FUNCTION;GH ADMINISTRATION;GH EXPOSURE;HEART DISEASE;HEART RATE;HORMONE REPLACEMENT;MASS INDEX;REPLACEMENT THERAPY;SERUM INSULIN;SS RECEPTOR;VENTRICULAR MASS;BREAST CANCER;CELLS EXPRESSED;COLLAGEN TURNOVER","14;9;9;8;8;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5;5;5;4;4;4",17,0.09,3.25,5,1,2,0,2,4.5,0,1.75,5,0,0,5,1.75,1.75,0,2,2,2,0,0,30,30,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2001,172,7.13372093023256,3.02325581395349,0.563953488372093,0.412790697674419,0.569767441860465,1.31313131313131,1.18292682926829,1.18333333333333,1.20987654320988,0.267441860465116,13,74,57,10,14,0.43,0.33,0.06,0.08,48.04,1.05139294851674,NA,0.267441860465116,0.604651162790698,0.391,0.317,0.33,0.316,"ANNAMARIA STAIANO;ALFREDO GUARINO;GIOVANNI DE SIMONE;ALDO CELENTANO;G. MAZZACCA;GAETANO LOMBARDI;FABRIZIO PASANISI;FRANCO CONTALDO;PAOLA IOVINO;VINCENZO BONIFATI;MARCO DURANTE;LUCIO SANTORO;ROSARIO PIVONELLO;FRANCESCO DI SALLE;CAROLINA CIACCI;G. MECO;EUGENIA BRUZZESE;ANNAMARIA COLAO;LIBUSE TAUCHMANOVÀ;PAOLO BARONE","7;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3","ANNAMARIA STAIANO;ALFREDO GUARINO;L FERRARA;LUCA MARTIRANI;F. ALBANO;SALVATORE CUCCHIARA;FEDERICO PISCIONE;NICOLA DE LUCA;PAOLO MAURIELLO;E BRUZZESE A GUARINO;D. PATELLA;MARIO MUSELLA;RAFFAELE IZZO;MARIA CAROLINA SALERNO;CARLO BRIGUORI;P BIANCO;EVELINA TOSCANO;GIOVANNI DE SIMONE;ALDO CELENTANO;MARCO DURANTE","2.17;1.95;1.25;1.2;1.2;1.14;1.11;1.1;1;1;1;1;1;1;1;1;1;0.93;0.93;0.93","ANNAMARIA STAIANO;ALFREDO GUARINO;GIOVANNI DE SIMONE;ALDO CELENTANO;G. MAZZACCA;GAETANO LOMBARDI;FABRIZIO PASANISI;FRANCO CONTALDO;PAOLA IOVINO;MARCO DURANTE;LUCIO SANTORO;ROSARIO PIVONELLO;FRANCESCO DI SALLE;CAROLINA CIACCI;EUGENIA BRUZZESE;ANNAMARIA COLAO;LIBUSE TAUCHMANOVÀ;PAOLO BARONE;I PIETROPAOLO;ANTONGIULIO FAGGIANO","7;6;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3","ANNAMARIA STAIANO;ALFREDO GUARINO;L FERRARA;LUCA MARTIRANI;F. ALBANO;SALVATORE CUCCHIARA;FEDERICO PISCIONE;NICOLA DE LUCA;E BRUZZESE A GUARINO;D. PATELLA;MARIO MUSELLA;RAFFAELE IZZO;MARIA CAROLINA SALERNO;CARLO BRIGUORI;P BIANCO;EVELINA TOSCANO;GIOVANNI DE SIMONE;ALDO CELENTANO;MARCO DURANTE;EUGENIA BRUZZESE","2.17;1.95;1.25;1.2;1.2;1.14;1.11;1.1;1;1;1;1;1;1;1;1;0.93;0.93;0.93;0.75","GABRIELE RICCARDI;A. MAFFETONE;A.A. RIVELLESE;ANNE LOUHERANTA;B. VESSBY;BIRTHE M. RASMUSSEN;CECILIA NÄLSÉN;ERIK MORRE PEDERSEN;G. D. CALVERT;INGA‐BRITT GUSTAFSSON;KJELD HERMANSEN;L. H. STORLIEN;LARS BERGLUND;LINDA C TAPSELL;M UUSITUPA;GAETANO LOMBARDI;ANNAMARIA COLAO;GIOVANNI DE SIMONE;FABRIZIO PASANISI;FRANCO CONTALDO","1175;1119;1119;1119;1119;1119;1119;1119;1119;1119;1119;1119;1119;1119;1119;504;389;354;350;350","GABRIELE RICCARDI;A. MAFFETONE;A.A. RIVELLESE;FABRIZIO PASANISI;FERNANDO PARDO;LUIGI SACCÀ;VINCENZO GUARDASOLE;ANTONIO PISANI;DOMENICO RUSSO;GIUSEPPE SIGNORIELLO;M BALLETTA;MICHELE ANDREUCCI;RAFFAELA ESPOSITO;ROBERTO MINUTOLO;BRUNO TRIMARCO;CARLO DUILIO;CARMINE VECCHIONE;GIACOMO FRATI;GIUSEPPE LEMBO;FRANCESCO DI SALLE","1175;1119;1119;350;258;258;258;245;245;245;245;245;245;245;243;243;243;243;243;215","ANNAMARIA STAIANO;ALFREDO GUARINO;ALDO CELENTANO;ANNAMARIA COLAO;FABRIZIO PASANISI;GIOVANNI DE SIMONE;PAOLA IOVINO;GAETANO LOMBARDI;LUCIO SANTORO;MARCO DURANTE;G. MAZZACCA;GABRIELE RICCARDI;MARIA DI MEO;ALESSANDRO FILLA;CLAUDIA TROISE;EUGENIA BRUZZESE;FRANCESCO MANGUSO;GABRIELLA FABBROCINI;GENEROSO ANDRIA;GIUSEPPE DE MICHELE","7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;PSYCHOLOGY;MATHEMATICS;GEOLOGY;ECONOMICS;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;POLITICAL SCIENCE;ART;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY;SOCIOLOGY","141;53;28;21;10;9;7;6;5;5;3;3;3;2;2;1;1;1","INTERNAL MEDICINE;ENDOCRINOLOGY;PATHOLOGY;SURGERY;GENETICS;CARDIOLOGY;BIOCHEMISTRY;GASTROENTEROLOGY;IMMUNOLOGY;PEDIATRICS;OPTICS;ENVIRONMENTAL HEALTH;ANESTHESIA;PSYCHIATRY;INTENSIVE CARE MEDICINE;QUANTUM MECHANICS;CELL BIOLOGY;RADIOLOGY;MICROBIOLOGY;ORGANIC CHEMISTRY","108;43;30;30;28;27;26;19;19;18;17;12;10;10;9;9;7;7;6;6","DISEASE;GENE;HORMONE;INSULIN;BLOOD PRESSURE;DIABETES MELLITUS;ENZYME;POPULATION;BODY MASS INDEX;INCIDENCE (GEOMETRY);RECEPTOR;CANCER;NEUROLOGY;IMMUNE SYSTEM;ANTIBODY;ANTIGEN;BIOPSY;CHOLESTEROL;DIARRHEA;IMMUNOHISTOCHEMISTRY;PREGNANCY","21;21;14;13;12;11;11;11;9;9;9;8;8;7;6;6;6;6;6;6;6","INSULIN RESISTANCE;HEART RATE;GENOTYPE;MUTATION;PARKINSON'S DISEASE;BASAL (MEDICINE);CD8;DIASTOLE;ESCHERICHIA COLI;GROWTH HORMONE;NEURORADIOLOGY;PARKINSONISM;T CELL;TYPE 2 DIABETES;ALLELE;BACILLUS SUBTILIS;BREAST CANCER;CHROMOSOME;EJECTION FRACTION;FETUS;OVERWEIGHT;PLACEBO;ULCERATIVE COLITIS;WEIGHT LOSS","9;6;5;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","POLYCYSTIC OVARY;BARBUS;BOUGUER ANOMALY;CABERGOLINE;CD3;CLAUDICATION;GASTRIC BYPASS;GROEL;HYPERINSULINEMIA;IDIOPATHIC SHORT STATURE;INSULIN-LIKE GROWTH FACTOR;INTERMITTENT CLAUDICATION;MAGMA CHAMBER;METHYLENETETRAHYDROFOLATE REDUCTASE;OPERON;PARKIN;PROBAND;STREPTOCOCCUS THERMOPHILUS;STROKE VOLUME;STRUCTURAL GENE;THERMUS THERMOPHILUS;TRANSSPHENOIDAL SURGERY","3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;ADULT;MIDDLE AGED;;AGED;ADOLESCENT;HYPERTENSION;ITALY;ANIMALS;HYPERTROPHY, LEFT VENTRICULAR;BLOOD GLUCOSE;CHILD;INSULIN;CELIAC DISEASE;BLOOD PRESSURE;BRAIN;IMMUNOHISTOCHEMISTRY;TIME FACTORS","118;90;79;68;56;42;36;30;23;22;16;16;15;15;15;14;13;12;12;12","DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;HEPATITIS C INFECTION AND TREATMENT;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;COPPER AND ZINC IN HEALTH AND DISEASE;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;ESOPHAGEAL INTERVENTION TECHNIQUES;ETIOLOGY AND MANAGEMENT OF PERITONEAL ADHESIONS;FEEDING DISORDERS IN CHILDREN WITH AUTISM SPECTRUM DISORDERS;GEOPHYSICAL EXPLORATION AND MONITORING TECHNIQUES;GLOBAL CANCER INCIDENCE AND MORTALITY PATTERNS;HEALTH EFFECTS OF TEA POLYPHENOLS;IMPORTANCE AND CONSERVATION OF FRESHWATER BIODIVERSITY","5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","HYPERTENSION;BASAL (MEDICINE);DIARRHEA;LEFT VENTRICULAR FUNCTION;NEURORADIOLOGY;PATHOGENESIS;CELIAC DISEASE;DIABETES;DIAGNOSIS;ENDOTHELIAL DYSFUNCTION;INSULIN RESISTANCE;TREATMENT;ULCERATIVE COLITIS;ABSORBANCE;ACUTE GASTROENTERITIS;ADRENAL VEIN SAMPLING;ANOMALY (PHYSICS);ATTENDANCE;BARBEL;BARBUS","6;5;5;5;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2","LEFT VENTRICULAR;CHEMINFORM ABSTRACT;SOUTHERN ITALY;VENTRICULAR MASS;BREAST CANCER;CAROTID ATHEROSCLEROSIS;GROWTH HORMONE;INAPPROPRIATE LEFT;ULCERATIVE COLITIS;ABNORMAL GH;ACUTE DIARRHEA;ACUTE DIARRHOEA;ADHESION MOLECULES;ALIEN SPECIES;BISMUTH SUBSALICYLATE;BOWEL SYNDROME;CAMPI FLEGREI;CANCER TREATMENT;CARE PEDIATRICIANS;CELIAC DISEASE;CENTRAL REGION;CLINICAL PICTURE;CLINICAL SIGNIFICANCE;CONTROLLED STUDY;CORIICEPS METALLOTHIONEIN;DNA-BINDING PROTEIN;ENDOSCOPIC SURGERY;ENTERIC INFECTIONS;ESTABLISHED ALIEN;FISH FAUNA","6;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","MITOCHONDRIAL ACTIVITY;FATTY ACID;GH RECEPTOR;ACID DIET;CONTROL SUBJECTS;FREE IGF-I;LEFT VENTRICULAR;NATRIURETIC PEPTIDE;BLOOD FLOW;BRAIN NATRIURETIC;CLINICAL EVIDENCE;GH INSENSITIVITY;HUMAN OOCYTES;IDIOPATHIC SHORT;SHORT STATURE;CELIAC DISEASE;PEPTIDE PLASMA;PLASMA LEVELS;TYROSINE PHOSPHORYLATION;CORONARY HEART;DISEASE PATIENTS;HEART DISEASE;IGF-I LEVELS;INSULIN SENSITIVITY;MATERNAL AGE;MONOUNSATURATED FATTY;RR MIN-;BODY MASS;BONE LOSS;BREAST CANCER","12;11;10;9;9;9;9;9;8;8;8;8;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5",22,0.13,6,4.5,4,1,0,2.75,8.75,0,1,4.5,0,1,44,4.75,4,0,9,30,5,0,0,55.5,55.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,18,60052.5,0.54,1,0.5,128,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1","CLINICAL RESEARCH;HEMATOLOGY;CANCER;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;RARE DISEASES;STEM CELL RESEARCH","2;2;1;1;1;1;1;1;1;1;1","CANCER","1","5.1 PHARMACEUTICALS;6.1 PHARMACEUTICALS;7.3 MANAGEMENT AND DECISION MAKING","1;1;1","BLOOD CANCER;LEUKEMIA / LEUKAEMIA","1;1","5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2002,201,7.38308457711443,3.14427860696517,0.552238805970149,0.45771144278607,0.587064676616915,1.34182590233546,1.20652173913043,1.22666666666667,1.21649484536082,0.263681592039801,8,82,58,13,29,0.41,0.29,0.06,0.14,46.91,0.850218759830468,NA,0.258706467661692,0.621890547263682,0.406,0.35,0.394,0.356,"ANNAMARIA COLAO;ENRICO DE DIVITIIS;PAOLO CAPPABIANCA;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;GAETANO LOMBARDI;LUIGI MARIA CAVALLO;BRUNO ROTOLI;LUIGI SACCÀ;SALVATORE PANICO;ROSARIO PIVONELLO;MAURIZIO GALDERISI;MARCO SALVATORE;KIM OVERVAD;LIBUSE TAUCHMANOVÀ;PAOLO BARONE;NADIA SLIMANI;GAETANO DE ROSA;STEFANIA STAIBANO;GENEROSO ANDRIA","10;8;8;8;7;7;5;5;5;5;5;5;5;4;4;4;4;4;4;4","GIOVANNI DE SIMONE;ENRICO DE DIVITIIS;PAOLO CAPPABIANCA;PAOLO MARZULLO;M PORCELLINI;MAURIZIO GALDERISI;LUIGI MARIA CAVALLO;ANTONIO CITTADINI;ANNAMARIA COLAO;PAOLO PAUCIULLO;CARLO AMIRANTE;SERGIO CAVALIERE;MASSIMO MORLINO;GIANPAOLO EVANGELISTA;DOMENICO RUSSO;GIUSEPPE DEL RE;GAETANO LOMBARDI;FRANCESCO MAIURI;PAOLO BARONE;MASSIMO CHIARIELLO","2.17;1.73;1.64;1.4;1.2;1.14;1.11;1.1;1.08;1;1;1;1;1;1;1;0.89;0.84;0.76;0.71","ANNAMARIA COLAO;ENRICO DE DIVITIIS;PAOLO CAPPABIANCA;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;GAETANO LOMBARDI;LUIGI MARIA CAVALLO;BRUNO ROTOLI;LUIGI SACCÀ;SALVATORE PANICO;ROSARIO PIVONELLO;MAURIZIO GALDERISI;MARCO SALVATORE;LIBUSE TAUCHMANOVÀ;PAOLO BARONE;STEFANIA STAIBANO;GENEROSO ANDRIA;SANDRO BETOCCHI;PAOLO MARZULLO;FRANCO CONTALDO","10;8;8;8;7;7;5;5;5;5;5;5;5;4;4;4;4;4;4;4","GIOVANNI DE SIMONE;ENRICO DE DIVITIIS;PAOLO CAPPABIANCA;PAOLO MARZULLO;M PORCELLINI;MAURIZIO GALDERISI;LUIGI MARIA CAVALLO;ANTONIO CITTADINI;ANNAMARIA COLAO;PAOLO PAUCIULLO;CARLO AMIRANTE;SERGIO CAVALIERE;MASSIMO MORLINO;GIANPAOLO EVANGELISTA;DOMENICO RUSSO;GIUSEPPE DEL RE;GAETANO LOMBARDI;FRANCESCO MAIURI;PAOLO BARONE;MASSIMO CHIARIELLO","2.17;1.73;1.64;1.4;1.2;1.14;1.11;1.1;1.08;1;1;1;1;1;1;1;0.89;0.84;0.76;0.71","ANNAMARIA COLAO;PAOLO CAPPABIANCA;ENRICO DE DIVITIIS;LUIGI MARIA CAVALLO;GAETANO LOMBARDI;LIBUSE TAUCHMANOVÀ;SALVATORE PANICO;ANNE TJØNNELAND;KIM OVERVAD;NADIA SLIMANI;GIOVANNI DE SIMONE;ELIO RÍBOLI;SERGIO FAZIO;FELICE ESPOSITO;H. BAS BUENO‐DE‐MESQUITA;RICCARDO ROSSI;DAVID E.J. LINDEN;RAINER GOEBEL;BERNADETTE BIONDI;CARLOS A. GONZÁLEZ","1579;1239;1228;1187;989;721;715;704;704;704;653;644;616;597;559;552;519;519;508;499","PAOLO CAPPABIANCA;ANNAMARIA COLAO;SALVATORE PANICO;SERGIO FAZIO;ENRICO DE DIVITIIS;LUIGI MARIA CAVALLO;FELICE ESPOSITO;GIOVANNI DE SIMONE;S. CIRILLO;EMILIANO-ANTONIO PALMIERI;GIUSEPPE LOMBARDI;MARIALAURA DEL BASSO DE;GAETANO LOMBARDI;FRANCESCO DI SALLE;BRUNO ROTOLI;PIETRO BUONO;PAOLO MARZULLO;ALFREDO PROCINO;CLEMENTE CILLO;LUCA CINDOLO","1187;782;715;616;610;606;597;553;424;408;334;334;326;321;236;220;218;206;206;206","ANNAMARIA COLAO;GIOVANNI DE SIMONE;PAOLO CAPPABIANCA;ENRICO DE DIVITIIS;GAETANO LOMBARDI;SALVATORE PANICO;PAOLO MARZULLO;CLAUDIO PIGNATA;LUIGI MARIA CAVALLO;LUIGI SACCÀ;MARCO SALVATORE;MAURIZIO GALDERISI;PAOLO BARONE;SERGIO FAZIO;ROSARIO PIVONELLO;SANDRO BETOCCHI;ALBA ROCCO;ALBERTO CUOCOLO;ALESSANDRO SETTIMI;BRUNO ROTOLI","9;7;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;PSYCHOLOGY;ECONOMICS;SOCIOLOGY;MATERIALS SCIENCE;ENGINEERING;ART;PHILOSOPHY;BUSINESS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY;POLITICAL SCIENCE","161;62;25;21;17;11;10;8;7;6;5;3;3;2;2;2;2;2","INTERNAL MEDICINE;ENDOCRINOLOGY;CARDIOLOGY;GENETICS;PATHOLOGY;SURGERY;RADIOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;PSYCHIATRY;IMMUNOLOGY;GASTROENTEROLOGY;MOLECULAR BIOLOGY;NEUROSCIENCE;PEDIATRICS;PHYSICAL THERAPY;COMBINATORIAL CHEMISTRY;ORGANIC CHEMISTRY;CANCER RESEARCH;ARTIFICIAL INTELLIGENCE;CELL BIOLOGY;MATHEMATICAL ANALYSIS;NUCLEAR MEDICINE;PHARMACOLOGY","125;50;36;34;32;31;25;24;19;18;17;15;10;10;9;9;8;8;7;6;6;6;6;6","GENE;BLOOD PRESSURE;DISEASE;POPULATION;RECEPTOR;HEART FAILURE;HORMONE;BODY MASS INDEX;DIABETES MELLITUS;CANCER;ENZYME;ADENOMA;ALTERNATIVE MEDICINE;ENDOSCOPY;HEMODYNAMICS;IMMUNE SYSTEM;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;ATROPHY;CATALYSIS;CONFIDENCE INTERVAL;INSULIN;NITRIC OXIDE;OBESITY;ODDS RATIO;PREGNANCY;PROSPECTIVE COHORT STUDY","25;23;19;18;13;12;12;11;10;9;8;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5","DIASTOLE;LEFT VENTRICULAR HYPERTROPHY;EJECTION FRACTION;GENE EXPRESSION;GROWTH HORMONE;MUTATION;PITUITARY ADENOMA;INSULIN RESISTANCE;EXON;PLACEBO;RNA;AGE OF ONSET;ALZHEIMER'S DISEASE;ANGIOTENSIN-CONVERTING ENZYME;BONE MINERAL;CHEMOTAXIS;COELIAC DISEASE;COMPLEMENTARY DNA;DEGENERATIVE DISEASE;DEMENTIA;DOPAMINERGIC;ENDOCRINE SYSTEM;ENDOSCOPIC ENDONASAL SURGERY;ESSENTIAL HYPERTENSION;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;FETUS;GASTRITIS;GENOTYPE;HEART RATE;INTRON;T CELL;THYROID FUNCTION;TRANSCRIPTION FACTOR;WHITE MATTER","13;9;6;6;6;6;6;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","TRANSSPHENOIDAL SURGERY;ACROMEGALY;DIASTOLIC FUNCTION;COMPOUND HETEROZYGOSITY;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;ENALAPRIL;STROKE VOLUME;ALTERNATIVE SPLICING;COMPONENT-BASED SOFTWARE ENGINEERING;DISCRETE WAVELET TRANSFORM;FRACTIONAL SHORTENING;FRAMESHIFT MUTATION;GLUCOSE HOMEOSTASIS;HOX GENE;IMPAIRED GLUCOSE TOLERANCE;ISOVOLUMETRIC CONTRACTION;LOSARTAN;MISSENSE MUTATION;PRENATAL DIAGNOSIS;RIGHT CORONARY ARTERY;RNA SPLICING;SOFTWARE CONSTRUCTION;UNTRANSLATED REGION;WAVELET PACKET DECOMPOSITION","6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;ADULT;MIDDLE AGED;;AGED;HYPERTENSION;HYPERTROPHY, LEFT VENTRICULAR;ADOLESCENT;ADENOMA;ITALY;HUMAN GROWTH HORMONE;RNA, MESSENGER;TIME FACTORS;ANIMALS;CAROTID ARTERY DISEASES;CHILD;DNA;ECHOCARDIOGRAPHY","143;106;105;80;75;46;41;30;26;21;19;18;17;17;17;15;15;15;15;15","DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EPILEPSY AND SEIZURES;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;ASTHMA;BIOLOGICAL PROPERTIES OF ALOE VERA AND RELATED COMPOUNDS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;EATING DISORDERS AND BODY IMAGE CONCERNS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIDEMIOLOGY AND TREATMENT OF MENINGIOMAS;HETEROCYCLIC COMPOUNDS FOR DRUG DISCOVERY;IMAGE DENOISING TECHNIQUES AND ALGORITHMS","9;6;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","LEFT VENTRICULAR FUNCTION;HYPERTENSION;TRANSSPHENOIDAL SURGERY;ECHOCARDIOGRAPHY;TREATMENT;ACROMEGALY;HEART RATE VARIABILITY;METABOLISM;SUBCLINICAL INFECTION;B CELL ABNORMALITIES;BLOOD PRESSURE;CARDIAC IMAGING;CARDIAC METABOLISM;CAROTID INTIMA-MEDIA THICKNESS;COMPOUND HETEROZYGOSITY;DIABETES;DIASTOLIC FUNCTION;DOPPLER IMAGING;ENDOSCOPIC ENDONASAL SURGERY;ESSENTIAL HYPERTENSION","12;9;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","LEFT VENTRICULAR;CHEMINFORM ABSTRACT;BLOOD PRESSURE;ENDONASAL TRANSSPHENOIDAL;ENDOSCOPIC ENDONASAL;GROWTH HORMONE;HYPERTROPHIC CARDIOMYOPATHY;COELIAC DISEASE;EUROPEAN PROSPECTIVE;GROWTH FACTOR;MYOCARDIAL INFARCTION;NUTRITION EPIC;PROSPECTIVE INVESTIGATION;TRANSSPHENOIDAL APPROACH;VENTRICULAR FUNCTION;VENTRICULAR MASS;ABSTRACT SYNTHESIS;ACTIVE COMPONENT;ACUTE MYOCARDIAL;ALZHEIMERS DISEASE;ANOREXIA NERVOSA;ARTERIAL SYSTEMIC;BONE MARROW;CARDIAC MORPHOLOGY;CAROTID ARTERY;CAROTID ATHEROSCLEROSIS;CHAIN GENE;CLINICAL EXPERIENCE;COMPARATIVE EFFECTS;DIABETES MELLITUS","10;8;4;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","PUBMED SCOPUS;SPLICE SITE;CROSSREF PUBMED;CBS INS;CHOLESTEROL BIOSYNTHESIS;LEFT VENTRICULAR;DISTAL SPLICE;INS CONTEXT;GENET -CROSSREF;BLOOD PRESSURE;CBS ΔG-G;HUM GENET;LV MASS;PROXIMAL SPLICE;COELIAC DISEASE;KELLEY RI;PUBMED GOOGLE;SLO SYNDROME;AORTIC VALVE;AUTOSOMAL RECESSIVE;MASS INDEX;INS INSERTION;BP INSERTION;BROUGHT CLOSE;CELL HISTIOCYTOSIS;HEAVY CHAIN;KELLEY KELLEY;LANGERHANS CELL;SITE SELECTION;Μ HEAVY","56;52;50;28;19;17;15;15;13;12;12;12;12;12;11;11;11;11;10;10;10;9;8;8;8;8;8;8;8;8",29,0.14,3,3,13,1,0,1,3,0,1,3,1,0,1,2,4.5,1,1,1,1,0,0,59,59,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2003,228,7.62280701754386,3.1140350877193,0.574561403508772,0.469298245614035,0.574561403508772,1.39566929133858,1.20183486238532,1.27380952380952,1.20183486238532,0.241228070175439,12,116,52,16,24,0.51,0.23,0.07,0.11,46.9,0.886177370600828,NA,0.228070175438596,0.609649122807018,0.424,0.368,0.391,0.371,"GIOVANNI DE SIMONE;VITTORIO PALMIERI;MAURIZIO GALDERISI;MARCO SALVATORE;ANNAMARIA COLAO;GABRIELE RICCARDI;D. PALADINI;GAETANO LOMBARDI;BRUNO ROTOLI;SALVATORE PANICO;FRANCO CONTALDO;MASSIMO CHIARIELLO;FABRIZIO PASANISI;SILVANA CICALA;ANGELA A. RIVELLESE;GENEROSO ANDRIA;FRANCO BERRINO;­ROSARIO ­TUMINO;LUCIO SANTORO;ROSARIO PIVONELLO","10;8;8;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5","D. PALADINI;ANTONIO CITTADINI;VITTORIO PALMIERI;GIOVANNI DE SIMONE;MAURIZIO GALDERISI;FRANCO CONTALDO;MARCO SALVATORE;PAOLO STASSANO;PAOLO RUBBA;L. ROMIS;FABRIZIO PASANISI;GABRIELE RICCARDI;ROBERTO MINUTOLO;G. CIMINO;ELENA CARDONA;PASQUALE INNELLI;SERGIO BRAVI;ALESSANDRO GARASSINO;ANNAMARIA STAIANO;ANTONIO DE MAIO","2.28;2.19;1.9;1.47;1.23;1.19;1.17;1.17;1.16;1.12;1.08;1.03;1;1;1;1;1;1;1;0.83","GIOVANNI DE SIMONE;VITTORIO PALMIERI;MAURIZIO GALDERISI;MARCO SALVATORE;ANNAMARIA COLAO;GABRIELE RICCARDI;D. PALADINI;GAETANO LOMBARDI;BRUNO ROTOLI;SALVATORE PANICO;FRANCO CONTALDO;MASSIMO CHIARIELLO;FABRIZIO PASANISI;SILVANA CICALA;ANGELA A. RIVELLESE;GENEROSO ANDRIA;LUCIO SANTORO;ROSARIO PIVONELLO;ALDO CELENTANO;P. BOCCELLA","10;8;8;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;4","D. PALADINI;ANTONIO CITTADINI;VITTORIO PALMIERI;GIOVANNI DE SIMONE;MAURIZIO GALDERISI;FRANCO CONTALDO;MARCO SALVATORE;PAOLO STASSANO;PAOLO RUBBA;L. ROMIS;FABRIZIO PASANISI;GABRIELE RICCARDI;ROBERTO MINUTOLO;G. CIMINO;ELENA CARDONA;PASQUALE INNELLI;SERGIO BRAVI;ANNAMARIA STAIANO;ANTONIO DE MAIO;GAETANO LOMBARDI","2.28;2.19;1.9;1.47;1.23;1.19;1.17;1.17;1.16;1.12;1.08;1.03;1;1;1;1;1;1;0.83;0.83","ANNAMARIA COLAO;GAETANO LOMBARDI;ANTONIO CITTADINI;ANTONIO SILVESTRO;GREGORIO BREVETTI;MASSIMO CHIARIELLO;SALVATORE AURICCHIO;VITTORIO SCHIANO;VALERIA RAIA;CAROLINA CIACCI;IDA RICCIARDELLI;J PICARD;LOREDANA VACCA;LUIGI MAIURI;MARCO LONDEI;MOHAMED OSMAN;SONIA QUARATINO;SALVATORE PANICO;DOMENICO PALLI;FRANCO BERRINO","937;828;817;792;792;783;762;721;700;602;602;602;602;602;602;602;602;565;542;542","ANTONIO CITTADINI;ANNAMARIA COLAO;GREGORIO BREVETTI;GAETANO LOMBARDI;CAROLINA CIACCI;IDA RICCIARDELLI;LOREDANA VACCA;VALERIA RAIA;ANTONIO SILVESTRO;VITTORIO SCHIANO;MASSIMO CHIARIELLO;FRANCESCO DI SALLE;ANGELA A. RIVELLESE;GIANCARLO PARENTI;SALVATORE PANICO;GABRIELE RICCARDI;IDA ANNUNZIATA;CAROLINA DI SOMMA;MARIA CRISTINA DE MARTINO;MARIAGIOVANNA FILIPPELLA","817;711;627;622;602;602;602;602;556;556;498;477;454;435;430;426;360;333;333;333","D. PALADINI;GIOVANNI DE SIMONE;ANNAMARIA COLAO;GABRIELE RICCARDI;MAURIZIO GALDERISI;VITTORIO PALMIERI;GENEROSO ANDRIA;ALDO CELENTANO;ANGELA A. RIVELLESE;ANTONIO CITTADINI;GAETANO LOMBARDI;LUCIO SANTORO;SALVATORE PANICO;ANTONIETTA D’ERRICO;MARCELLO CHINALI;P. BOCCELLA;PASQUALE STRIANO;SALVATORE STRIANO;FRANCO CONTALDO;MARCO SALVATORE","7;7;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;SOCIOLOGY;PSYCHOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;ART;ENVIRONMENTAL SCIENCE;GEOLOGY;POLITICAL SCIENCE;GEOGRAPHY;HISTORY","194;81;36;30;16;13;12;10;7;6;5;5;3;3;2;2;1;1","INTERNAL MEDICINE;CARDIOLOGY;ENDOCRINOLOGY;PATHOLOGY;GENETICS;BIOCHEMISTRY;IMMUNOLOGY;SURGERY;ENVIRONMENTAL HEALTH;RADIOLOGY;GASTROENTEROLOGY;PEDIATRICS;PSYCHIATRY;NUCLEAR MEDICINE;OPTICS;CELL BIOLOGY;ANATOMY;ANESTHESIA;ORGANIC CHEMISTRY;DEMOGRAPHY","151;52;49;44;43;41;34;32;20;20;19;17;15;13;13;12;11;11;10;9","GENE;BLOOD PRESSURE;BODY MASS INDEX;POPULATION;DISEASE;CANCER;MYOCARDIAL INFARCTION;RECEPTOR;HEART FAILURE;OBESITY;ANTIBODY;ENZYME;DIABETES MELLITUS;PREGNANCY;ANTIGEN;HORMONE;ALTERNATIVE MEDICINE;CHOLESTEROL;IMMUNE SYSTEM;INCIDENCE (GEOMETRY)","36;20;19;18;17;16;14;14;13;13;12;12;11;11;10;10;9;9;9;9","EJECTION FRACTION;FETUS;MUTATION;BREAST CANCER;HEART RATE;INSULIN RESISTANCE;OVERWEIGHT;PHENOTYPE;PLACEBO;ALLELE;ARTERIAL DISEASE;BRACHIAL ARTERY;CHROMOSOME;GROWTH HORMONE;RECOMBINANT DNA;CARDIOMYOPATHY;CORONARY FLOW RESERVE;DIASTOLE;EPITOPE;GENOTYPE;GESTATIONAL AGE;INTIMA-MEDIA THICKNESS;LIPOPROTEIN;REVASCULARIZATION;VIRAL DISEASE","8;8;8;6;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4","ACROMEGALY;PRENATAL DIAGNOSIS;STROKE VOLUME;DOPPLER ECHOCARDIOGRAPHY;OSTEOCALCIN;POLYCYSTIC OVARY;POLYMORPHISM (COMPUTER SCIENCE);ALLELE FREQUENCY;ANEUPLOIDY;ANTIRETROVIRAL THERAPY;CARIDEA;CARTILAGE OLIGOMERIC MATRIX PROTEIN;COLONOSCOPY;DIASTOLIC FUNCTION;ESTROGEN RECEPTOR;FORAMEN OVALE (HEART);FRACTIONAL FLOW RESERVE;IN UTERO;INSULIN-LIKE GROWTH FACTOR;INTERATRIAL SEPTUM;LDL RECEPTOR;MALACOSTRACA;MAMMOGRAPHY;NOISE-INDUCED HEARING LOSS;OFF-PUMP CORONARY ARTERY BYPASS;PALAEMONIDAE;POINT MUTATION;SIDA;TENASCIN;THIOBARBITURIC ACID;THORACICA","4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;;AGED;OBESITY;ITALY;HYPERTENSION;ANIMALS;ADOLESCENT;MYOCARDIAL INFARCTION;BREAST NEOPLASMS;CARDIOVASCULAR DISEASES;HYPERTROPHY, LEFT VENTRICULAR;PERIPHERAL VASCULAR DISEASES;RISK FACTORS;CHILD;RETROSPECTIVE STUDIES","155;116;115;84;80;55;47;33;29;25;24;22;20;19;19;19;18;18;16;16","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;BODY COMPOSITION ASSESSMENT AND ANALYSIS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;HEPATITIS C INFECTION AND TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;CHEMICAL KINETICS OF COMBUSTION PROCESSES;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEVELOPMENT AND APPLICATIONS OF RADIOPHARMACEUTICALS;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;DIAGNOSIS AND MANAGEMENT OF CARDIAC TUMORS;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS","10;7;6;6;6;5;4;4;3;3;3;3;2;2;2;2;2;2;2;2","CARDIAC IMAGING;LEFT VENTRICULAR FUNCTION;CARDIOVASCULAR RISK ASSESSMENT;HYPERTENSION;ECHOCARDIOGRAPHY;GLUTEN SENSITIVITY;PERIPHERAL ARTERIAL DISEASE;BIOELECTRICAL IMPEDANCE ANALYSIS;BODY MASS INDEX;BRACHIAL ARTERY;TREATMENT;ACROMEGALY;ARTERIAL STIFFNESS;CORONARY FLOW RESERVE;ENDOTHELIAL DYSFUNCTION;FETAL ECHOCARDIOGRAPHY;INTIMA-MEDIA THICKNESS;OBESITY;PRENATAL DIAGNOSIS;STROKE (ENGINE)","10;10;8;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4","LEFT VENTRICULAR;CARDIOVASCULAR RISK;CORONARY FLOW;PERIPHERAL ARTERIAL;RISK FACTORS;ARTERIAL DISEASE;CELIAC DISEASE;FLOW RESERVE;HYPERTENSIVE PATIENTS;VENTRICULAR MASS;BREAST CANCER;GROWTH HORMONE;HEART FAILURE;LIZARD PODARCIS;MYOCARDIAL INFARCTION;PODARCIS SICULA;SOMATOSTATIN ANALOGS;ACID BALANCE;ACOUSTIC DENSITY;ACUTE MYOCARDIAL;ANOREXIA NERVOSA;ANTIRETROVIRAL THERAPY;ARTERY DISEASE;BILE DUCT;BIOCHEMICAL STUDY;BIOELECTRICAL IMPEDANCE;BIOIMPEDANCE ANALYSIS;BLEEDING ADVANTAGE;BODY MASS;CARDIAC MYXOMA","12;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","LEFT VENTRICULAR;CORONARY FLOW;VENTRICULAR MASS;HEART FAILURE;BODY MASS;BRACHIAL ARTERY;REACTIVE HYPEREMIA;FLOW RESERVE;LUNG CANCER;ALLOGENEIC SCT;AVASCULAR NECROSIS;CANCER RISK;FAT MASS;MASS INDEX;MINERAL WATER;NATURAL MINERAL;NYHA CLASS;PROSTATE CANCER;SF PATIENTS;SUBARACHNOID SPACES;ADIPONECTIN LEVELS;AFRICAN ORIGIN;ANOREXIA NERVOSA;CONTROL SUBJECTS;DISEASE ACTIVITY;ENDOTHELIAL FUNCTION;FETAL ECHOCARDIOGRAPHY;GESTATIONAL AGE;GONADAL STATUS;ION TRANSPORT","15;9;9;8;7;7;7;6;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4",33,0.14,9,6,7,1.5,0,1.5,5,1,1,7,0,1,3.5,1,5,0,2,4,1,0,0,91,91,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2004,241,7.42323651452282,3.05809128630705,0.58091286307054,0.410788381742739,0.622406639004149,1.44597249508841,1.28440366972477,1.33783783783784,1.28205128205128,0.190871369294606,12,108,66,21,28,0.45,0.27,0.09,0.12,36.4,0.773638563845859,NA,0.307053941908714,0.655601659751037,0.418,0.343,0.347,0.361,"BRUNO TRIMARCO;GIOVANNI DE SIMONE;VITTORIO PALMIERI;MARCO DURANTE;GAETANO LOMBARDI;FRANCESCO ORIO;BRUNO ROTOLI;PASQUALE STRAZZULLO;ANGELA A. RIVELLESE;GABRIELE RICCARDI;ORESTE DE DIVITIIS;MAURIZIO GALDERISI;MARCO SALVATORE;R. DI PALO;D. PALADINI;MASSIMO CHIARIELLO;ANNAMARIA COLAO;LIBUSE TAUCHMANOVÀ;DANIELA MELIS;PAOLO GASPARINI","10;7;6;6;6;5;5;5;5;5;5;5;5;5;5;5;4;4;4;4","FRANCO CONTALDO;GUGLIELMO BORGIA;BRUNO TRIMARCO;VITTORIO PALMIERI;B. GASPARRINI;L. ZICARELLI;MARCO DURANTE;DANIELA MELIS;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;BJÖRN DAHLÖF;NICOLA PASQUINO;ANTONINO DRAGO;A DEBLASIO;MAIK HORSTMANN;D. PALADINI;G. OBE;ANGELA A. RIVELLESE;ENRICO DE DIVITIIS;R. DI PALO","2.42;2;1.83;1.6;1.49;1.45;1.4;1.36;1.09;1.01;1;1;1;1;0.98;0.93;0.9;0.87;0.83;0.83","BRUNO TRIMARCO;GIOVANNI DE SIMONE;VITTORIO PALMIERI;MARCO DURANTE;GAETANO LOMBARDI;FRANCESCO ORIO;BRUNO ROTOLI;PASQUALE STRAZZULLO;ANGELA A. RIVELLESE;GABRIELE RICCARDI;ORESTE DE DIVITIIS;MAURIZIO GALDERISI;R. DI PALO;D. PALADINI;MASSIMO CHIARIELLO;ANNAMARIA COLAO;DANIELA MELIS;PAOLO GASPARINI;GUIDO IACCARINO;V. BONAVITA","10;7;6;6;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4","FRANCO CONTALDO;GUGLIELMO BORGIA;BRUNO TRIMARCO;VITTORIO PALMIERI;B. GASPARRINI;L. ZICARELLI;MARCO DURANTE;DANIELA MELIS;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;BJÖRN DAHLÖF;NICOLA PASQUINO;ANTONINO DRAGO;A DEBLASIO;D. PALADINI;ANGELA A. RIVELLESE;ENRICO DE DIVITIIS;R. DI PALO;V. BONAVITA;PAOLO CAPPABIANCA","2.42;2;1.83;1.6;1.49;1.45;1.4;1.36;1.09;1.01;1;1;1;1;0.93;0.87;0.83;0.83;0.79;0.75","GAETANO LOMBARDI;ANNAMARIA COLAO;FRANCESCO ORIO;FULVIO ZULLO;STEFANO PALOMBA;TERESA CASCELLA;GIOVANNI DE SIMONE;LETÌZIA SPINELLI;TIZIANA RUSSO;ANDREA BALLABIO;DONATO LABELLA;SEBASTIANO DI BIASE;VITTORIO E. ANDREUCCI;LIBUSE TAUCHMANOVÀ;ALBERTO AURICCHIO;BIAGIO DE SIMONE;GIORGIO CASARI;A. DEL FAVERO;ANNAMARIA NOSARI;LIVIO PAGANO","783;680;665;652;652;652;450;426;398;395;395;395;379;337;330;326;317;306;306;306","GIOVANNI DE SIMONE;LETÌZIA SPINELLI;ANDREA BALLABIO;BIAGIO DE SIMONE;MARCO PICARDI;ANTONIETTA P. DE BLASIO;DOMENICO RUSSO;GIUSEPPE PALMIERO;M BALLETTA;VITTORIO E. ANDREUCCI;MAURIZIO GALDERISI;VINCENZO ESPOSITO VINZI;GENEROSO ANDRIA;C IOVINE;R. DI PALO;LUIGI GRECO;ALESSANDRO PERRELLA;B. GASPARRINI;CARMELA ROMANO;MARCELLO CHINALI","450;426;395;326;306;281;281;281;281;281;271;258;218;212;209;200;198;197;192;192","BRUNO TRIMARCO;GIOVANNI DE SIMONE;MARCO DURANTE;R. DI PALO;D. PALADINI;MAURIZIO GALDERISI;VITTORIO PALMIERI;ANDREA BALLABIO;B. GASPARRINI;C IOVINE;ERSILIA CIPOLLETTA;GABRIELE RICCARDI;GIOVANNI DOMENICO DE PALMA;GUIDO IACCARINO;LETÌZIA SPINELLI;ORESTE DE DIVITIIS;RAFFAELE IZZO;V. BONAVITA;ANGELA A. RIVELLESE;BRUNO ROTOLI","10;7;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;GEOLOGY;MATERIALS SCIENCE;ART;ECONOMICS;PHILOSOPHY;ENGINEERING;GEOGRAPHY;ENVIRONMENTAL SCIENCE;HISTORY;POLITICAL SCIENCE;BUSINESS","195;88;32;22;19;12;7;7;6;6;4;4;4;3;3;2;2;2;1","INTERNAL MEDICINE;GENETICS;ENDOCRINOLOGY;CARDIOLOGY;PATHOLOGY;SURGERY;BIOCHEMISTRY;IMMUNOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;RADIOLOGY;PEDIATRICS;ORGANIC CHEMISTRY;CELL BIOLOGY;MOLECULAR BIOLOGY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;ANATOMY;NEUROSCIENCE","150;57;52;37;32;32;29;26;22;20;16;16;14;13;12;12;11;10;9;9","GENE;DISEASE;BLOOD PRESSURE;POPULATION;RECEPTOR;DIABETES MELLITUS;INSULIN;HEART FAILURE;ANTIBODY;CANCER;BODY MASS INDEX;CHOLESTEROL;IMMUNOHISTOCHEMISTRY;TRANSPLANTATION;ENZYME;HORMONE;IMMUNE SYSTEM;OBESITY;OSTEOPOROSIS;ALTERNATIVE MEDICINE;IN VITRO;PREGNANCY;VENTRICLE","52;31;22;19;18;13;13;11;10;10;9;9;9;8;7;7;7;7;7;6;6;6;6","CHROMOSOME;GENOTYPE;INSULIN RESISTANCE;MUTATION;PHENOTYPE;DIASTOLE;EJECTION FRACTION;LEFT VENTRICULAR HYPERTROPHY;ALLELE;TRIGLYCERIDE;FETUS;PLACEBO;POSTPRANDIAL;ADRENERGIC;CARDIOMYOPATHY;COELIAC DISEASE;COLORECTAL CANCER;GENE EXPRESSION;GLIADIN;HEART RATE;OVERWEIGHT;PARKINSON'S DISEASE;TYPE 2 DIABETES","12;11;10;10;9;8;8;7;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","HAPLOTYPE;POLYMORPHISM (COMPUTER SCIENCE);POLYCYSTIC OVARY;PRENATAL DIAGNOSIS;COLONOSCOPY;DOPPLER ECHOCARDIOGRAPHY;GENE MAPPING;GERMLINE MUTATION;KARYOTYPE;PROBAND;ALLELE FREQUENCY;BETA-3 ADRENERGIC RECEPTOR;BLASTOCYST;BREAKPOINT;CLASTOGEN;DIASTOLIC FUNCTION;GLUCOSE HOMEOSTASIS;GLYCOGEN STORAGE DISEASE TYPE I;HEREDITARY SPASTIC PARAPLEGIA;HYPERINSULINEMIA;IN VITRO MATURATION;MISSENSE MUTATION;OOCYTE ACTIVATION","7;6;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;ITALY;ANIMALS;HYPERTENSION;VENTRICULAR DYSFUNCTION, LEFT;ADOLESCENT;TREATMENT OUTCOME;CARDIOVASCULAR DISEASES;RISK FACTORS;TRANSCRIPTION FACTORS;DNA-BINDING PROTEINS;HEART VENTRICLES;POLYCYSTIC OVARY SYNDROME;CASE-CONTROL STUDIES","145;114;106;75;68;62;44;31;28;26;26;21;20;19;18;17;16;16;16;14","ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;THYROID DISEASE AND HORMONE REGULATION;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;GENETIC ADAPTATION OF LACTASE PERSISTENCE IN HUMANS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MICROARRAY DATA ANALYSIS AND GENE EXPRESSION PROFILING;MOLECULAR MECHANISMS OF DNA DAMAGE RESPONSE;NF-?B SIGNALING IN INFLAMMATION AND CANCER;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;BONE TUMORS AND TUMOR-LIKE CONDITIONS IN SKELETAL SYSTEM;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS","5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;2;2;2","HYPERTENSION;LEFT VENTRICULAR FUNCTION;DIABETES;GLUTEN SENSITIVITY;HYPERTHYROIDISM;HYPOTHYROIDISM;CARDIAC IMAGING;CELL CYCLE CHECKPOINTS;GLIADIN;INSULIN RESISTANCE;POLYCYSTIC OVARY SYNDROME;TREATMENT;TYPE 1 DIABETES;ANGIOGENIC SIGNALING;ANTI-ANGIOGENIC THERAPY;CARDIOVASCULAR RISK ASSESSMENT;CONTINUOUS GLUCOSE MONITORING;CORONARY FLOW RESERVE;DIASTOLIC FUNCTION;DIPYRIDAMOLE","11;7;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3","LEFT VENTRICULAR;CARDIOVASCULAR RISK;COELIAC DISEASE;DISEASE TYPE;IMMUNE RESPONSES;RISK FACTORS;ADRENERGIC RECEPTOR;BLOOD PRESSURE;BUBALUS BUBALIS;BUFFALO BUBALUS;CORONARY ARTERY;CORONARY FLOW;DISEASE PATIENTS;FLOW RESERVE;GLYCOGEN STORAGE;HLA CLASS;HYPERTENSIVE PATIENTS;INTESTINAL MUCOSA;LIZARD PODARCIS;OVARY SYNDROME;PARKINSONS DISEASE;PEPTIDE PEP;PERIPHERAL ARTERIAL;PODARCIS SICULA;POLYCYSTIC OVARY;STORAGE DISEASE;TYPE DIABETES;VENTRICULAR MASS;ACUTE EFFECTS;AGLIADIN PEPTIDE","10;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2","PUBMED SCOPUS;CROSSREF PUBMED;AUTOIMMUNE HEPATITIS;HOMBERG JC;AORTIC ARCH;PUBMED GOOGLE;CHRONIC ACTIVE;LIVER DISEASE;DIABETIC PATIENTS;TYPE DIABETIC;LIVER CYTOSOL;AUTOIMMUNE LIVER;ANTI-LIVERKIDNEY MICROSOME;ANTIGEN TYPE;BLOOD PRESSURE;ACTIVE HEPATITIS;BIOPSY EXAMINATION;CEREBRAL PERFUSION;IMMUNOSUPPRESSIVE THERAPY;INSULIN SENSITIVITY;MM HG;YR YR;AIH TYPE;ANTI-LIVER CYTOSOL;AUTOIMMUNE CHRONIC;CIRCULATORY ARREST;EXAMINATION PERFORMED;HEPATITISHEPATOLOGY -CROSSREF;IMMUNOSUPPRESSIVE TREATMENT;LIVER FAILURE","47;30;23;18;16;16;15;15;14;13;12;11;9;9;9;8;8;8;8;8;8;8;7;7;7;7;7;7;7;7",29,0.12,5.35,3,0,1,0,7,5,0,1.5,4,1,0,2.5,1,2.5,0,1,2,0,0,0,54,55,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2,6635,0.42,0,0,169.5,0,0,0,0,1,0,0,1,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3210 NUTRITION AND DIETETICS","2;1;1","PREVENTION;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIABETES;HEALTH SERVICES;INFECTIOUS DISEASES;LUNG;NUTRITION;PEDIATRIC;PNEUMONIA","2;1;1;1;1;1;1;1;1;1","METABOLIC AND ENDOCRINE","1","6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2005,279,8.45878136200717,3.75627240143369,0.555555555555556,0.473118279569892,0.577060931899642,1.46164574616457,1.22047244094488,1.25714285714286,1.23846153846154,0.351254480286738,7,135,75,21,26,0.48,0.27,0.08,0.09,41.79,0.789368557383493,NA,0.279569892473118,0.666666666666667,0.428,0.374,0.424,0.379,"GIOVANNI DE SIMONE;ALBERTO CUOCOLO;MAURIZIO GALDERISI;GAETANO LOMBARDI;ANNAMARIA COLAO;MARCO SALVATORE;VITTORIA BUCCIGROSSI;D. PALADINI;ALFREDO GUARINO;PASQUALE STRIANO;ANTONIO CITTADINI;LUIGI SACCÀ;MARIA TERESA PELLECCHIA;SALVATORE STRIANO;PAOLO BARONE;FABRIZIO PASANISI;SALVATORE PANICO;ROBERTO BERNI CANANI;VITTORIO PALMIERI;GENEROSO ANDRIA","12;11;10;10;9;8;7;7;7;7;7;6;6;6;5;5;5;5;5;5","GIOVANNI DE SIMONE;MAURIZIO GALDERISI;ALBERTO CUOCOLO;PASQUALE STRIANO;D. PALADINI;PAOLO GRIECO;RAFFAELE NAPOLI;SALVATORE STRIANO;GAETANO LOMBARDI;MARCO SALVATORE;CLAUDIO PIGNATA;VALERIA RAIA;ANNAMARIA COLAO;PAOLO VOLPE;GIUSEPPE D’ARGENIO;GIOVANNI DOMENICO DE PALMA;G. FRANCESCHETTI;LUIGI SACCÀ;VITTORIA BUCCIGROSSI;ALFREDO GUARINO","1.9;1.69;1.62;1.43;1.37;1.3;1.29;1.29;1.26;1.22;1.1;1.1;1.08;1.01;1;1;1;0.9;0.87;0.87","GIOVANNI DE SIMONE;ALBERTO CUOCOLO;MAURIZIO GALDERISI;GAETANO LOMBARDI;ANNAMARIA COLAO;MARCO SALVATORE;VITTORIA BUCCIGROSSI;D. PALADINI;ALFREDO GUARINO;PASQUALE STRIANO;ANTONIO CITTADINI;LUIGI SACCÀ;MARIA TERESA PELLECCHIA;SALVATORE STRIANO;PAOLO BARONE;FABRIZIO PASANISI;SALVATORE PANICO;ROBERTO BERNI CANANI;VITTORIO PALMIERI;GENEROSO ANDRIA","12;11;10;10;9;8;7;7;7;7;7;6;6;6;5;5;5;5;5;5","GIOVANNI DE SIMONE;MAURIZIO GALDERISI;ALBERTO CUOCOLO;PASQUALE STRIANO;D. PALADINI;PAOLO GRIECO;RAFFAELE NAPOLI;SALVATORE STRIANO;GAETANO LOMBARDI;MARCO SALVATORE;CLAUDIO PIGNATA;VALERIA RAIA;ANNAMARIA COLAO;PAOLO VOLPE;GIUSEPPE D’ARGENIO;GIOVANNI DOMENICO DE PALMA;G. FRANCESCHETTI;LUIGI SACCÀ;VITTORIA BUCCIGROSSI;ALFREDO GUARINO","1.9;1.69;1.62;1.43;1.37;1.3;1.29;1.29;1.26;1.22;1.1;1.1;1.08;1.01;1;1;1;0.9;0.87;0.87","SALVATORE PANICO;ANNE TJØNNELAND;ANTONIA TRICHOPOULOU;CARLOS A. GONZÁLEZ;CARMEN NAVARRO;EILIV LUND;ELIO RÍBOLI;GÖRAN BERGLUND;GÖRAN HALLMANS;HEINER BOEING;J. RAMÓN QUIRÓS;KIM OVERVAD;NADIA SLIMANI;NICHOLAS DAY;PETRA H. PEETERS;SHEILA BINGHAM;TIMOTHY J. KEY;­ROSARIO ­TUMINO;ANJA OLSEN;FRANCO BERRINO","1339;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1294;1177;1177","SALVATORE PANICO;GIOVANNI DE SIMONE;MARCELLO PERSICO;ALEXANDRA NIETERS;ANJA OLSEN;ANNE TJØNNELAND;ANTONIA TRICHOPOULOU;BERTRAND HÉMON;CARLOS A. GONZÁLEZ;CARMEN NAVARRO;DAGRUN ENGESET;DIMITRIOS TRICHOPOULOS;DOMENICO PALLI;EILIV LUND;ELIO RÍBOLI;EMMANUELLE KESSE‐GUYOT;EVA ARDANÁZ;FRANCO BERRINO;FRANÇOISE CLAVEL;GURI SKEIE","1332;865;854;841;841;841;841;841;841;841;841;841;841;841;841;841;841;841;841;841","GIOVANNI DE SIMONE;GAETANO LOMBARDI;ALFREDO GUARINO;ANNAMARIA COLAO;ANTONIO CITTADINI;D. PALADINI;VITTORIA BUCCIGROSSI;PASQUALE STRIANO;SALVATORE STRIANO;ALBERTO CUOCOLO;LUIGI SACCÀ;MAURIZIO GALDERISI;G. DE MARCO;MARIA TERESA PELLECCHIA;GENEROSO ANDRIA;ROBERTO BERNI CANANI;FABRIZIO PASANISI;FRANCO CONTALDO;A. ZARRILLI;ALDO CELENTANO","12;8;7;7;7;7;7;7;6;6;6;6;5;5;5;5;5;5;4;4","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;MATERIALS SCIENCE;MATHEMATICS;GEOLOGY;ENGINEERING;PHILOSOPHY;SOCIOLOGY;ART;GEOGRAPHY;HISTORY;POLITICAL SCIENCE;ECONOMICS;ENVIRONMENTAL SCIENCE","232;107;38;36;20;14;10;9;7;4;4;4;3;3;3;2;1;1","INTERNAL MEDICINE;GENETICS;CARDIOLOGY;ENDOCRINOLOGY;BIOCHEMISTRY;PATHOLOGY;SURGERY;IMMUNOLOGY;GASTROENTEROLOGY;RADIOLOGY;CELL BIOLOGY;MOLECULAR BIOLOGY;ANESTHESIA;PSYCHIATRY;ANATOMY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;OPTICS;PEDIATRICS;QUANTUM MECHANICS","172;60;56;48;44;39;35;32;30;28;18;18;17;16;15;15;12;12;12;11","GENE;BLOOD PRESSURE;DISEASE;ENZYME;POPULATION;BODY MASS INDEX;CORONARY ARTERY DISEASE;HEART FAILURE;HORMONE;CANCER;INSULIN;PREGNANCY;RECEPTOR;IN VITRO;ALTERNATIVE MEDICINE;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;ARTERY;HEPATITIS C;OBESITY;VIRUS","52;30;30;16;15;14;14;14;14;13;12;12;12;10;9;9;9;8;8;8;8","MUTATION;GENOTYPE;DIASTOLE;ALLELE;FETUS;GROWTH HORMONE;CORONARY FLOW RESERVE;EJECTION FRACTION;GENE EXPRESSION;INSULIN RESISTANCE;PHENOTYPE;CHROMOSOME;ESCHERICHIA COLI;HAZARD RATIO;HEART RATE;LEFT VENTRICULAR HYPERTROPHY;PLACEBO;BIOELECTRICAL IMPEDANCE ANALYSIS;BRACHIAL ARTERY;EXON;GESTATIONAL AGE;HEPATITIS C VIRUS","14;12;11;9;8;7;6;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4","HAPLOTYPE;MISSENSE MUTATION;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;POLYMORPHISM (COMPUTER SCIENCE);PRENATAL DIAGNOSIS;METHYLENETETRAHYDROFOLATE REDUCTASE;POLY ADP RIBOSE POLYMERASE;STROKE VOLUME;ACROMEGALY;ANDROGEN RECEPTOR;COMPOUND HETEROZYGOSITY;CONNEXIN;CYSTINE;ENTEROTOXIN;FRACTIONAL FLOW RESERVE;GENETIC HETEROGENEITY;GROWTH HORMONE DEFICIENCY;HOX GENE;KARYOTYPE;PLACENTA;POLYCYSTIC OVARY;PROBAND;SINGLE-NUCLEOTIDE POLYMORPHISM;SOMATOTROPIC CELL;SYSTOLE;TAMOXIFEN;VERY LOW CALORIE DIET;VO2 MAX","6;5;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;;AGED;ITALY;ADOLESCENT;HYPERTENSION;HYPERTROPHY, LEFT VENTRICULAR;CARDIOVASCULAR DISEASES;TREATMENT OUTCOME;CHILD;ANIMALS;OBESITY;CORONARY ARTERY DISEASE;HUMAN GROWTH HORMONE;INSULIN-LIKE GROWTH FACTOR I;KIDNEY FAILURE, CHRONIC","187;141;137;102;83;80;57;32;29;27;27;24;20;19;17;17;16;16;16;16","RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;HEPATITIS C INFECTION AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;ROLE OF HOMOCYSTEINE IN HEALTH AND DISEASE;ACUTE MYELOID LEUKEMIA;COCHLEAR NEUROPATHY AND HEARING LOSS MECHANISMS;DEVELOPMENT AND DISORDERS OF FETAL BRAIN;DIAGNOSIS AND MANAGEMENT OF AORTIC DISEASES;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HUMAN IMMUNODEFICIENCY VIRUS/ACQUIRED IMMUNODEFICIENCY SYNDROME","11;8;7;6;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3","CARDIAC IMAGING;LEFT VENTRICULAR FUNCTION;CARDIOVASCULAR RISK ASSESSMENT;ECHOCARDIOGRAPHY;HEPATITIS C;HYPERTENSION;TREATMENT;CORONARY FLOW RESERVE;DIASTOLIC FUNCTION;BIOELECTRICAL IMPEDANCE ANALYSIS;PATHOGENESIS;BRACHIAL ARTERY;CAROTID ARTERY STENOSIS;DOPPLER IMAGING;GLUTEN SENSITIVITY;MYOCARDIAL PERFUSION;VASCULAR FUNCTION;VENTRICULAR FUNCTION;AORTIC DISSECTION;BODY FAT PERCENTAGE","13;12;8;8;8;8;7;6;6;5;5;4;4;4;4;4;4;4;3;3","LEFT VENTRICULAR;ARTERY DISEASE;CORONARY ARTERY;CARDIOVASCULAR RISK;CORONARY FLOW;FLOW RESERVE;SOUTHERN ITALY;CELIAC DISEASE;CHRONIC HEPATITIS;COELIAC PATIENTS;GROWTH HORMONE;TISSUE DOPPLER;VENTRICULAR FUNCTION;VENTRICULAR MASS;BLOOD PRESSURE;BODY COMPOSITION;DIABETIC PATIENTS;ENDOTHELIAL FUNCTION;HYPERTENSIVE PATIENTS;ION SECRETION;MULTIPLE SYSTEM;MYOCARDIAL PERFUSION;NATURAL HISTORY;PARENTERAL NUTRITION;PARKINSONS DISEASE;PERFUSION IMAGING;RISK FACTORS;STRESS ECHOCARDIOGRAPHY;SYSTEM ATROPHY;ACTIVATION IMPLICATIONS","18;9;9;5;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2","PUBMED SCOPUS;CROSSREF PUBMED;CROSSREFMEDLINEGOOGLE SCHOLAR;CELIAC DISEASE;CELL MIGRATION;CORONARY ARTERY;PUBMED GOOGLE;BLOOD FLOW;CARRIERO MV;IN-STENT RESTENOSIS;ALBUMINCREATININE RATIO;ARTERY DISEASE;CORONARY ARTERIES;HR CI;SMOOTH MUSCLE;CANCER RES;LEFT VENTRICULAR;RES -PUBMED;STOPPELLI MP;TISSUE TRANSGLUTAMINASE;BIOL CHEM;BLOOD PRESSURE;DEL VECCHIO;ITALY GDL;OVARIAN BLOOD;CARDIOVASCULAR DISEASE;MAX --;MV DEL;PROTEIN KINASE;RISK FACTOR","91;58;29;21;21;21;17;16;14;14;12;12;12;12;12;11;11;11;11;11;10;10;10;10;10;9;9;9;9;9",41,0.15,5.44,4,1,1,0,1.25,4.25,1,1,4,0,1,6,1,3.5,0,3,6.25,1,0,0,65,65,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,5.5,1391.5,0.29,1,0.5,123,0,0,0,0,2,0,0,0,0,2,0,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Italy;United States","1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES","2;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PATIENT SAFETY","2;2;1;1","BLOOD;CANCER","1;1","6.1 PHARMACEUTICALS","2","STOMACH CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2006,305,9.71803278688525,2.83606557377049,0.465573770491803,0.40983606557377,0.481967213114754,1.47610921501706,1.24561403508772,1.31578947368421,1.27826086956522,0.354098360655738,6,160,79,21,16,0.52,0.26,0.07,0.05,54.25,1.06208074485157,NA,0.295081967213115,0.767213114754098,0.419,0.431,0.39,0.428,"SALVATORE PANICO;MAURIZIO GALDERISI;KIM OVERVAD;­ROSARIO ­TUMINO;HEINER BOEING;ELIO RÍBOLI;ANNE TJØNNELAND;PASQUALE STRIANO;BRUNO ROTOLI;JAKOB LINSEISEN;ANTONIA TRICHOPOULOU;DOMENICO PALLI;GIOVANNI DE SIMONE;FEDERICO ZARA;SALVATORE STRIANO;SHEILA BINGHAM;GAETANO LOMBARDI;CARLOTTA SACERDOTE;PASQUALE INNELLI;PETRA H. PEETERS","13;13;11;11;11;11;11;11;10;10;10;10;10;9;9;9;9;8;8;8","MAURIZIO GALDERISI;GIOVANNI DE SIMONE;SALVATORE PANICO;PASQUALE INNELLI;ROBERTO BERNI CANANI;LUIGI DI TOMMASO;GIOVANNELLA PALMIERI;PASQUALE STRIANO;BRUNO ROTOLI;PAOLO STASSANO;SALVATORE STRIANO;MARTIN ROYLE;LILIANA BÀCULO;ALESSANDRO SERPE;FRANCESCO ORIO;GABRIELE RICCARDI;GIULIANA VALERIO;MILENA SIDIROPULOS;GAETANO LOMBARDI;GIOVANNI TARANTINO","2.48;1.8;1.51;1.41;1.38;1.26;1.09;1.08;1.07;1.06;1;1;1;1;0.99;0.99;0.98;0.98;0.92;0.87","SALVATORE PANICO;MAURIZIO GALDERISI;PASQUALE STRIANO;BRUNO ROTOLI;GIOVANNI DE SIMONE;SALVATORE STRIANO;GAETANO LOMBARDI;PASQUALE INNELLI;ANNAMARIA COLAO;LUIGI DI TOMMASO;FRANCESCO ORIO;CARMINE SELLERI;GABRIELE RICCARDI;PAOLO STASSANO;FABRIZIO PANE;ANNAMARIA COLAO;PAOLO BARONE;GIOVANNI TARANTINO;RAFFAELE IORIO;ANTONIO M. RISITANO","13;13;11;10;10;9;9;8;7;7;6;6;6;6;6;5;5;5;5;5","MAURIZIO GALDERISI;GIOVANNI DE SIMONE;SALVATORE PANICO;PASQUALE INNELLI;ROBERTO BERNI CANANI;LUIGI DI TOMMASO;GIOVANNELLA PALMIERI;PASQUALE STRIANO;BRUNO ROTOLI;PAOLO STASSANO;SALVATORE STRIANO;MARTIN ROYLE;LILIANA BÀCULO;ALESSANDRO SERPE;FRANCESCO ORIO;GABRIELE RICCARDI;MILENA SIDIROPULOS;GAETANO LOMBARDI;GIOVANNI TARANTINO;GIUSEPPE DE CRECCHIO","2.48;1.8;1.51;1.41;1.38;1.26;1.09;1.08;1.07;1.06;1;1;1;1;0.99;0.99;0.98;0.92;0.87;0.83","ANNAMARIA COLAO;ANDRÉE RASQUIN;ANNAMARIA STAIANO;CARLO DI LORENZO;DAVID FORBES;ERNESTO GUIRALDES;JEFFREY S. HYAMS;LYNN S. WALKER;ANTONIO M. RISITANO;ANITA HILL;GÈRARD SOCIÉ;HUBERT SCHREZENMEIER;JEFF SZER;JÖRG SCHUBERT;LUCIO LUZZATTO;NEAL S. YOUNG;PETER HILLMEN;PETRA MUUS;ROBERT A. BRODSKY;RUSSELL P. ROTHER","1886;1694;1694;1694;1694;1694;1694;1694;1174;1161;1161;1161;1161;1161;1161;1161;1161;1161;1161;1161","ANNAMARIA STAIANO;ANNAMARIA COLAO;ANTONIO M. RISITANO;SALVATORE PANICO;PAOLO CAPPABIANCA;PASQUALE STRIANO;RAFFAELLA VECCHIONE;MASSIMO CHIARIELLO;GAETANO LOMBARDI;MARC COHEN;GABRIELE RICCARDI;ADRIANA FRANZESE;GIOVANNI DE SIMONE;PAOLO BARONE;SALVATORE STRIANO;ANGELA A. RIVELLESE;GIUSEPPE DE MICHELE;MAURIZIO GALDERISI;LAURA VANOLI;G. RICCARDI","1694;1634;1162;1028;891;662;384;366;362;356;351;349;347;326;322;301;295;287;275;268","SALVATORE PANICO;MAURIZIO GALDERISI;GIOVANNI DE SIMONE;PASQUALE STRIANO;ANNAMARIA COLAO;BRUNO ROTOLI;GABRIELE RICCARDI;PASQUALE INNELLI;SALVATORE STRIANO;PAOLO STASSANO;FABRIZIO PANE;GIOVANNI TARANTINO;ANGELA VEGNENTE;CARMINE SELLERI;D. PALADINI;LUIGI DI TOMMASO;MILENA SIDIROPULOS;RAFFAELE IORIO;PAOLO BARONE;ALFREDO GUARINO","13;11;10;9;8;7;7;7;7;6;5;5;5;5;5;5;5;5;5;4","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;ENGINEERING;SOCIOLOGY;MATERIALS SCIENCE;GEOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;ART;BUSINESS;GEOGRAPHY;HISTORY","261;118;34;29;24;16;16;11;9;8;6;5;5;5;2;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;CARDIOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;SURGERY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;RADIOLOGY;PSYCHIATRY;PEDIATRICS;CELL BIOLOGY;ONCOLOGY;ANATOMY;CANCER RESEARCH;NEUROSCIENCE;PHYSICAL THERAPY;OPTICS;PALEONTOLOGY","202;67;59;51;49;45;44;41;40;27;26;24;23;21;20;15;14;14;13;12;12","GENE;DISEASE;CANCER;BLOOD PRESSURE;POPULATION;HEART FAILURE;ANTIBODY;BODY MASS INDEX;DIABETES MELLITUS;PROSPECTIVE COHORT STUDY;INSULIN;EPILEPSY;RECEPTOR;CONFIDENCE INTERVAL;ENZYME;HORMONE;MYOCARDIAL INFARCTION;OBESITY;PREGNANCY;TRANSPLANTATION;VIRUS","56;34;27;26;24;22;20;16;16;15;13;12;12;11;11;11;10;10;10;9;9","DIASTOLE;MUTATION;INSULIN RESISTANCE;PHENOTYPE;EJECTION FRACTION;GENOTYPE;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HEART RATE;HEPATITIS C VIRUS;OVERWEIGHT;FETUS;PROSTATE;TYPE 2 DIABETES;CHROMOSOME;CORONARY ANGIOGRAPHY;CORONARY FLOW RESERVE;PARKINSON'S DISEASE;SEROLOGY;WAIST;ALLELE;CARDIOMYOPATHY;CHRONIC HEPATITIS;ENDOCRINE SYSTEM;ENTEROCYTE;LEFT VENTRICULAR HYPERTROPHY;MONOCLONAL ANTIBODY;PLACEBO;PROSTATE CANCER;REFLUX;TRIGLYCERIDE;VIRAL LOAD","13;13;11;10;9;8;7;7;7;7;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4","MISSENSE MUTATION;DOPPLER ECHOCARDIOGRAPHY;DOPPLER IMAGING;FRAMESHIFT MUTATION;POLYCYSTIC OVARY;ANTIRETROVIRAL THERAPY;PRENATAL DIAGNOSIS;PROBAND;STROKE VOLUME;ACROMEGALY;AZOOSPERMIA;CARDIOTOCOGRAPHY;CONSERVED SEQUENCE;CXCR4;CYCLIN D1;ECULIZUMAB;GASTRO-;GERD;HAPLOTYPE;HEART RATE VARIABILITY;HEREDITARY SPASTIC PARAPLEGIA;HSP70;IMATINIB MESYLATE;IMPAIRED GLUCOSE TOLERANCE;INCLUSION BODIES;INTRAEPITHELIAL NEOPLASIA;ISOVOLUMETRIC CONTRACTION;LIVER STEATOSIS;MARGINAL ZONE;MEN1;MONOCLONAL;PANCREATIC HORMONE;PARKIN;PROSTATECTOMY;RIGHT CORONARY ARTERY;SUBTELOMERE;TRANSCRIPTOME;WAIST–HIP RATIO","6;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;MIDDLE AGED;;ADULT;AGED;OBESITY;ADOLESCENT;VENTRICULAR DYSFUNCTION, LEFT;CHILD;EUROPE;ITALY;RISK FACTORS;ADENOMA;ANIMALS;MAGNETIC RESONANCE IMAGING;CARDIOVASCULAR DISEASES;PROSPECTIVE STUDIES;MUTATION","199;154;151;96;89;89;68;35;30;29;25;23;22;22;21;21;21;20;20;19","RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;HEPATITIS C INFECTION AND TREATMENT;LYMPHOID NEOPLASMS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;DIAGNOSIS AND MANAGEMENT OF ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;EFFECTS OF KETOGENIC DIET ON HEALTH;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;EPILEPSY AND SEIZURES;MANAGEMENT OF HYPERBILIRUBINEMIA IN NEWBORN INFANTS;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;PARTICLE THERAPY FOR CANCER TREATMENT;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES","13;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3","LEFT VENTRICULAR FUNCTION;ECHOCARDIOGRAPHY;CARDIAC IMAGING;DIASTOLIC FUNCTION;TREATMENT;DIABETES;INSULIN RESISTANCE;INTESTINAL PERMEABILITY;ARRHYTHMOGENIC RIGHT VENTRICULAR CARDIOMYOPATHY;CORONARY FLOW RESERVE;DILATED CARDIOMYOPATHY;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;BASELINE (SEA);CARDIOVASCULAR RISK ASSESSMENT;CONTRACTILITY;DIAGNOSIS;DOPPLER IMAGING;ENTEROCYTE;FATTY ACID METABOLISM;HEALTHY EATING INDEX","17;13;10;10;8;7;6;6;5;5;5;5;4;4;4;4;4;4;4;4","LEFT VENTRICULAR;EUROPEAN PROSPECTIVE;HEART FAILURE;PROSPECTIVE INVESTIGATION;STEM CELL;CARDIOVASCULAR RISK;CORONARY FLOW;NOCTURNAL HEMOGLOBINURIA;NUTRITION EPIC;PAROXYSMAL NOCTURNAL;TISSUE DOPPLER;TYPE DIABETES;ANTIREMODELING EFFECT;CELL TRANSPLANTATION;CHRONIC HEART;CORONARY ARTERY;DIABETES MELLITUS;DIASTOLIC FUNCTION;DOSE MG;FILLING PRESSURE;FLOW RESERVE;HCV INFECTION;ITALIAN PATIENTS;MILD CHRONIC;SOUTHERN ITALY;VENTRICULAR DIASTOLIC;VENTRICULAR FILLING;BASELINE DATA;BOWEL SYNDROME;CANCER RISK","17;9;9;9;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;ROME II;ABDOMINAL PAIN;SURG -ABSTRACT;CORONARY ARTERY;GASTROENTEROL NUTR;NUTR -CROSSREF;PEDIATR GASTROENTEROL;CANCER RISK;FUNCTIONAL GASTROINTESTINAL;II CRITERIA;LEFT VENTRICULAR;BREAST CANCER;LINEAR SKIN;SKIN DEFECTS;THORAC SURG;CORONARY FLOW;FUNCTIONAL ABDOMINAL;GASTROINTESTINAL DISORDERS;RUMINATION SYNDROME;INSULIN RESISTANCE;TAKO-TSUBO SYNDROME;DIASTOLIC FUNCTION;CELL LINES;LEFT ATRIAL;LEFT ATRIUM;ROME III;APPLIED BIOSYSTEMS;CAPILLARY WEDGE","122;82;30;25;25;24;24;24;24;22;22;22;20;19;19;17;15;14;14;14;14;13;13;12;11;11;11;11;10;10",56,0.18,6,3,1,1,1,1,3,0,1,3,0,1,1,1,2.75,0,1,1,1,0,0,73,73.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,7.5,885.5,0.36,0,0,47,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,2,0,0,2,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","2;1;1;1","CLINICAL RESEARCH;CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;GENETICS;HEMATOLOGY;LYMPHOMA;RARE DISEASES","2;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL","1;1","2.4 SURVEILLANCE AND DISTRIBUTION;6.1 PHARMACEUTICALS","1;1","COLON AND RECTAL CANCER;NON-HODGKIN'S LYMPHOMA","1;1","4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2007,327,9.3914373088685,3.3302752293578,0.553516819571865,0.464831804281346,0.568807339449541,1.5273492286115,1.26573426573427,1.44761904761905,1.29166666666667,0.370030581039755,8,182,83,23,17,0.56,0.25,0.07,0.05,42.85,0.811925122427975,NA,0.324159021406728,0.703363914373089,0.414,0.398,0.445,0.414,"­ROSARIO ­TUMINO;GIOVANNI DE SIMONE;SALVATORE PANICO;ELIO RÍBOLI;KIM OVERVAD;JAKOB LINSEISEN;MAURIZIO GALDERISI;ANNE TJØNNELAND;RUDOLF KAAKS;ANTONIA TRICHOPOULOU;ALBERTO CUOCOLO;ANDREA BALLABIO;SHEILA BINGHAM;FRANÇOISE CLAVEL‐CHAPELON;HEINER BOEING;DOMENICO PALLI;PETRA H. PEETERS;BRUNO TRIMARCO;KAY‐TEE KHAW;TIMOTHY J. KEY","13;13;12;12;11;11;11;11;10;10;10;10;10;9;9;9;9;8;8;8","GIOVANNI TARANTINO;GIOVANNI DE SIMONE;MAURIZIO GALDERISI;L. ZICARELLI;ALBERTO CUOCOLO;FRANCESCO SADILE;F CIGALA;F.M. LOTITO;GIULIA GUERRIERO;D. PALADINI;ANDREA BALLABIO;B. GASPARRINI;GIUSEPPE CAMPANILE;R. DI PALO;MARCO DURANTE;FABIO DE ANGELIS;CONCETTA GIANCOLA;IACOPO GRASSI;V. COLANDREA;LUCIANO ROSATI","2.02;1.79;1.73;1.64;1.49;1.33;1.33;1.33;1.25;1.22;1.09;1.04;1.04;1.02;1.01;1;1;1;1;1","GIOVANNI DE SIMONE;SALVATORE PANICO;MAURIZIO GALDERISI;ALBERTO CUOCOLO;ANDREA BALLABIO;BRUNO TRIMARCO;ALBERTO AURICCHIO;GUIDO IACCARINO;AMALIA MATTIELLO;GIOVANNI TARANTINO;RAFFAELE IORIO;GIANLUCA NEGLIA;B. GASPARRINI;GIUSEPPE CAMPANILE;R. DI PALO;D. PALADINI;GAETANO LOMBARDI;GENEROSO ANDRIA;MARCELLO CHINALI;MASSIMO CHIARIELLO","13;12;11;10;10;8;7;7;7;7;7;7;7;7;7;7;7;6;6;6","GIOVANNI TARANTINO;GIOVANNI DE SIMONE;MAURIZIO GALDERISI;L. ZICARELLI;ALBERTO CUOCOLO;FRANCESCO SADILE;F CIGALA;F.M. LOTITO;GIULIA GUERRIERO;D. PALADINI;ANDREA BALLABIO;B. GASPARRINI;GIUSEPPE CAMPANILE;R. DI PALO;MARCO DURANTE;FABIO DE ANGELIS;CONCETTA GIANCOLA;IACOPO GRASSI;V. COLANDREA;LUCIANO ROSATI","2.02;1.79;1.73;1.64;1.49;1.33;1.33;1.33;1.25;1.22;1.09;1.04;1.04;1.02;1.01;1;1;1;1;1","­ROSARIO ­TUMINO;ANDREA BALLABIO;ANNE TJØNNELAND;ELIO RÍBOLI;SALVATORE PANICO;JAKOB LINSEISEN;KIM OVERVAD;HEINER BOEING;ANTONIA TRICHOPOULOU;SHEILA BINGHAM;FRANÇOISE CLAVEL‐CHAPELON;PETRA H. PEETERS;RUDOLF KAAKS;H. BAS BUENO‐DE‐MESQUITA;DIMITRIOS TRICHOPOULOS;MARIE‐CHRISTINE BOUTRON‐RUAULT;EILIV LUND;CARMINE SETTEMBRE;ANNAMARIA COLAO;TIMOTHY J. KEY","1174;1103;1088;1035;1019;1009;1009;965;946;940;893;871;865;831;825;798;781;773;760;746","ANDREA BALLABIO;SALVATORE PANICO;ALBERTO AURICCHIO;ANTONIO M. RISITANO;ANNAMARIA COLAO;AMALIA MATTIELLO;GIOVANNI DE SIMONE;PAOLO BARONE;MAURIZIO GALDERISI;ALESSANDRO FILLA;ANNA SCAFARTO;CAROLINA RUOCCO;DOMENICO RUSSO;ELISA BUONANNO;IRATXE DÍEZ MIRANDA;LUIGI RUSSO;SIMONA MANZI;VITTORIO E. ANDREUCCI;YURI BATTAGLIA;MARIANNA AMBONI","1055;1019;570;547;494;478;434;383;382;351;333;333;333;333;333;333;333;333;333;327","GIOVANNI DE SIMONE;SALVATORE PANICO;MAURIZIO GALDERISI;ANDREA BALLABIO;GIUSEPPE CAMPANILE;AMALIA MATTIELLO;GIOVANNI TARANTINO;R. DI PALO;B. GASPARRINI;ALBERTO AURICCHIO;ALBERTO CUOCOLO;MASSIMO CHIARIELLO;RAFFAELE IORIO;MARCELLO CHINALI;GIANLUCA NEGLIA;L. ZICARELLI;LUIGI DI TOMMASO;PAOLO STASSANO;PASQUALE STRIANO;ANNAMARIA STAIANO","13;12;10;9;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;MATERIALS SCIENCE;SOCIOLOGY;POLITICAL SCIENCE;ECONOMICS;BUSINESS;GEOLOGY;PHILOSOPHY;GEOGRAPHY;ART;ENVIRONMENTAL SCIENCE;HISTORY","261;127;43;37;21;20;20;19;13;13;9;7;6;6;5;4;3;2;1","INTERNAL MEDICINE;GENETICS;CARDIOLOGY;ENDOCRINOLOGY;BIOCHEMISTRY;SURGERY;PATHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;RADIOLOGY;CELL BIOLOGY;IMMUNOLOGY;PEDIATRICS;PSYCHIATRY;ORGANIC CHEMISTRY;OPTICS;ANESTHESIA;DEMOGRAPHY;ECOLOGY;NUCLEAR MEDICINE;ONCOLOGY","192;73;56;53;51;46;41;39;31;27;25;23;21;17;16;14;13;12;12;12;12","GENE;POPULATION;DISEASE;BLOOD PRESSURE;CANCER;BODY MASS INDEX;PREGNANCY;HEART FAILURE;DIABETES MELLITUS;ENZYME;HORMONE;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;OBESITY;MYOCARDIAL INFARCTION;RECEPTOR;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);COHORT;CORONARY ARTERY DISEASE;IMMUNOHISTOCHEMISTRY;PROPORTIONAL HAZARDS MODEL;VIRUS","60;38;32;28;25;21;21;20;19;19;18;17;16;16;13;12;11;9;8;8;8;8;8","DIASTOLE;GENOTYPE;EJECTION FRACTION;FETUS;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;ALLELE;HAZARD RATIO;LEFT VENTRICULAR HYPERTROPHY;MUTATION;INSULIN RESISTANCE;METABOLIC SYNDROME;CORONARY FLOW RESERVE;GENE EXPRESSION;HEART RATE;PHENOTYPE;PLACEBO;TYPE 2 DIABETES;CARDIOMYOPATHY;GESTATION;GESTATIONAL AGE;OVERWEIGHT;QUARTILE;TOLERABILITY;TRANSCRIPTION FACTOR;WEIGHT LOSS","14;14;11;11;10;9;9;9;9;8;7;6;6;6;6;6;6;5;5;5;5;5;5;5;5","HAPLOTYPE;SINGLE-NUCLEOTIDE POLYMORPHISM;DOPPLER ECHOCARDIOGRAPHY;FETAL HEAD;POLYCYSTIC OVARY;STROKE VOLUME;BLASTOCYST;HIPPOCAMPAL SCLEROSIS;MISSENSE MUTATION;PRENATAL DIAGNOSIS;ACROMEGALY;AROMATASE;BILIARY ATRESIA;BIODOSIMETRY;BUSERELIN;ECULIZUMAB;EXPRESSED SEQUENCE TAG;FETAL HEART;FILAMIN;FRACTIONAL FLOW RESERVE;FRAMESHIFT MUTATION;G PROTEIN-COUPLED RECEPTOR KINASE;GLUCOSE HOMEOSTASIS;GLYCOGEN STORAGE DISEASE TYPE II;IMATINIB MESYLATE;INTERPLANETARY SPACEFLIGHT;ISOVOLUMETRIC CONTRACTION;LEVODOPA;METHYLENETETRAHYDROFOLATE REDUCTASE;NEUROENDOCRINE DIFFERENTIATION;PLACEBO GROUP;POLYMORPHISM (COMPUTER SCIENCE);PRESSURE OVERLOAD;RIBAVIRIN","7;7;6;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;MIDDLE AGED;ADULT;AGED;ANIMALS;ADOLESCENT;HYPERTENSION;ITALY;CHILD;RISK FACTORS;PROSPECTIVE STUDIES;FOLLOW-UP STUDIES;LIVER;EUROPE;CHILD, PRESCHOOL;DIABETES MELLITUS, TYPE 2;RETROSPECTIVE STUDIES","180;144;143;118;98;79;59;38;32;32;30;29;27;26;22;22;21;20;20;20","LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPIDEMIOLOGY AND MANAGEMENT OF CONGENITAL HEART DISEASE;METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE;DIAGNOSIS AND MANAGEMENT OF POLYCYSTIC OVARY SYNDROME;EPILEPSY AND SEIZURES;FEMOROACETABULAR IMPINGEMENT SYNDROME AND HIP PATHOLOGY;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;REPRODUCTIVE HEALTH IN DAIRY CATTLE;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;BRAIN FLUID DYNAMICS AND WASTE CLEARANCE MECHANISMS;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EATING DISORDERS AND BODY IMAGE CONCERNS;FERTILITY PRESERVATION IN CANCER PATIENTS;GENETIC ADAPTATION OF LACTASE PERSISTENCE IN HUMANS;HEPATITIS C INFECTION AND TREATMENT;LYMPHOID NEOPLASMS","10;8;8;5;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3","CARDIAC IMAGING;LEFT VENTRICULAR FUNCTION;ECHOCARDIOGRAPHY;CARDIAC METABOLISM;DIABETES;METABOLIC SYNDROME;CARDIOVASCULAR RISK ASSESSMENT;CORONARY FLOW RESERVE;DIASTOLIC FUNCTION;HEALTHY EATING INDEX;HYPERTENSION;DIETARY PATTERNS;LYSOSOMAL STORAGE DISORDERS;QUARTILE;TOLERABILITY;TREATMENT;BLOOD PRESSURE;DIPYRIDAMOLE;EPILEPSY;FETAL HEAD","13;12;8;7;7;7;6;6;6;6;6;5;5;5;5;5;4;4;4;4","LEFT VENTRICULAR;CANCER RISK;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;CORONARY FLOW;FLOW RESERVE;METABOLIC SYNDROME;MYOCARDIAL INFARCTION;RISK FACTORS;DIABETES MELLITUS;PROSPECTIVE STUDY;SURGICAL TREATMENT;CARDIOVASCULAR RISK;CELIAC DISEASE;CELL CARCINOMA;CHRONIC HEPATITIS;COMPUTED TOMOGRAPHY;CORONARY HEART;EMISSION COMPUTED;ENDOMETRIAL CANCER;HEART DISEASE;HYPERTENSIVE PATIENTS;ITALIAN MEDITERRANEAN;LEFT ATRIAL;MEDITERRANEAN BUFFALO;MOUSE MODEL;MULTIPLE SULFATASE;MYOCLONIC EPILEPSY;NOCTURNAL HEMOGLOBINURIA;NUTRITION EPIC","12;7;7;7;5;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;ITALY SEARCH;CORONARY ARTERY;BACILLUS SUBTILIS;GENET -CROSSREF;HELA CELLS;INT -ABSTRACT;CELL LINES;PRE-DIALYSIS PATIENTS;MEDICINE TIGEM;MITOTIC CELLS;TELETHON INSTITUTE;WESTERN BLOTTING;TIGEM NAPLES;CALCIUM CARBONATE;FRTL-K-RAS CELLS;PUBMED GOOGLE;SULFATASE ACTIVITIES;CONFIDENCE INTERVAL;FETAL HEART;HLXFS CLONE;SURG -ABSTRACT;ARTERY CALCIFICATION;CAS GOOGLE;CONDITIONED MEDIUM;HUM GENET;MEDLINE CAS;SUMF MEFS;CANCER RISK","175;113;28;26;24;24;23;23;22;19;18;18;18;18;17;16;16;16;16;15;15;15;15;14;14;14;14;14;14;13",54,0.17,9,4,1,1,2,2,6.75,1,1,4,0,1,1.5,4,2,1,1,1.25,1,0,0,85,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,9.2,416.8,0.75,3,0.6,64,0,0,2,0,3,0,0,0,0,5,0,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Japan","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","5;4;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;HEMATOLOGY;RARE DISEASES;AGING;CHRONIC PAIN;DIGESTIVE DISEASES;KIDNEY DISEASE;ORPHAN DRUG;PAIN RESEARCH;POLYCYSTIC KIDNEY DISEASE;PREVENTION","5;4;2;2;2;1;1;1;1;1;1;1;1","CANCER;ORAL AND GASTROINTESTINAL;RENAL AND UROGENITAL","1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS","4;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER","2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2008,356,9.11516853932584,3.1123595505618,0.485955056179775,0.390449438202247,0.514044943820225,1.49932341001353,1.21830985915493,1.37623762376238,1.21192052980132,0.317415730337079,7,171,85,43,35,0.48,0.24,0.12,0.1,42.69,0.77796148941138,NA,0.300561797752809,0.74438202247191,0.409,0.397,0.424,0.384,"PASQUALE STRIANO;SALVATORE STRIANO;GIOVANNI DE SIMONE;GIOVANNI TARANTINO;MARCO SALVATORE;FEDERICO PISCIONE;ALESSANDRO FILLA;GIUSEPPE DE MICHELE;GIUSEPPE CAMPANILE;MAURIZIO GALDERISI;MARCELLO CHINALI;ALFREDO GUARINO;L. ZICARELLI;GIANCARLO PARENTI;PAOLO BARONE;DANIELA MELIS;PASQUALE STRAZZULLO;FEDERICO ZARA;B. GASPARRINI;MARIA TERESA PELLECCHIA","17;14;9;8;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6","PASQUALE STRIANO;SALVATORE STRIANO;GIOVANNI DE SIMONE;RICCARDO BONFANTI;GIOVANNI TARANTINO;DIEGO IANNUZZI;WILMA BUFFOLANO;MAURIZIO GALDERISI;MARCELLO CHINALI;ALBERTO CUOCOLO;FEDERICO PISCIONE;GIOVANNA DE MINICO;GIUSEPPE SERVILLO;BRUNA GUIDA;ALDO MASULLO;DANIELA LUIGIA CAGLIOTI;MARCO SALVATORE;FEDERICO ZARA;ROSARIA SCUDIERO;FRANCESCA TRINCHELLA","2.88;1.8;1.4;1.39;1.38;1.33;1.17;1.15;1.09;1.08;1.06;1;1;1;1;1;0.96;0.94;0.93;0.93","PASQUALE STRIANO;SALVATORE STRIANO;GIOVANNI DE SIMONE;GIOVANNI TARANTINO;MARCO SALVATORE;FEDERICO PISCIONE;ALESSANDRO FILLA;GIUSEPPE DE MICHELE;GIUSEPPE CAMPANILE;MAURIZIO GALDERISI;MARCELLO CHINALI;ALFREDO GUARINO;L. ZICARELLI;GIANCARLO PARENTI;PAOLO BARONE;DANIELA MELIS;PASQUALE STRAZZULLO;B. GASPARRINI;MARIA TERESA PELLECCHIA;R. DI PALO","17;14;9;8;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6","PASQUALE STRIANO;SALVATORE STRIANO;GIOVANNI DE SIMONE;RICCARDO BONFANTI;GIOVANNI TARANTINO;DIEGO IANNUZZI;WILMA BUFFOLANO;MAURIZIO GALDERISI;MARCELLO CHINALI;ALBERTO CUOCOLO;FEDERICO PISCIONE;GIOVANNA DE MINICO;GIUSEPPE SERVILLO;BRUNA GUIDA;ALDO MASULLO;DANIELA LUIGIA CAGLIOTI;MARCO SALVATORE;ROSARIA SCUDIERO;FRANCESCA TRINCHELLA;ALFREDO GUARINO","2.88;1.8;1.4;1.39;1.38;1.33;1.17;1.15;1.09;1.08;1.06;1;1;1;1;1;0.96;0.93;0.93;0.88","ALBERTO AURICCHIO;SANDRO BANFI;ALBERT M. MAGUIRE;ARKADY LYUBARSKY;BARBARA A. KONKLE;BERND HAUCK;EDWARD N. PUGH;EDWIN M. STONE;ENRICO MARIA SURACE;ERIC A. PIERCE;FEDERICO MINGOZZI;FRANCESCA SIMONELLI;FRANCESCO TESTA;J. FRASER WRIGHT;JEAN BENNETT;JEANNETTE BENNICELLI;JENNIFER WELLMAN MCDONNELL;JIAN‐XING MA;JONATHAN B. JACOBS;JUNWEI SUN","2113;2062;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047;2047","ALBERTO AURICCHIO;GIOVANNI DE SIMONE;ANNAMARIA COLAO;PAOLO BARONE;MAURIZIO GALDERISI;FEDERICO PISCIONE;MARCELLO CHINALI;FRANCESCO RAIMONDI;PASQUALE STRIANO;SALVATORE STRIANO;MARIA TERESA PELLECCHIA;SALVATORE PANICO;ROSARIO PIVONELLO;GAETANO LOMBARDI;PIETRO VAJRO;PAOLO CAPPABIANCA;MARIA CRISTINA DE MARTINO;PASQUALE STRAZZULLO;ANTONGIULIO FAGGIANO;MONICA DE LEO","2113;769;697;524;499;486;486;458;458;450;425;425;365;360;356;336;335;319;307;307","PASQUALE STRIANO;SALVATORE STRIANO;GIOVANNI DE SIMONE;ALFREDO GUARINO;MARCELLO CHINALI;ALESSANDRO FILLA;PAOLO BARONE;GIUSEPPE DE MICHELE;ANNAMARIA COLAO;L. ZICARELLI;B. GASPARRINI;DANIELA MELIS;FEDERICO PISCIONE;GIUSEPPE CAMPANILE;MAURIZIO GALDERISI;MARIA TERESA PELLECCHIA;F. RENGO;GIANCARLO PARENTI;LUIGI SACCÀ;PASQUALE STRAZZULLO","14;12;9;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;MATERIALS SCIENCE;ECONOMICS;GEOLOGY;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;SOCIOLOGY;ART;ENVIRONMENTAL SCIENCE;HISTORY","281;121;50;43;38;25;23;19;15;10;9;9;8;6;6;6;3;3;2","INTERNAL MEDICINE;GENETICS;ENDOCRINOLOGY;PATHOLOGY;CARDIOLOGY;IMMUNOLOGY;SURGERY;BIOCHEMISTRY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;RADIOLOGY;PSYCHIATRY;PEDIATRICS;OPTICS;CELL BIOLOGY;NEUROSCIENCE;ORGANIC CHEMISTRY;VIROLOGY;ANATOMY;ECOLOGY","210;74;60;52;50;49;44;41;41;34;27;24;22;21;19;18;17;15;14;13","GENE;DISEASE;POPULATION;BLOOD PRESSURE;DIABETES MELLITUS;MYOCARDIAL INFARCTION;CANCER;EPILEPSY;OBESITY;CHEMOTHERAPY;HEART FAILURE;PREGNANCY;RECEPTOR;HORMONE;ANTIBODY;VIRUS;INSULIN;BODY MASS INDEX;ENZYME;INCIDENCE (GEOMETRY)","63;55;33;26;19;19;17;17;17;16;16;16;16;14;13;12;11;10;10;10","MUTATION;DIASTOLE;METABOLIC SYNDROME;LEFT VENTRICULAR HYPERTROPHY;PHENOTYPE;FETUS;EJECTION FRACTION;INSULIN RESISTANCE;CHROMOSOME;ALLELE;CORONARY FLOW RESERVE;GENOTYPE;BEVACIZUMAB;BREAST CANCER;CORONARY ANGIOGRAPHY;EXON;AUTOPHAGY;BASAL (MEDICINE);CONVENTIONAL PCI;CRYOPRESERVATION;ESSENTIAL THROMBOCYTHEMIA;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;GENE EXPRESSION;GESTATION;GLIADIN;HEART RATE;HEPATITIS C VIRUS;PARKINSON'S DISEASE;PARKINSONISM;PERCUTANEOUS CORONARY INTERVENTION;RECOMBINANT DNA;TISSUE TRANSGLUTAMINASE;TOLERABILITY;TYPE 2 DIABETES;UNIVARIATE ANALYSIS;WESTERN BLOT","15;13;11;10;10;9;8;8;7;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4","DOPPLER ECHOCARDIOGRAPHY;FRACTIONAL FLOW RESERVE;DOPPLER IMAGING;KARYOTYPE;PRENATAL DIAGNOSIS;ABCIXIMAB;BLASTOCYST;COMPOUND HETEROZYGOSITY;DIASTOLIC FUNCTION;HAPLOTYPE;MISSENSE MUTATION;MITOPHAGY;PROBAND;ACROMEGALY;ALTERNATIVE SPLICING;BUSERELIN;ECULIZUMAB;EMBRYO CULTURE;FLUORESCENCE IN SITU HYBRIDIZATION;GENE FAMILY;HERPESVIRIDAE;HETEROZYGOTE ADVANTAGE;LOSARTAN;LRRK2;MAMMOGRAPHY;NORMAL PRESSURE HYDROCEPHALUS;PRIMARY CILIARY DYSKINESIA;REPRODUCTIVE TECHNOLOGY;RETEPLASE;RIBAVIRIN;VECTOR (MOLECULAR BIOLOGY);VERY LOW-DENSITY LIPOPROTEIN;VITRONECTIN","11;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;ADOLESCENT;ANIMALS;HYPERTROPHY, LEFT VENTRICULAR;ITALY;TREATMENT OUTCOME;CARDIOVASCULAR DISEASES;HEPATITIS C, CHRONIC;METABOLIC SYNDROME;HYPERTENSION;FOLLOW-UP STUDIES;PROSPECTIVE STUDIES;RETROSPECTIVE STUDIES;AGED, 80 AND OVER","216;166;159;118;114;104;73;34;32;31;30;29;26;25;25;24;23;22;22;21","RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;GLYCOGEN METABOLISM AND MYOCLONIC DISORDERS;HEPATITIS C INFECTION AND TREATMENT;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;EPILEPSY AND SEIZURES;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;LYMPHOID NEOPLASMS;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;AGE-RELATED MACULAR DEGENERATION RESEARCH;GASTROINTESTINAL VIRAL INFECTIONS AND VACCINES DEVELOPMENT;IMPACT OF HIV INFECTION ON CARDIOVASCULAR HEALTH;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS","10;9;8;7;6;6;6;6;4;4;4;4;4;4;3;3;3;3;3;3","LEFT VENTRICULAR FUNCTION;CARDIAC IMAGING;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;DIASTOLIC FUNCTION;HYPERTENSION;STROKE (ENGINE);CORONARY FLOW RESERVE;ECHOCARDIOGRAPHY;CONCOMITANT;DIAGNOSIS;EPILEPSY;FRACTIONAL FLOW RESERVE;GLUTEN SENSITIVITY;METABOLIC SYNDROME;AORTIC DISSECTION;BASAL (MEDICINE);CARDIAC METABOLISM;CELIAC DISEASE;DIAGNOSTIC CRITERIA","17;14;9;7;7;7;7;6;6;5;5;5;5;5;5;4;4;4;4;4","LEFT VENTRICULAR;METABOLIC SYNDROME;CELIAC DISEASE;CORONARY FLOW;FLOW RESERVE;CHRONIC HEPATITIS;CORONARY ARTERY;TYPE DIABETES;BUBALUS BUBALIS;ESSENTIAL THROMBOCYTHEMIA;EUROPEAN PROSPECTIVE;HEART FAILURE;INSULIN RESISTANCE;LEFT ATRIAL;LIVER DISEASE;PROSPECTIVE INVESTIGATION;ANTIVIRAL THERAPY;ARTERY DISEASE;ATRIAL SYSTOLIC;BUFFALO BUBALUS;CARDIOVASCULAR EVENTS;CHEST PAIN;CYSTIC FIBROSIS;FILLING PRESSURE;GENE POLYMORPHISMS;GLYCOGEN STORAGE;GROWTH HORMONE;HYPERTENSIVE PATIENTS;HYPERTROPHIC CARDIOMYOPATHY;LATERAL TEMPORAL","13;8;6;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;GASTRIC EMPTYING;LIVER DISEASE;HIV-INFECTED CHILDREN;CELIAC DISEASE;DIS SCI;SCI -CROSSREF;MALATTIE METABOLICHE;METABOLICHE IRCCS;AUTOIMMUNE LIVER;DYSPEPTIC SYMPTOMS;LIVER DAMAGE;DYSPEPTIC CHILDREN;IMMUNOSUPPRESSIVE THERAPY;METABOLIC SYNDROME;EMPTYING TIME;JOINT SYMPTOMS;BURLO GAROFOLO;DI MALATTIE;DIAGNOSI PRE-POSTNATALE;GENOVA ITALYSEARCH;GGASLINI GENOVA;GI TRACT;HIV INFECTION;IRCCS BURLO;IRCCS GGASLINI;PRE-POSTNATALE MALATTIE;RECTAL DISTENSION;RV VACCINATION","86;68;41;28;23;22;21;21;20;18;17;15;13;12;12;12;11;11;10;10;10;10;10;10;10;10;10;10;10;10",57,0.16,6,3,2,1,0,8.5,5,1,1,3,0,1,5,1,2,1,2.75,4,1.5,0,0,75,75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,9.6,255.75,0.72,1,0.2,39.4,0,0,2,0,0,0,1,2,0,3,2,0,0,0,0,0,0,5,0,0,5,0,0,0,0,0,0,0,0,0,"Italy;United States","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY","5;3;2;1;1","CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;CANCER;HEMATOLOGY;PATIENT SAFETY;ARTHRITIS;AUTOIMMUNE DISEASE;BIOMEDICAL IMAGING;LYMPHOMA;PEDIATRIC CANCER;REGENERATIVE MEDICINE;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;TRANSPLANTATION","4;4;3;3;2;2;2;1;1;1;1;1;1;1;1;1","CANCER;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE","2;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS","3;1;1","HODGKIN'S DISEASE;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA","1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING","2;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2009,368,9.73913043478261,3.0679347826087,0.483695652173913,0.456521739130435,0.535326086956522,1.47258485639687,1.26241134751773,1.25373134328358,1.25477707006369,0.383152173913043,9,187,87,40,35,0.51,0.24,0.11,0.1,46.68,1.00918436029574,NA,0.296195652173913,0.722826086956522,0.426,0.388,0.41,0.411,"KIM OVERVAD;­ROSARIO ­TUMINO;DOMENICO PALLI;ELIO RÍBOLI;KAY‐TEE KHAW;GIOVANNI TARANTINO;HEINER BOEING;ANTONIA TRICHOPOULOU;ANNE TJØNNELAND;SHEILA BINGHAM;SALVATORE PANICO;JONAS MANJER;EILIV LUND;PAOLO VINEIS;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;PETRA H. PEETERS;RUDOLF KAAKS;PASQUALE STRIANO;ANNAMARIA COLAO","13;13;13;13;11;11;11;11;11;11;10;10;10;10;10;10;10;9;9;8","RAIMONDO FORTE;SALVATORE STRIANO;PASQUALE STRIANO;GIOVANNI TARANTINO;GIOVANNI DI MINNO;FRANCO CONTALDO;RAFFAELE RAGONE;MARIA FIAMMETTA ROMANO;SILVIA SAVASTANO;MATTEO NICOLA DARIO DI MINNO;GIOVANNI DE SIMONE;PAOLO STASSANO;LUIGI DI TOMMASO;MASSIMO CHIARIELLO;GUGLIELMO BORGIA;FRANCESCO TRAMONTANO;GIOVANNA DE MINICO;FEDERICO GUARRACINO;MIRONE;PAOLO CONCA","2.25;1.66;1.61;1.49;1.43;1.39;1.34;1.33;1.24;1.21;1.2;1.12;1.12;1.11;1.11;1;1;1;1;0.96","GIOVANNI TARANTINO;SALVATORE PANICO;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;PASQUALE STRIANO;ANNAMARIA COLAO;MATTEO NICOLA DARIO DI MINNO;RAIMONDO FORTE;FRANCO CONTALDO;SALVATORE STRIANO;GIANCARLO PARENTI;BRUNO ROTOLI;ANGELA A. RIVELLESE;VINCENZO MIRONE;PAOLO STASSANO;FABRIZIO PANE;PAOLO CONCA;LUIGI DI TOMMASO;FABRIZIO PASANISI;GABRIELE RICCARDI","11;10;10;10;9;8;8;8;8;8;7;7;7;7;7;7;7;7;6;6","RAIMONDO FORTE;SALVATORE STRIANO;PASQUALE STRIANO;GIOVANNI TARANTINO;GIOVANNI DI MINNO;FRANCO CONTALDO;RAFFAELE RAGONE;MARIA FIAMMETTA ROMANO;SILVIA SAVASTANO;MATTEO NICOLA DARIO DI MINNO;GIOVANNI DE SIMONE;PAOLO STASSANO;LUIGI DI TOMMASO;MASSIMO CHIARIELLO;GUGLIELMO BORGIA;FRANCESCO TRAMONTANO;GIOVANNA DE MINICO;FEDERICO GUARRACINO;MIRONE;PAOLO CONCA","2.25;1.66;1.61;1.49;1.43;1.39;1.34;1.33;1.24;1.21;1.2;1.12;1.12;1.11;1.11;1;1;1;1;0.96","GIANCARLO PARENTI;FRANCESCA DONAUDY;ALBERTO DI RONZA;ANDREA BALLABIO;CHIARA DI MALTA;DIEGO L. MEDINA;ELENA CATTANEO;MARCO SARDIELLO;MARTA VALENZA;MICHELA PALMIERI;ROMAN POLISHCHUK;SANDRO BANFI;VALERIO EMBRIONE;VINCENZO A. GENNARINO;ELIO RÍBOLI;KIM OVERVAD;DOMENICO PALLI;­ROSARIO ­TUMINO;HEINER BOEING;ANNE TJØNNELAND","2516;2273;2187;2187;2187;2187;2187;2187;2187;2187;2187;2187;2187;2187;1489;1489;1468;1468;1393;1325","GIANCARLO PARENTI;ANDREA BALLABIO;SALVATORE PANICO;GIOVANNI DE SIMONE;AMALIA MATTIELLO;FABRIZIO PANE;GIOVANNI TARANTINO;MAURIZIO GALDERISI;ANGELA A. RIVELLESE;GABRIELE RICCARDI;ANNAMARIA COLAO;PAOLO STASSANO;LUIGI DI TOMMASO;BRUNO ROTOLI;ANTONIO M. RISITANO;EZIO RICCA;VINCENZO LA VALVA;BERNADETTE BIONDI;ANDREA CAMERA;ELISA SENECA","2506;2187;972;845;778;642;588;480;471;471;466;464;453;372;343;337;314;313;308;307","GIOVANNI TARANTINO;GIOVANNI DE SIMONE;MASSIMO CHIARIELLO;SALVATORE PANICO;RAIMONDO FORTE;ANNAMARIA COLAO;SALVATORE STRIANO;FRANCO CONTALDO;ANGELA A. RIVELLESE;PAOLO STASSANO;GABRIELE RICCARDI;GIANCARLO PARENTI;BRUNO ROTOLI;FABRIZIO PANE;GAETANO LOMBARDI;LUIGI DI TOMMASO;ANTONIO M. RISITANO;VINCENZO MIRONE;AMALIA MATTIELLO;GIOVANNI ESPOSITO","11;10;10;10;8;8;7;7;7;7;6;6;6;6;6;6;6;6;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;PSYCHOLOGY;ENGINEERING;MATERIALS SCIENCE;SOCIOLOGY;ECONOMICS;BUSINESS;POLITICAL SCIENCE;GEOGRAPHY;GEOLOGY;ENVIRONMENTAL SCIENCE;PHILOSOPHY","304;121;48;41;38;22;18;17;17;11;10;7;7;6;5;4;2","INTERNAL MEDICINE;GENETICS;ENDOCRINOLOGY;SURGERY;PATHOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;CARDIOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;PSYCHIATRY;PEDIATRICS;RADIOLOGY;OPTICS;ONCOLOGY;CELL BIOLOGY;ECOLOGY;ORGANIC CHEMISTRY;MOLECULAR BIOLOGY;NUCLEAR MEDICINE","230;60;59;59;57;56;55;50;43;33;29;25;24;22;19;15;15;14;13;13","GENE;DISEASE;CANCER;POPULATION;BLOOD PRESSURE;ANTIBODY;BODY MASS INDEX;OBESITY;DIABETES MELLITUS;RECEPTOR;CONFIDENCE INTERVAL;HEART FAILURE;HORMONE;PROSPECTIVE COHORT STUDY;VIRUS;CHEMOTHERAPY;MYOCARDIAL INFARCTION;MYELOID LEUKEMIA;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;COHORT;EPILEPSY;LEUKEMIA","53;46;30;30;24;23;23;20;16;16;15;15;14;14;14;13;13;12;12;11;11;11;11","EJECTION FRACTION;HAZARD RATIO;PHENOTYPE;WAIST;DIASTOLE;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;METABOLIC SYNDROME;MUTATION;REVASCULARIZATION;COMPLEMENT SYSTEM;IMATINIB;OVERWEIGHT;BREAST CANCER;CLINICAL ENDPOINT;GROWTH HORMONE;HEMOGLOBINURIA;HEPATITIS C VIRUS;INSULIN RESISTANCE;WEIGHT LOSS;CHROMOSOME;FATTY LIVER;FETUS;GENE EXPRESSION;GENOTYPE;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;TOLERABILITY;TYPE 2 DIABETES;VIRAL LOAD","10;10;9;9;8;8;8;8;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5","ECULIZUMAB;IMATINIB MESYLATE;RIBAVIRIN;STROKE VOLUME;ABDOMINAL OBESITY;ANTIRETROVIRAL THERAPY;INSULIN-LIKE GROWTH FACTOR;NILOTINIB;NONALCOHOLIC FATTY LIVER DISEASE;OSTEOPENIA;VERY LOW-DENSITY LIPOPROTEIN;ANDROGEN RECEPTOR;ATAXIA-TELANGIECTASIA;BLASTOCYST;CAPECITABINE;CARDIAC RESYNCHRONIZATION THERAPY;CD59;CHEMICAL CHAPERONE;CORONARY STENT;CYTOGENETICS;DASATINIB;DOPPLER ECHOCARDIOGRAPHY;ESOPHAGITIS;FLUORESCENCE IN SITU HYBRIDIZATION;GENE MUTATION;GROWTH HORMONE DEFICIENCY;HEART RATE VARIABILITY;HEARTBURN;IMAGE TEXTURE;INEFFECTIVE ERYTHROPOIESIS;KARYOTYPE;LOW-AFFINITY NERVE GROWTH FACTOR RECEPTOR;MIMO-OFDM;MISSENSE MUTATION;PHY;POLYMORPHISM (COMPUTER SCIENCE);PRIMARY CILIARY DYSKINESIA;PROMOTER;REED–STERNBERG CELL;SCALE-SPACE SEGMENTATION;SINGLE-NUCLEOTIDE POLYMORPHISM;TROPOMYOSIN RECEPTOR KINASE A;WAIST–HIP RATIO","7;7;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;;AGED;ITALY;HYPERTENSION;TREATMENT OUTCOME;ADOLESCENT;OBESITY;YOUNG ADULT;ANIMALS;CHILD;FOLLOW-UP STUDIES;RISK FACTORS;CARDIOVASCULAR DISEASES;PROSPECTIVE STUDIES;EPILEPSY","239;190;178;123;118;103;82;51;47;47;43;40;39;37;32;31;31;29;29;28","EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EFFICACY AND RESISTANCE IN CML TREATMENT;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;ACUTE MYELOID LEUKEMIA;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND MANAGEMENT OF GASTROESOPHAGEAL REFLUX DISEASE;EPILEPSY AND SEIZURES;HEPATITIS C INFECTION AND TREATMENT;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DENTAL IMPLANTOLOGY AND PERI-IMPLANT DISEASES;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;LYMPHOID NEOPLASMS;PREVENTION AND TREATMENT OF HIV/AIDS INFECTION;AGE-RELATED MACULAR DEGENERATION RESEARCH;AMYOTROPHIC LATERAL SCLEROSIS AND FRONTOTEMPORAL DEMENTIA;CARDIAC SURGERY AND BYPASS GRAFTING OUTCOMES;GEOPHYSICAL EXPLORATION AND MONITORING TECHNIQUES","13;7;7;6;5;5;5;5;5;5;5;5;4;4;4;4;3;3;3;3","LEFT VENTRICULAR FUNCTION;TREATMENT;HYPERTENSION;ECHOCARDIOGRAPHY;ECULIZUMAB;IMATINIB;IMATINIB MESYLATE;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;CARDIOVASCULAR RISK ASSESSMENT;CLINICAL ENDPOINT;HEMOGLOBINURIA;METABOLISM;REGIMEN;STEATOSIS;EPILEPSY;HEPATITIS C;INTERQUARTILE RANGE;MYOCARDIAL REVASCULARIZATION;TOLERABILITY;ANTIRETROVIRAL THERAPY","13;11;9;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;4","EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;LEFT VENTRICULAR;CHRONIC MYELOID;MYELOID LEUKEMIA;NOCTURNAL HEMOGLOBINURIA;PAROXYSMAL NOCTURNAL;CANCER RISK;RISK FACTORS;COMPUTED TOMOGRAPHY;HEART FAILURE;PHASE II;BLOOD PRESSURE;HEMOGLOBINURIA PNH;MAGNETIC RESONANCE;SOUTHERN ITALY;WEIGHT LOSS;CORONARY ARTERY;EMISSION COMPUTED;GIMEMA CML;GIMEMA EXPERIENCE;GROWTH FACTOR;GROWTH HORMONE;HEPATIC STEATOSIS;HYPERTENSIVE PATIENTS;IATROGENIC MALNUTRITION;II STUDY;ITALY STUDY;LONGITUDINAL STUDY;METABOLIC SYNDROME","10;10;8;7;7;7;7;6;6;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","BLOOD PRESSURE;AMICUS THERAPEUTICS;POMPE DISEASE;CANCER RISK;HR CI;II UNIVERSITY;BREAST CANCER;METABOLIC SYNDROME;PEDIATRICS FEDERICO;INCREASED RISK;INSULIN RESISTANCE;LDL CHOLESTEROL;MPS IIIB;NAPLES ITALYSEARCH;UNIVERSITY NAPLES;VAN DER;ACID ALPHA-GLUCOSIDASE;MASS INDEX;REPLACEMENT THERAPY;SPLENO-RENAL SHUNTS;WAIST CIRCUMFERENCE;BODY MASS;EUROPEAN PROSPECTIVE;HYPERTENSIVE PATIENTS;MM HG;PANCREATIC CANCER;PROSPECTIVE INVESTIGATION;LEFT VENTRICULAR;RECOMBINANT HUMAN;REUSER AJ","33;20;20;17;17;17;15;15;14;13;13;12;12;12;12;12;11;11;11;11;11;10;10;10;10;10;10;9;9;9",63,0.17,8,3,3.5,1,0,2,7.5,1,1.5,4,0,1,2.25,1,2.25,1,1,9,2.5,0,0,105,105.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,7.86,593.57,0.95,1,0.14,42.57,0,0,1,0,4,0,1,1,0,6,1,0,0,0,0,0,0,4,1,2,7,0,0,0,0,0,0,0,0,0,"United States;Japan","2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","7;6;4","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;PATIENT SAFETY;PROSTATE CANCER;RARE DISEASES;UROLOGIC DISEASES;AGING;BRAIN DISORDERS;CERVICAL CANCER;COLO-RECTAL CANCER;DIGESTIVE DISEASES;LUNG;NEUROSCIENCES;PEDIATRIC;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;STEM CELL RESEARCH","6;5;4;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER","3","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","7;1","PROSTATE CANCER;BONE CANCER, OSTEOSARCOMA / MALIGNANT FIBROUS HISTIOCYTOMA;CERVICAL CANCER;NOT SITE-SPECIFIC CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","4;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2010,340,10.9117647058824,3.23823529411765,0.502941176470588,0.426470588235294,0.558823529411765,1.57142857142857,1.23913043478261,1.38095238095238,1.23376623376623,0.364705882352941,8,167,74,45,29,0.49,0.22,0.13,0.09,39.6,0.87635363913366,NA,0.367647058823529,0.717647058823529,0.412,0.387,0.399,0.387,"­ROSARIO ­TUMINO;ANNE TJØNNELAND;KIM OVERVAD;ELIO RÍBOLI;GIOVANNI DE SIMONE;SALVATORE PANICO;RUDOLF KAAKS;KAY‐TEE KHAW;ANTONIA TRICHOPOULOU;HEINER BOEING;EILIV LUND;PAOLO VINEIS;MARCELLO CHINALI;PETRA H. PEETERS;NADIA SLIMANI;JONAS MANJER;B. GASPARRINI;DOMENICO PALLI;BRUNO TRIMARCO;AMALIA MATTIELLO","18;18;16;16;16;14;13;13;13;12;12;12;11;11;10;10;10;10;9;9","FRANCESCO VERDE;GIOVANNI DE SIMONE;MATTEO NICOLA DARIO DI MINNO;ANNA SCAGLIONE;A. NIZZA;B. GASPARRINI;MARCELLO CHINALI;BRUNO TRIMARCO;FEDERICO PISCIONE;MAURIZIO GALDERISI;LUIGI SACCÀ;GIOVANNA DE MINICO;MARCELLO PERSICO;GIOVANNI LAINO;UGO OLIVIERO;STEFANIA ERRICO;DAVIDE LEOPARDO;PASQUALE STRAZZULLO;MASSIMO CHIARIELLO;BOGDAN LUDUSAN","1.95;1.86;1.74;1.7;1.33;1.31;1.27;1.22;1.16;1.02;1;1;1;1;1;1;1;0.95;0.93;0.92","GIOVANNI DE SIMONE;SALVATORE PANICO;MARCELLO CHINALI;B. GASPARRINI;BRUNO TRIMARCO;AMALIA MATTIELLO;MAURIZIO GALDERISI;FEDERICO PISCIONE;MASSIMO CHIARIELLO;MATTEO NICOLA DARIO DI MINNO;PASQUALE STRAZZULLO;ANNAMARIA COLAO;FRANCESCO VERDE;ANTONIO RAPACCIUOLO;M. DE MARCO;GIOVANNI DI MINNO;DANIELA GIRFOGLIO;RAIMONDO FORTE;RAFFAELE IZZO;NICOLA DE LUCA","16;14;11;10;9;9;9;8;8;7;7;6;6;6;6;6;5;5;5;5","FRANCESCO VERDE;GIOVANNI DE SIMONE;MATTEO NICOLA DARIO DI MINNO;A. NIZZA;B. GASPARRINI;MARCELLO CHINALI;BRUNO TRIMARCO;FEDERICO PISCIONE;MAURIZIO GALDERISI;LUIGI SACCÀ;GIOVANNA DE MINICO;MARCELLO PERSICO;GIOVANNI LAINO;UGO OLIVIERO;STEFANIA ERRICO;DAVIDE LEOPARDO;PASQUALE STRAZZULLO;MASSIMO CHIARIELLO;BOGDAN LUDUSAN;ANTONIO ORIGLIA","1.95;1.86;1.74;1.33;1.31;1.27;1.22;1.16;1.02;1;1;1;1;1;1;1;0.95;0.93;0.92;0.92","ANNE TJØNNELAND;ELIO RÍBOLI;SALVATORE PANICO;NAOMI E. ALLEN;­ROSARIO ­TUMINO;PAOLO VINEIS;KIM OVERVAD;H. BAS BUENO-DE-MESQUITA;FRANÇOISE CLAVEL‐CHAPELON;KAY‐TEE KHAW;PETRA H. PEETERS;CARMEN NAVARRO;DIMITRIOS TRICHOPOULOS;HEINER BOEING;CARLOTTA SACERDOTE;MARÍA‐JOSÉ SÁNCHEZ;RUDOLF KAAKS;BÖRJE LJUNGBERG;LAMBERTUS A. KIEMENEY;KATJA K.H. ABEN","1610;1506;1360;1299;1154;1053;1014;992;978;962;958;948;920;891;852;809;808;795;795;765","SALVATORE PANICO;GIOVANNI DE SIMONE;ANDREA BALLABIO;CARMELA BRAVACCIO;ADRIANO MAGLI;TERESA DE BERARDINIS;MAURIZIO GALDERISI;CLAUDIO PIGNATA;NICOLA BRUNETTI‐PIERRI;ALESSANDRO LUCIANI;SPERANZA ESPOSITO;STEFANO GUIDO;VALERIA RACHELA VILLELLA;VALERIA RAIA;AMALIA MATTIELLO;EMILIA CIRILLO;MATTEO NICOLA DARIO DI MINNO;ALESSANDRO SANTORO;V. SCHIANO LOMORIELLO;MARINELLA OLIBET","1360;688;644;638;545;545;495;480;448;437;437;437;437;437;362;357;348;336;336;334","GIOVANNI DE SIMONE;SALVATORE PANICO;B. GASPARRINI;MAURIZIO GALDERISI;AMALIA MATTIELLO;BRUNO TRIMARCO;MARCELLO CHINALI;MATTEO NICOLA DARIO DI MINNO;PASQUALE STRAZZULLO;ANNAMARIA COLAO;FEDERICO PISCIONE;MASSIMO CHIARIELLO;GIOVANNI DI MINNO;FRANCESCO VERDE;GAETANO LOMBARDI;M. DE MARCO;CLAUDIO PIGNATA;RAFFAELE IZZO;DANIELA GIRFOGLIO;GABRIELE RICCARDI","15;14;10;9;9;9;9;7;7;7;7;7;6;6;6;6;5;5;5;5","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;POLITICAL SCIENCE;GEOGRAPHY;ART;ENVIRONMENTAL SCIENCE;GEOLOGY","271;118;49;37;32;20;20;19;18;13;10;10;8;7;6;5;4;4","INTERNAL MEDICINE;GENETICS;ENDOCRINOLOGY;CARDIOLOGY;SURGERY;BIOCHEMISTRY;PATHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;IMMUNOLOGY;CELL BIOLOGY;PSYCHIATRY;PEDIATRICS;RADIOLOGY;CANCER RESEARCH;ANATOMY;ECOLOGY;ONCOLOGY;OPTICS;ORGANIC CHEMISTRY","203;59;58;51;45;44;37;34;30;30;28;25;23;20;18;17;16;15;14;14","GENE;BLOOD PRESSURE;CANCER;POPULATION;DISEASE;CONFIDENCE INTERVAL;DIABETES MELLITUS;PROSPECTIVE COHORT STUDY;BODY MASS INDEX;HEART FAILURE;OBESITY;RECEPTOR;COHORT;PROPORTIONAL HAZARDS MODEL;ANTIBODY;MYOCARDIAL INFARCTION;ODDS RATIO;PREGNANCY;TRANSPLANTATION;COHORT STUDY","48;40;35;30;29;25;23;22;21;20;20;17;14;12;11;11;11;11;11;10","DIASTOLE;EJECTION FRACTION;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HAZARD RATIO;METABOLIC SYNDROME;GENOTYPE;LEFT VENTRICULAR HYPERTROPHY;MUTATION;BREAST CANCER;COLORECTAL CANCER;HEART RATE;TYPE 2 DIABETES;WAIST;ALLELE;INSULIN RESISTANCE;PHENOTYPE;RELATIVE RISK;RELAY;CAPACITATION;CROHN'S DISEASE;EMBRYOGENESIS;GENE EXPRESSION;GENOME;GROWTH FACTOR;HAEMATOPOIESIS;INFLAMMATORY BOWEL DISEASE;NEPHRECTOMY;OVERWEIGHT;PERCUTANEOUS CORONARY INTERVENTION;PLACEBO;PROTEIN KINASE B;RECOMBINANT DNA","19;14;13;13;12;10;10;8;7;7;6;6;6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4","DOPPLER ECHOCARDIOGRAPHY;SINGLE-NUCLEOTIDE POLYMORPHISM;DIASTOLIC FUNCTION;STROKE VOLUME;COOPERATIVE DIVERSITY;SPECKLE TRACKING ECHOCARDIOGRAPHY;VINCRISTINE;ACROMEGALY;BAG3;BLASTOCYST;CHEMOKINE RECEPTOR;COMPLEMENTATION;CONCENTRIC HYPERTROPHY;CORONARY STENT;DOPPLER IMAGING;GENOTYPING;HERITABILITY OF AUTISM;HLA-B;HORMONE THERAPY;INSULIN-LIKE GROWTH FACTOR;MACULOPATHY;NONALCOHOLIC FATTY LIVER DISEASE;P38 MITOGEN-ACTIVATED PROTEIN KINASES;RANIBIZUMAB;SOMATOSTATIN RECEPTOR 2;SPACE–TIME BLOCK CODE;TOTAL MESORECTAL EXCISION","6;6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;FEMALE;MALE;;MIDDLE AGED;ADULT;AGED;ITALY;HYPERTROPHY, LEFT VENTRICULAR;ADOLESCENT;YOUNG ADULT;RISK FACTORS;CHILD;TREATMENT OUTCOME;ANIMALS;FOLLOW-UP STUDIES;HEART FAILURE;EUROPE;PROSPECTIVE STUDIES;OBESITY","198;155;148;119;101;88;77;38;36;35;31;30;29;27;26;26;26;25;23;22","RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;AGE-RELATED MACULAR DEGENERATION RESEARCH;COOPERATIVE DIVERSITY IN WIRELESS NETWORKS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;EPILEPSY AND SEIZURES;LYMPHOID NEOPLASMS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;PERCEPTION AND FACTORS OF RABBIT MEAT QUALITY;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;FERTILITY PRESERVATION IN CANCER PATIENTS;GENE THERAPY TECHNIQUES AND APPLICATIONS;GLIOMAS;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;MALE REPRODUCTIVE HEALTH","12;5;5;5;5;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3","LEFT VENTRICULAR FUNCTION;ECHOCARDIOGRAPHY;CARDIOVASCULAR RISK ASSESSMENT;HYPERTENSION;DIASTOLIC FUNCTION;METABOLIC SYNDROME;STROKE (ENGINE);CARDIAC IMAGING;CARDIOVASCULAR RISK;COOPERATIVE RELAYING;NETWORK CODING;BUBALUS;CAPACITATION;CARDIAC METABOLISM;HEART RATE VARIABILITY;MACULAR DEGENERATION;MAGNETIC RESONANCE IMAGING;SUBCLINICAL INFECTION;TREATMENT;ANGIOLOGY","15;10;8;8;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;3","LEFT VENTRICULAR;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;METABOLIC SYNDROME;BUBALUS BUBALIS;CANCER RISK;HEART FAILURE;BUFFALO BUBALUS;MAGNETIC RESONANCE;BREAST CANCER;RESONANCE IMAGING;VENTRICULAR HYPERTROPHY;VENTRICULAR MASS;AUTISM SPECTRUM;CARDIOVASCULAR RISK;CELL CARCINOMA;PATIENTS TREATED;TYPE DIABETES;AGE-RELATED MACULAR;ARTERIAL HYPERTENSION;ASSOCIATION STUDY;BLADDER CANCER;BOWEL DISEASE;CARDIAC MAGNETIC;CARDIOVASCULAR EVENTS;CENTRAL INDIA;CHEMINFORM ABSTRACT;COHORT STUDY;CORONARY ARTERY;DIABETIC PATIENTS","16;11;11;9;8;7;7;6;6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;GENET -CROSSREF;FETAL DNA;MATERNAL PLASMA;LV MASS;LEFT VENTRICULAR;PRENATAL DIAGNOSIS;LAU TK;MATERNAL BLOOD;NONINVASIVE PRENATAL;STAGE III;LEUNG TN;MED GENET;CANCER RISK;MEDICINE DEPARTMENT;MPS VI;PEDIATRICS UNIVERSITY;BREAST CANCER;FLNA GENE;HUM GENET;LV GEOMETRY;RET REARRANGEMENTS;BLOOD CELL;BLOOD PRESSURE;GRAECIA CATANZARO;MAGNA GRAECIA;NPM MUTATION;UNIVERSITY MAGNA;VENTRICULAR LV","76;61;22;20;19;18;16;16;15;14;14;14;13;13;12;12;12;12;11;11;11;11;11;10;10;10;10;10;10;10",58,0.17,6,3,1,1.5,1.5,2,4.75,1,1,4,0,1,2,2.5,1,1,1,1,1,0,0,107.5,107.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,4.17,305.17,0.9,0,0,40.83,1,0,0,0,3,0,0,2,0,5,1,0,0,0,0,0,0,6,0,0,6,0,0,0,0,0,0,0,0,0,"Italy;Japan;United States","1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","6;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;HEMATOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;PATIENT SAFETY;ATHEROSCLEROSIS;BEHAVIORAL AND SOCIAL SCIENCE;BRAIN DISORDERS;CARDIOVASCULAR;DIABETES;MENTAL HEALTH;SCHIZOPHRENIA;SERIOUS MENTAL ILLNESS;STEM CELL RESEARCH;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN","6;4;3;3;2;2;1;1;1;1;1;1;1;1;1;1","BLOOD;CANCER;CARDIOVASCULAR","1;1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS","4;1;1","LEUKEMIA / LEUKAEMIA","2","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2011,396,11.520202020202,3.15909090909091,0.452020202020202,0.439393939393939,0.505050505050505,1.65039577836412,1.23448275862069,1.392,1.27388535031847,0.421717171717172,6,193,97,26,41,0.49,0.24,0.07,0.1,49.38,1.1609766294303,NA,0.366161616161616,0.755050505050505,0.433,0.425,0.421,0.426,"­ROSARIO ­TUMINO;GIOVANNI DE SIMONE;ELIO RÍBOLI;ANNE TJØNNELAND;KIM OVERVAD;RUDOLF KAAKS;DOMENICO PALLI;ANTONIA TRICHOPOULOU;CARLOTTA SACERDOTE;HEINER BOEING;NICHOLAS J. WAREHAM;FRANCESCA L. CROWE;KAY‐TEE KHAW;B. GASPARRINI;MARIE‐CHRISTINE BOUTRON‐RUAULT;GIOVANNI DI MINNO;SALVATORE PANICO;BRUNO TRIMARCO;MAZDA JENAB;PETRA H. PEETERS","24;21;20;20;19;17;17;15;14;14;14;13;12;12;12;12;11;11;11;11","GIOVANNI DI MINNO;GIOVANNI TARANTINO;GIOVANNI DE SIMONE;B. GASPARRINI;BRUNO TRIMARCO;FRANCESCO VERDE;RAFFAELE SCARPA;ROSARIO PELUSO;ANGELA A. RIVELLESE;MARINA DE MARCO;M. RUBESSA;MATTEO NICOLA DARIO DI MINNO;A. CONTI;MARIA ALESSIO;LUIGI CAMERA;RENATA DEL GIUDICE;EMILIANO GRIMALDI;M. DE BLASI;FRANCESCO SANTULLO;ANNAMARIA COLAO","2.8;2.56;2.56;1.62;1.34;1.2;1.16;1.16;1.15;1.11;1.11;1.1;1.1;1.1;1.08;1.04;1;1;0.98;0.96","GIOVANNI DE SIMONE;B. GASPARRINI;GIOVANNI DI MINNO;SALVATORE PANICO;BRUNO TRIMARCO;ANNAMARIA COLAO;AMALIA MATTIELLO;MARINA DE MARCO;MATTEO NICOLA DARIO DI MINNO;M. RUBESSA;RENATA DEL GIUDICE;MARIA ALESSIO;FRANCESCO SANTULLO;M. DE BLASI;ANGELA A. RIVELLESE;MARCELLO CHINALI;RAFFAELE SCARPA;ROSARIO PELUSO;FRANCESCA SANTAMARIA;SILVIA MONTELLA","21;12;12;11;11;10;10;9;8;8;8;8;7;7;7;7;7;7;6;6","GIOVANNI DI MINNO;GIOVANNI TARANTINO;GIOVANNI DE SIMONE;B. GASPARRINI;BRUNO TRIMARCO;FRANCESCO VERDE;RAFFAELE SCARPA;ROSARIO PELUSO;ANGELA A. RIVELLESE;MARINA DE MARCO;M. RUBESSA;MATTEO NICOLA DARIO DI MINNO;A. CONTI;MARIA ALESSIO;LUIGI CAMERA;RENATA DEL GIUDICE;EMILIANO GRIMALDI;M. DE BLASI;FRANCESCO SANTULLO;ANNAMARIA COLAO","2.8;2.56;2.56;1.62;1.34;1.2;1.16;1.16;1.15;1.11;1.11;1.1;1.1;1.1;1.08;1.04;1;1;0.98;0.96","ANDREA BALLABIO;MARCO SARDIELLO;DIEGO L. MEDINA;PASQUALINA COLELLA;CARMINE SETTEMBRE;CHIARA DI MALTA;DAVID C. RUBINSZTEIN;FRANCESCO VETRINI;MOISÉS GARCÍA-ARENCIBIA;SERKAN ERDIN;SERPIL UCKAC ERDIN;TUONG HUYNH;VINICIA ASSUNTA POLITO;­ROSARIO ­TUMINO;ELIO RÍBOLI;ANNE TJØNNELAND;KIM OVERVAD;ANTONIA TRICHOPOULOU;HEINER BOEING;MICHELA PALMIERI","4913;4320;3424;2822;2785;2785;2785;2785;2785;2785;2785;2785;2785;1976;1903;1885;1757;1584;1481;1480","ANDREA BALLABIO;SALVATORE PANICO;AMALIA MATTIELLO;MASSIMO TRIGGIANI;NICOLA LONGO;VINCENZO MIRONE;FABIANA CASTIGLIONE;SALVATORE STRIANO;ANNAMARIA COLAO;MAURIZIO GALDERISI;RAFFAELE SCARPA;ROSARIO PELUSO;ALESSANDRO FILLA;ALBERTO AURICCHIO;GIOVANNI DE SIMONE;GIOVANNI TARANTINO;SANTO DELLEGROTTAGLIE;GIOVANNI DI MINNO;FABRIZIO PASANISI;FRANCO CONTALDO","4913;1121;672;574;521;521;353;332;327;323;315;315;311;305;297;286;270;262;258;258","GIOVANNI DE SIMONE;B. GASPARRINI;GIOVANNI DI MINNO;SALVATORE PANICO;BRUNO TRIMARCO;AMALIA MATTIELLO;ANNAMARIA COLAO;GIOVANNI TARANTINO;M. RUBESSA;MARIA ALESSIO;MARINA DE MARCO;ANGELA A. RIVELLESE;M. DE BLASI;FRANCESCO SANTULLO;RAFFAELE SCARPA;ROSARIO PELUSO;RENATA DEL GIUDICE;LORENZO BOCCIA;ALESSANDRO FILLA;MATTEO NICOLA DARIO DI MINNO","20;12;11;11;10;10;9;8;8;8;8;7;7;7;7;7;7;6;6;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;MATERIALS SCIENCE;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;ART;GEOGRAPHY;HISTORY;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;PHILOSOPHY;GEOLOGY;BUSINESS","322;142;56;36;35;27;20;14;13;11;6;5;5;5;5;4;4;3;2","INTERNAL MEDICINE;GENETICS;ENDOCRINOLOGY;CARDIOLOGY;SURGERY;BIOCHEMISTRY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;PATHOLOGY;IMMUNOLOGY;PEDIATRICS;RADIOLOGY;ONCOLOGY;CELL BIOLOGY;ORGANIC CHEMISTRY;PSYCHIATRY;ARTIFICIAL INTELLIGENCE;PHYSICAL THERAPY;PHARMACOLOGY;ANATOMY;INTENSIVE CARE MEDICINE;NEUROSCIENCE","258;77;70;60;59;57;52;46;41;39;31;25;22;21;20;20;18;18;17;14;14;14","GENE;DISEASE;CANCER;POPULATION;BLOOD PRESSURE;DIABETES MELLITUS;OBESITY;PROSPECTIVE COHORT STUDY;HEART FAILURE;MYOCARDIAL INFARCTION;CONFIDENCE INTERVAL;BODY MASS INDEX;COHORT;RECEPTOR;CHEMOTHERAPY;ANTIBODY;ENZYME;INSULIN;PREGNANCY;ADVERSE EFFECT;COHORT STUDY;EMBRYO;EPIDEMIOLOGY;RHEUMATOLOGY","55;50;39;34;32;30;25;24;19;19;18;16;16;16;15;14;14;12;12;11;11;11;11;11","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;DIASTOLE;TYPE 2 DIABETES;EJECTION FRACTION;HAZARD RATIO;INSULIN RESISTANCE;METABOLIC SYNDROME;MUTATION;PHENOTYPE;FETUS;GENOTYPE;OVERWEIGHT;ALLELE;CHROMOSOME;EMBRYOGENESIS;IMATINIB;RECOMBINANT DNA;CRYOPRESERVATION;GENE EXPRESSION;PSORIATIC ARTHRITIS;REVASCULARIZATION;SPIROMETRY","20;15;11;9;9;9;9;9;9;8;8;8;7;7;7;7;7;6;6;6;6;6","BLASTOCYST;EMBRYO CULTURE;IMATINIB MESYLATE;IN VITRO MATURATION;DOPPLER ECHOCARDIOGRAPHY;PRENATAL DIAGNOSIS;PRIMARY CILIARY DYSKINESIA;SINGLE-NUCLEOTIDE POLYMORPHISM;VECTOR (MOLECULAR BIOLOGY);BETA ADRENERGIC RECEPTOR KINASE;CARDIAC RESYNCHRONIZATION THERAPY;CYTOGENETICS;FRACTIONAL FLOW RESERVE;HAPLOTYPE;KARYOTYPE;MISSENSE MUTATION;REPRODUCTIVE TECHNOLOGY;SYSTOLE;TFEB;ANAGRELIDE;CANADIAN CARDIOVASCULAR SOCIETY;CD3;CD38;CRYOPROTECTANT;DIASTOLIC FUNCTION;DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;DOPAMINE AGONIST;ENOS;GENE EXPRESSION PROFILING;HAPLOINSUFFICIENCY;HOMEOSTATIC MODEL ASSESSMENT;HOX GENE;HYPOTAURINE;IL-2 RECEPTOR;INFLAMMATORY BOWEL DISEASES;INSULIN-LIKE GROWTH FACTOR;KRAS;LEVODOPA;NONALCOHOLIC FATTY LIVER DISEASE;PARIS' LAW;RUBELLA;SPUTUM CULTURE;STEATOHEPATITIS;STROKE VOLUME;TBARS;UBIQUITIN LIGASE;VERY LOW-DENSITY LIPOPROTEIN;VINCRISTINE;Β2 ADRENERGIC RECEPTOR","7;6;6;6;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;MIDDLE AGED;ADULT;AGED;ADOLESCENT;ITALY;YOUNG ADULT;PROSPECTIVE STUDIES;RISK FACTORS;CHILD;DIABETES MELLITUS, TYPE 2;MYOCARDIAL INFARCTION;OBESITY;ANIMALS;BIOMARKERS;AGED, 80 AND OVER;EUROPE","239;178;177;137;131;102;90;56;51;43;41;41;40;35;34;34;33;33;32;32","RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;FERTILITY PRESERVATION IN CANCER PATIENTS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;EFFICACY AND RESISTANCE IN CML TREATMENT;LYMPHOID NEOPLASMS;RENAL CELL CARCINOMA;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HELICOBACTER PYLORI INFECTION AND GASTRIC CANCER;MANAGEMENT AND TREATMENT OF HEMOPHILIA;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;BISPHOSPHONATES IN CANCER TREATMENT AND BONE HEALTH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;GENOMIC REARRANGEMENTS AND COPY NUMBER VARIATIONS","12;10;8;7;6;6;5;5;5;4;4;4;4;4;4;3;3;3;3;3","LEFT VENTRICULAR FUNCTION;DIABETES;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;DIASTOLIC FUNCTION;ECHOCARDIOGRAPHY;EMBRYO DEVELOPMENT;CANCER RISK;HEALTHY EATING INDEX;HYPERTENSION;IMATINIB MESYLATE;IN VITRO MATURATION;REGIMEN;TREATMENT;TYPE 2 DIABETES;CLINICAL ENDPOINT;DIETARY PATTERNS;GLUCOSE METABOLISM;INSULIN RESISTANCE;OOCYTE MATURATION","17;10;9;9;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5;5","EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;LEFT VENTRICULAR;RISK FACTORS;CANCER RISK;HEART FAILURE;TYPE DIABETES;CELL CARCINOMA;DIABETIC PATIENTS;EPIC COHORT;GASTRIC CANCER;MULTICENTER STUDY;NUTRITION EPIC;PHASE II;PSORIATIC ARTHRITIS;RENAL CELL;CARDIOVASCULAR RISK;CHRONIC MYELOID;CLINICAL PRACTICE;DIABETES MELLITUS;GROWTH FACTOR;HEART STUDY;INSULIN-LIKE GROWTH;LEFT ATRIAL;MYELOID LEUKEMIA;VITRO EMBRYO;CANCER PATIENTS;CARCINOMA RESULTS;CARDIOMETABOLIC RISK;CILIARY DYSKINESIA","13;13;10;9;7;7;7;5;5;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3","PUBMED SCOPUS;CROSSREF PUBMED;STEM CELL;FONDAZIONE GPASCALE;GPASCALE IRCCS;ISTITUTO NAZIONALE;NAZIONALE TUMORI;TUMORI FONDAZIONE;UNIT ISTITUTO;CELL TRANSPLANTATION;IRCCS NAPLESSEARCH;RISK FACTORS;TRANSPLANTATION UNIT;PANCREATIC CANCER;CD CD;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;PAEDIATRIC GASTROENTEROLOGY;LEFT VENTRICULAR;SPONDYLOEPIMETAPHYSEAL DYSPLASIA;MASS INDEX;T-CELL LYMPHOMA;HEART FAILURE;CARDIOVASCULAR RISK;JOINT LAXITY;ALCOHOL CONSUMPTION;CANCER RISK;GENE EXPRESSION;LOGISTIC REGRESSION;MYOCARDIAL INFARCTION","37;29;27;26;26;26;26;26;26;25;24;23;23;21;19;18;18;17;14;14;13;13;12;11;11;10;10;10;10;10",108,0.27,5.01,4,1,1,1,3,10,1,1,4.25,0,1,3,3,3.25,1,1,2,1,0,0,98,98,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,6.6,591,0.68,1,0.2,66.4,0,0,1,0,0,0,1,3,0,2,3,0,0,0,0,0,0,4,0,1,5,0,0,0,0,0,0,0,0,0,"Japan","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","4;3;2;1;1","CLINICAL RESEARCH;CANCER;HEMATOLOGY;AGING;ANTIMICROBIAL RESISTANCE;CHILDHOOD LEUKEMIA;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;DIGESTIVE DISEASES - (PEPTIC ULCER);EMERGING INFECTIOUS DISEASES;INFECTIOUS DISEASES;ORPHAN DRUG;PATIENT SAFETY;PEDIATRIC;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;PROSTATE CANCER;RARE DISEASES;UROLOGIC DISEASES","4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;INFECTION","1;1","6.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","3;1","LEUKEMIA / LEUKAEMIA;PROSTATE CANCER;STOMACH CANCER","1;1;1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2012,444,12.2905405405405,3.17342342342342,0.443693693693694,0.394144144144144,0.506756756756757,1.74597273853779,1.27922077922078,1.4957264957265,1.27840909090909,0.43018018018018,10,239,85,43,52,0.54,0.19,0.1,0.12,42.24,1.01137005864955,4.82845744680852,0.373873873873874,0.765765765765766,0.421,0.398,0.436,0.44,"­ROSARIO ­TUMINO;KIM OVERVAD;ANNE TJØNNELAND;ANTONIA TRICHOPOULOU;ELIO RÍBOLI;NICHOLAS J. WAREHAM;DOMENICO PALLI;SALVATORE PANICO;RUDOLF KAAKS;KAY‐TEE KHAW;MARÍA‐JOSÉ SÁNCHEZ;BIRGIT TEUCHER;HEINER BOEING;EVA ARDANÁZ;AMALIA MATTIELLO;FRANÇOISE CLAVEL‐CHAPELON;PILAR AMIANO;MARIE‐CHRISTINE BOUTRON‐RUAULT;PAOLO VINEIS;CLAUDIO PIGNATA","37;32;32;29;29;25;24;23;23;22;21;19;19;19;18;17;17;16;16;15","MATTEO NICOLA DARIO DI MINNO;CLAUDIO PIGNATA;GIOVANNI TARANTINO;FRANCESCO BRIGANTI;RAFFAELE IZZO;GIOVANNI DI MINNO;GIOVANNI DE SIMONE;RAFFAELE SCARPA;MARCO SALVATORE;ANTONINO POLLIO;GIUSEPPE MARINIELLO;MARIACAROLINA SALERNO;CARMINE FINELLI;PASQUALE PERRONE FILARDI;ROSARIO PELUSO;G. KOTSIKOS;MARZIO GRASSO;DOMINGA LAPI;FLORA AFFUSO;EMILIANO GRIMALDI","1.77;1.68;1.68;1.65;1.51;1.51;1.44;1.26;1.15;1.14;1.12;1.11;1.08;1.05;1.01;1;1;1;1;1","SALVATORE PANICO;AMALIA MATTIELLO;CLAUDIO PIGNATA;MATTEO NICOLA DARIO DI MINNO;FABRIZIO PANE;GIOVANNI DE SIMONE;RAFFAELE IZZO;MARIACAROLINA SALERNO;GIUSEPPE DI LORENZO;MARCO SALVATORE;GIOVANNI ESPOSITO;PASQUALE PERRONE FILARDI;RAFFAELE SCARPA;BRUNO TRIMARCO;GIANCARLO TRONCONE;GIUSEPPE DE MICHELE;ANTONIO M. RISITANO;MAURIZIO GALDERISI;GIOVANNI DI MINNO;ROSARIO PELUSO","23;18;15;14;12;11;10;10;10;10;9;9;9;8;8;8;8;8;8;8","MATTEO NICOLA DARIO DI MINNO;CLAUDIO PIGNATA;GIOVANNI TARANTINO;FRANCESCO BRIGANTI;RAFFAELE IZZO;GIOVANNI DI MINNO;GIOVANNI DE SIMONE;RAFFAELE SCARPA;MARCO SALVATORE;ANTONINO POLLIO;GIUSEPPE MARINIELLO;MARIACAROLINA SALERNO;PASQUALE PERRONE FILARDI;ROSARIO PELUSO;MARZIO GRASSO;DOMINGA LAPI;FLORA AFFUSO;EMILIANO GRIMALDI;FRANCESCO DOMENICO MOCCIA;STEFANIA ERRICO","1.77;1.68;1.68;1.65;1.51;1.51;1.44;1.26;1.15;1.14;1.12;1.11;1.05;1.01;1;1;1;1;1;1","­ROSARIO ­TUMINO;ANNE TJØNNELAND;KIM OVERVAD;ELIO RÍBOLI;HEINER BOEING;ANTONIA TRICHOPOULOU;KAY‐TEE KHAW;DOMENICO PALLI;NICHOLAS J. WAREHAM;RUDOLF KAAKS;SALVATORE PANICO;MARÍA‐JOSÉ SÁNCHEZ;BIRGIT TEUCHER;PAOLO VINEIS;ANDREA BALLABIO;CARMINE SETTEMBRE;FRANÇOISE CLAVEL‐CHAPELON;DAVID M. SABATINI;DIEGO L. MEDINA;FRANCESCO VETRINI","3319;3133;2984;2780;2734;2656;2567;2502;2422;2409;2279;1939;1916;1835;1822;1822;1716;1682;1682;1682","SALVATORE PANICO;ANDREA BALLABIO;AMALIA MATTIELLO;GIOVANNI DE SIMONE;ALBERTO AURICCHIO;FRANCESCO PAOLO CERASE;PAOLA DE VIVO;MATTEO NICOLA DARIO DI MINNO;ANNAMARIA COLAO;LUCIO SANTORO;MARINA PICILLO;ROBERTO ERRO;MARIANNA AMBONI;MAURIZIO GALDERISI;DOMENICO RUSSO;GIOVANNI ESPOSITO;GIOVANNI DI MINNO;FABRIZIO PANE;GIUSEPPE DE MICHELE;GABRIELE RICCARDI","2279;1822;1024;660;538;509;509;498;411;403;392;392;355;349;345;325;323;308;296;285","SALVATORE PANICO;AMALIA MATTIELLO;ANNAMARIA COLAO;CLAUDIO PIGNATA;GIOVANNI DE SIMONE;MATTEO NICOLA DARIO DI MINNO;FABRIZIO PANE;MARIACAROLINA SALERNO;PASQUALE PERRONE FILARDI;GIOVANNI ESPOSITO;GIUSEPPE DE MICHELE;GIUSEPPE DI LORENZO;MAURIZIO GALDERISI;RAFFAELE IZZO;ANTONIO M. RISITANO;GIANCARLO TRONCONE;VINCENZO BRESCIA MORRA;LOREDANA PALAMARO;LUIGI DEL VECCHIO;BRUNO TRIMARCO","23;18;12;11;11;10;9;9;9;8;8;8;8;8;8;7;7;6;6;6","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;MATERIALS SCIENCE;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOLOGY;ART;ENVIRONMENTAL SCIENCE;GEOGRAPHY;HISTORY","373;141;42;39;36;29;27;26;18;14;13;10;9;8;8;6;6;6;3","INTERNAL MEDICINE;SURGERY;ENDOCRINOLOGY;GENETICS;CARDIOLOGY;ONCOLOGY;BIOCHEMISTRY;IMMUNOLOGY;PATHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;RADIOLOGY;PEDIATRICS;PSYCHIATRY;CELL BIOLOGY;PHARMACOLOGY;CANCER RESEARCH;NEUROSCIENCE;OPTICS;PALEONTOLOGY","291;76;70;65;54;54;50;50;44;43;37;33;32;29;26;24;21;18;18;18","CANCER;GENE;PROSPECTIVE COHORT STUDY;DISEASE;CONFIDENCE INTERVAL;POPULATION;DIABETES MELLITUS;BLOOD PRESSURE;COHORT;BODY MASS INDEX;OBESITY;HEART FAILURE;PROPORTIONAL HAZARDS MODEL;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;ANTIBODY;CHEMOTHERAPY;COHORT STUDY;ENZYME;RECEPTOR","68;53;48;40;36;36;30;28;26;25;24;23;20;18;17;17;16;16;16;16","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;BREAST CANCER;HAZARD RATIO;PHENOTYPE;TYPE 2 DIABETES;MUTATION;COLORECTAL CANCER;EJECTION FRACTION;METABOLIC SYNDROME;INSULIN RESISTANCE;PSORIATIC ARTHRITIS;WAIST;DIASTOLE;GENOTYPE;LOWER RISK;METASTASIS;NEUROPSYCHOLOGY;AUTOPHAGY;CARDIOTOXICITY;CHROMOSOME;CLINICAL ENDPOINT;COMPLEMENT SYSTEM;IMATINIB;PANCREATIC CANCER;PARKINSON'S DISEASE;RELATIVE RISK;WEIGHT LOSS","24;22;22;13;13;12;11;11;11;9;9;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6","ESTROGEN RECEPTOR;KRAS;ABDOMINAL OBESITY;CETUXIMAB;GASTRIC BYPASS;GLYCEMIC INDEX;IMATINIB MESYLATE;TRASTUZUMAB;ACINETOBACTER BAUMANNII;ALTERNATIVE COMPLEMENT PATHWAY;BETA ADRENERGIC RECEPTOR KINASE;BLASTOCYST;CD59;COMPLEMENT MEMBRANE ATTACK COMPLEX;DASATINIB;ECULIZUMAB;EMBRYO CULTURE;HEART RATE VARIABILITY;IMPAIRED GLUCOSE TOLERANCE;MISSENSE MUTATION;NILOTINIB;SINGLE-NUCLEOTIDE POLYMORPHISM","5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;AGED;ITALY;PROSPECTIVE STUDIES;TREATMENT OUTCOME;RISK FACTORS;CHILD;HYPERTENSION;ADOLESCENT;BREAST NEOPLASMS;FOLLOW-UP STUDIES;CARDIOVASCULAR DISEASES;OBESITY;DIABETES MELLITUS, TYPE 2;EUROPE","279;220;199;154;142;112;111;61;59;46;44;40;40;39;39;39;38;38;37;36","ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;EFFICACY AND RESISTANCE IN CML TREATMENT;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND TREATMENT OF PERIPHERAL ARTERIAL DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;RENAL CELL CARCINOMA;THYROID DISEASE AND HORMONE REGULATION;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN LUNG CANCER RESEARCH;CARDIOTOXICITY OF CANCER TREATMENTS;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;FERTILITY PRESERVATION IN CANCER PATIENTS;GENETIC BASIS OF PRIMARY IMMUNODEFICIENCY DISORDERS","10;7;7;6;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4","HYPERTENSION;HEALTHY EATING INDEX;CANCER RISK;DIABETES;BREAST CANCER;LEFT VENTRICULAR FUNCTION;DIETARY PATTERNS;LOWER RISK;STEATOSIS;CARDIOTOXICITY;CLINICAL ENDPOINT;CONCOMITANT;REGIMEN;TREATMENT;CARDIAC IMAGING;ECHOCARDIOGRAPHY;HEMOGLOBINURIA;MEDITERRANEAN DIET;PAROXYSMAL NOCTURNAL HEMOGLOBINURIA;PSORIATIC ARTHRITIS","12;10;9;9;8;8;7;7;7;6;6;6;6;6;5;5;5;5;5;5","EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;BREAST CANCER;CANCER RISK;COLORECTAL CANCER;HYPERTENSIVE PATIENTS;PSORIATIC ARTHRITIS;RISK FACTORS;CELL CARCINOMA;COHORT STUDY;DIABETIC PATIENTS;HEART FAILURE;PANCREATIC CANCER;TYPE DIABETES;CORONARY ARTERY;DISEASE ACTIVITY;NOCTURNAL HEMOGLOBINURIA;NUTRITION EPIC;PARKINSONS DISEASE;PAROXYSMAL NOCTURNAL;PROSPECTIVE STUDY;ARTERY DISEASE;CHRONIC MYELOID;CYSTIC FIBROSIS;DI CHIRURGIA;DIABETES MELLITUS;DISEASE PATIENTS;HEPATIC STEATOSIS;ITALIANA DI;LEFT VENTRICULAR","20;19;14;7;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4","PUBMED SCOPUS;CROSSREF PUBMED;HOUSTON TX;PANCREATIC CANCER;TX USA;USA SEARCH;CAMBRIDGE MA;EUROPEAN PROSPECTIVE;MA USA;PROSPECTIVE INVESTIGATION;LINEAR SKIN;MASS INDEX;NUCLEAR TRANSLOCATION;HR CI;CONFIDENCE INTERVAL;CD CD;HELA CELLS;SKIN DEFECTS;LEFT VENTRICULAR;BREAST CANCER;RISK FACTORS;TFEB FLAG;TFEB NUCLEAR;BAYLOR COLLEGE;BLOOD PRESSURE;COLORECTAL CANCER;GENETICS BAYLOR;HUMAN GENETICS;LV MASS;MEDICINE HOUSTON","44;34;27;27;27;22;21;21;21;21;20;20;20;18;17;16;16;16;15;14;14;14;14;13;13;13;13;13;13;13",157,0.35,6,4,2,1,1,2,3,1,1,5,1,1,4,2,1.25,1,2,4,2,0,0,89,89,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,7,359.12,1.08,2,0.25,50.88,0,1,3,0,1,0,0,3,0,6,2,0,0,0,0,0,0,7,1,0,8,0,0,0,0,0,0,0,0,0,"United States","2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3215 REPRODUCTIVE MEDICINE","8;4;2;2;1;1","CLINICAL RESEARCH;CANCER;HEMATOLOGY;PEDIATRIC;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;STEM CELL RESEARCH;CHILDHOOD LEUKEMIA;PATIENT SAFETY;PEDIATRIC CANCER;PEDIATRIC RESEARCH INITIATIVE;PREVENTION;TRANSPLANTATION;AGING;GENETICS;INFECTIOUS DISEASES;REGENERATIVE MEDICINE;STEM CELL RESEARCH - NONEMBRYONIC - HUMAN;STEM CELL RESEARCH - NONEMBRYONIC - NON-HUMAN","8;4;4;4;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1","CANCER;INFECTION","3;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;5.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES","6;3;1;1","LEUKEMIA / LEUKAEMIA","5","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","5;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","8;4","CLINICAL RESEARCH;KIDNEY DISEASE;PREVENTION","2;1;1",NA,NA,NA,NA,NA,NA,"CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_FEDERICOII",2013,572,11.3146853146853,3.33216783216784,0.437062937062937,0.435314685314685,0.536713286713287,1.80056710775047,1.28865979381443,1.5859872611465,1.26337448559671,0.538461538461538,11,257,147,66,33,0.45,0.26,0.12,0.06,38.86,1.1138085350961,4.82931496364333,0.368881118881119,0.786713286713287,0.444,0.396,0.445,0.439,"­ROSARIO ­TUMINO;ELIO RÍBOLI;ANNE TJØNNELAND;KIM OVERVAD;KAY‐TEE KHAW;ANTONIA TRICHOPOULOU;HEINER BOEING;NICHOLAS J. WAREHAM;SALVATORE PANICO;RUDOLF KAAKS;DOMENICO PALLI;BRUNO TRIMARCO;AMALIA MATTIELLO;AURELIO BARRICARTE;FRANÇOISE CLAVEL‐CHAPELON;ELISABETE WEIDERPASS;PETRA H. PEETERS;TIMOTHY J. KEY;RUTH C. TRAVIS;MARÍA‐JOSÉ SÁNCHEZ","33;33;33;30;28;26;25;24;23;21;21;20;20;20;19;19;19;18;17;17","BRUNO TRIMARCO;GIOVANNA DE MINICO;EMILIANO GRIMALDI;FERDINANDO CARANCI;GIOVANNI DE SIMONE;MARIA ALESSIO;ARTURO BRUNETTI;FRANCESCO VERDE;MICHELE DANZI;BRUNO AMATO;STEFANO REGGIO;LUCIANO GRIMALDI;GIOVANNI TARANTINO;ALBERTO CUOCOLO;GIUSEPPE RENGO;MAURIZIO GALDERISI;GIUSEPPE DI LORENZO;ANNAMARIA COLAO;GIULIA GUERRIERO;MARZIO GRASSO","2.47;2;2;1.88;1.76;1.64;1.59;1.53;1.51;1.45;1.38;1.38;1.33;1.3;1.3;1.29;1.28;1.26;1.25;1.2","SALVATORE PANICO;BRUNO TRIMARCO;AMALIA MATTIELLO;MAURIZIO GALDERISI;ANNAMARIA COLAO;GIOVANNI DE SIMONE;GIUSEPPE RENGO;GIUSEPPE DI LORENZO;ALBERTO CUOCOLO;LUCIO SANTORO;PASQUALE PERRONE FILARDI;MARIA ALESSIO;MICHELE DANZI;MARINA PICILLO;BRUNO AMATO;DARIO LEOSCO;MARCO SALVATORE;STEFANO REGGIO;ROBERTO ERRO;ROSARIO PIVONELLO","23;20;20;15;13;13;12;12;12;11;11;11;10;10;10;10;10;9;9;9","BRUNO TRIMARCO;GIOVANNA DE MINICO;EMILIANO GRIMALDI;FERDINANDO CARANCI;GIOVANNI DE SIMONE;MARIA ALESSIO;ARTURO BRUNETTI;FRANCESCO VERDE;MICHELE DANZI;BRUNO AMATO;STEFANO REGGIO;LUCIANO GRIMALDI;GIOVANNI TARANTINO;ALBERTO CUOCOLO;GIUSEPPE RENGO;MAURIZIO GALDERISI;GIUSEPPE DI LORENZO;ANNAMARIA COLAO;GIULIA GUERRIERO;MARZIO GRASSO","2.47;2;2;1.88;1.76;1.64;1.59;1.53;1.51;1.45;1.38;1.38;1.33;1.3;1.3;1.29;1.28;1.26;1.25;1.2","MAURIZIO GALDERISI;­ROSARIO ­TUMINO;ANNE TJØNNELAND;KIM OVERVAD;ELIO RÍBOLI;PETER M. NILSSON;KAY‐TEE KHAW;HEINER BOEING;NICHOLAS J. WAREHAM;DOMENICO PALLI;DIEDERICK E. GROBBEE;ANTONIA TRICHOPOULOU;GIUSEPPE MANCIA;ALBERTO ZANCHETTI;AURELIO BARRICARTE;PETRA H. PEETERS;SALVATORE PANICO;ANNA F. DOMINICZAK;ATHANASIOS MANOLIS;BERNARD WAEBER","3053;2672;2538;2425;2418;2301;2294;2139;2128;2092;1947;1922;1864;1840;1838;1824;1822;1797;1797;1797","MAURIZIO GALDERISI;SALVATORE PANICO;AMALIA MATTIELLO;ANDREA BALLABIO;FABIANA CASTIGLIONE;LUCIO SANTORO;ANTONIO M. RISITANO;MARINA PICILLO;ANNAMARIA COLAO;MARCELLO MOCCIA;CLEMENTE CILLO;ALFREDO PROCINO;BRUNO TRIMARCO;GIUSEPPE DI LORENZO;RAFFAELE SCARPA;BRUNELLA FRANCO;ANNA DE ROSA;MATTEO NICOLA DARIO DI MINNO;GIOVANNI ESPOSITO;ANNA FRANZONE","3053;1822;1114;832;775;680;570;483;469;443;428;417;416;411;377;358;352;351;345;332","SALVATORE PANICO;AMALIA MATTIELLO;BRUNO TRIMARCO;MAURIZIO GALDERISI;ANNAMARIA COLAO;GIUSEPPE DI LORENZO;GIOVANNI DE SIMONE;ALBERTO CUOCOLO;LUCIO SANTORO;MARINA PICILLO;MARIA ALESSIO;BRUNO AMATO;GIUSEPPE RENGO;MARCELLO MOCCIA;MARCO SALVATORE;LUCIANO GRIMALDI;MICHELE DANZI;STEFANO REGGIO;CLAUDIO PIGNATA;DARIO BRUZZESE","23;20;17;15;15;12;12;11;11;10;10;9;9;9;9;9;9;9;8;8","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;MATERIALS SCIENCE;SOCIOLOGY;ENVIRONMENTAL SCIENCE;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;GEOLOGY;GEOGRAPHY;BUSINESS;ART;HISTORY","461;201;59;57;45;42;34;31;22;22;15;13;12;11;10;9;8;6;2","INTERNAL MEDICINE;SURGERY;ENDOCRINOLOGY;GENETICS;BIOCHEMISTRY;PATHOLOGY;CARDIOLOGY;IMMUNOLOGY;RADIOLOGY;GASTROENTEROLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;ONCOLOGY;CELL BIOLOGY;PEDIATRICS;OPTICS;CANCER RESEARCH;ECOLOGY;NEUROSCIENCE;PHARMACOLOGY","360;98;95;94;77;77;71;58;56;52;50;47;45;38;37;28;23;23;23;23","GENE;CANCER;DISEASE;DIABETES MELLITUS;POPULATION;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;HEART FAILURE;COHORT;BLOOD PRESSURE;OBESITY;RECEPTOR;BODY MASS INDEX;PROPORTIONAL HAZARDS MODEL;INCIDENCE (GEOMETRY);MAGNETIC RESONANCE IMAGING;RANDOMIZED CONTROLLED TRIAL;CHEMOTHERAPY;HORMONE;MYOCARDIAL INFARCTION","89;74;71;43;41;41;35;34;32;29;29;28;23;22;21;21;19;18;18;18","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;EJECTION FRACTION;HAZARD RATIO;BREAST CANCER;MUTATION;PHENOTYPE;COLORECTAL CANCER;DIASTOLE;TYPE 2 DIABETES;GENE EXPRESSION;GENOTYPE;INSULIN RESISTANCE;OVERWEIGHT;PARKINSON'S DISEASE;ALLELE;CARDIAC FUNCTION CURVE;PROSTATE CANCER;WAIST;AUTOPHAGY;CLINICAL ENDPOINT;METASTASIS;RELATIVE RISK;TRANSCRIPTION FACTOR;WEIGHT LOSS","28;22;22;21;17;16;13;12;12;11;11;11;9;9;8;8;7;7;6;6;6;6;6;6","SINGLE-NUCLEOTIDE POLYMORPHISM;ANDROGEN DEPRIVATION THERAPY;DOPPLER ECHOCARDIOGRAPHY;ECULIZUMAB;POINT MUTATION;SEX HORMONE-BINDING GLOBULIN;ACROMEGALY;ADIPOKINE;ADIPONECTIN;CANAKINUMAB;DNA METHYLATION;ESTROGEN RECEPTOR;HEART RATE VARIABILITY;MOTOR SYMPTOMS;POLYCYSTIC OVARY;PRIMARY CILIARY DYSKINESIA;PROBAND;SPECKLE TRACKING ECHOCARDIOGRAPHY;TFEB;ABDOMINAL OBESITY;ALTERNATIVE COMPLEMENT PATHWAY;ANDROGEN RECEPTOR;ANDROSTENEDIONE;ATG16L1;BETA ADRENERGIC RECEPTOR KINASE;BILIARY ATRESIA;BLASTOCYST;CARBOPLATIN;CARDIAC RESYNCHRONIZATION THERAPY;CERVICAL INTRAEPITHELIAL NEOPLASIA;CLINICAL PHENOTYPE;COLONOSCOPY;COMPLEMENTATION;CONGENITAL MYOPATHY;CONSERVED SEQUENCE;COPY-NUMBER VARIATION;DANDER;DOPPLER IMAGING;EMBRYO CULTURE;ENHANCER;FRAMESHIFT MUTATION;GEFITINIB;GENE MUTATION;GROWTH HORMONE DEFICIENCY;HAPLOTYPE;HEME OXYGENASE;IL-2 RECEPTOR;IMATINIB MESYLATE;INSULIN-LIKE GROWTH FACTOR;IVACAFTOR;LEISHMANIA INFANTUM;LYMPHOPOIESIS;MEMANTINE;METASTATIC BREAST CANCER;METHYLENETETRAHYDROFOLATE REDUCTASE;MISSENSE MUTATION;NILOTINIB;PENETRANCE;PHENOCOPY;PHOTOMETRIC REDSHIFT;PRENATAL DIAGNOSIS;RANKL;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;SHORT QT SYNDROME;TAMOXIFEN;THYMOCYTE;TRANSCRIPTOME;VECTOR (MOLECULAR BIOLOGY);VILLOUS ATROPHY;VINCRISTINE","6;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;MALE;FEMALE;;MIDDLE AGED;ADULT;AGED;HYPERTENSION;ITALY;PROSPECTIVE STUDIES;CARDIOVASCULAR DISEASES;RISK FACTORS;ANIMALS;ADOLESCENT;YOUNG ADULT;DIABETES MELLITUS, TYPE 2;OBESITY;TREATMENT OUTCOME;FOLLOW-UP STUDIES;RETROSPECTIVE STUDIES","325;226;225;213;178;128;124;63;56;55;54;54;53;52;48;44;43;42;40;38","MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ROLE OF COMPLEMENT SYSTEM IN IMMUNE RESPONSE;METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;DIAGNOSIS AND MANAGEMENT OF PITUITARY DISORDERS;GALAXY FORMATION AND EVOLUTION IN THE UNIVERSE;HEALTH EFFECTS OF AIR POLLUTION;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;INSULIN-LIKE GROWTH FACTORS IN HEALTH AND DISEASE;MALE CIRCUMCISION FOR HIV PREVENTION AND PENILE HEALTH;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;MOLECULAR MECHANISMS OF INFLAMMASOME ACTIVATION AND REGULATION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;MOLECULAR PATHOGENESIS OF MYELOPROLIFERATIVE DISORDERS","12;8;8;8;7;6;6;6;5;4;4;4;4;4;4;4;4;4;4;4","DIABETES;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;CARDIAC IMAGING;HYPERTENSION;LEFT VENTRICULAR FUNCTION;CONCOMITANT;HEALTHY EATING INDEX;DIAGNOSIS;HEART RATE VARIABILITY;CLINICAL ENDPOINT;DIETARY PATTERNS;DISCONTINUATION;ECHOCARDIOGRAPHY;ETIOLOGY;LOWER RISK;GLUTEN SENSITIVITY;HYDROLOGICAL MODELING;SOIL MOISTURE;BREAST CANCER","15;15;12;11;11;11;8;8;7;7;6;6;6;6;6;6;5;5;5;4","EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;HEART FAILURE;BREAST CANCER;LEFT VENTRICULAR;TYPE DIABETES;EPIC COHORT;PARKINSONS DISEASE;COHORT STUDY;DIABETIC PATIENTS;MAGNETIC RESONANCE;NUTRITION EPIC;PROSTATE CANCER;CANCER RISK;CARDIOVASCULAR RISK;CELL CARCINOMA;GROWTH FACTOR;SOUTHERN ITALY;COLORECTAL CANCER;DIABETES MELLITUS;ELDERLY PATIENTS;HEPATOCELLULAR CARCINOMA;MULTIPLE SCLEROSIS;PERFUSION IMAGING;PROSPECTIVE STUDY;RESONANCE IMAGING;CANCER PATIENTS;COMPARATIVE STUDY;DISEASE ACTIVITY;FLOW RESERVE","16;16;14;13;10;10;8;8;7;7;7;7;7;6;6;6;6;6;5;5;5;5;5;5;5;5;4;4;4;4","BLOOD PRESSURE;BREAST CANCER;HR CI;TYPE DIABETES;RISK FACTORS;GENE TRANSFER;PIZ MICE;HDAD-TFEB INJECTED;CROSSREFMEDLINEGOOGLE SCHOLAR;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;CARDIOVASCULAR DISEASE;MEDICINE NAPLES;TELETHON INSTITUTE;CARDIOVASCULAR RISK;ITALY SEARCH;LEFT VENTRICULAR;INJECTED MICE;MASS INDEX;DIABETIC PATIENTS;HYPERTENSIVE PATIENTS;INCREASED RISK;INTERNAL MEDICINE;LIVER DISEASE;UNIVERSITY HOSPITAL;BODY MASS;CLINICAL PRACTICE;MAGNETIC RESONANCE;PUBMED SCOPUS;RISK FACTOR","40;34;34;28;27;26;25;24;23;23;23;22;21;21;20;20;20;19;18;17;16;16;16;16;16;15;15;15;15;15",188,0.33,7.27,5.25,2,1,1,2.25,5,1,1,6,1,1,4,1.75,3,1,2,3,2,0,0,104.75,104.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,8,1290.38,0.89,4,0.44,147.11,0,0,1,1,3,0,0,4,0,5,4,0,0,0,0,0,0,8,1,0,9,0,0,0,0,0,0,0,0,0,"United States","5","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3202 CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3505 HUMAN RESOURCES AND INDUSTRIAL RELATIONS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4205 NURSING","8;3;2;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;CANCER;HEMATOLOGY;AUTOIMMUNE DISEASE;PEDIATRIC;PREVENTION;AGING;BEHAVIORAL AND SOCIAL SCIENCE;BREAST CANCER;CHILDHOOD LEUKEMIA;COMPARATIVE EFFECTIVENESS RESEARCH;CONTRACEPTION/REPRODUCTION;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;LUNG;MYASTHENIA GRAVIS;NEUROSCIENCES;PATIENT SAFETY","8;6;6;4;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR;REPRODUCTIVE HEALTH AND CHILDBIRTH","2;1;1","6.1 PHARMACEUTICALS","5","LEUKEMIA / LEUKAEMIA;BREAST CANCER;COLON AND RECTAL CANCER;MELANOMA","4;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1",1,2450000,350000,4,7,5,1,19,87500,6.53714285714286,"FEDERICO II UNIVERSITY HOSPITAL;INSTITUT GUTTMANN;ROESSINGH RESEARCH AND DEVELOPMENT;TECHNICAL UNIVERSITY OF MADRID;UNIVERSITY COLLEGE CORK;UNIVERSITY OF LISBON;UNIVERSITY OF TWENTE","1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CP - COLLABORATIVE PROJECT (GENERIC) (FUNDING SCHEME);FP7-ICT - SPECIFIC PROGRAMME ""COOPERATION"": INFORMATION AND COMMUNICATION TECHNOLOGIES (PROGRAMME);FP7-ICT-2013-10 (CALL FOR PROPOSAL)","1;1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;4409 SOCIAL WORK;46 INFORMATION AND COMPUTING SCIENCES","1;1;1;1;1","AGING;BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;HEALTH SERVICES;PREVENTION","1;1;1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"C17 BUSINESS AND MANAGEMENT STUDIES","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2014,611,13.5335515548282,2.88870703764321,0.378068739770867,0.353518821603928,0.450081833060556,1.67045454545455,1.21578947368421,1.33333333333333,1.18025751072961,0.471358428805237,7,299,155,56,57,0.49,0.25,0.09,0.09,40.07,1.06038226955093,4.89425675675675,0.422258592471358,0.841243862520458,0.441,0.424,0.43,0.452,"ELIO RÍBOLI;­ROSARIO ­TUMINO;KIM OVERVAD;ANNE TJØNNELAND;ANTONIA TRICHOPOULOU;KAY‐TEE KHAW;HEINER BOEING;ELISABETE WEIDERPASS;SALVATORE PANICO;DOMENICO PALLI;GIUSEPPE DI LORENZO;NICHOLAS J. WAREHAM;RUDOLF KAAKS;PETRA H. PEETERS;MARÍA‐JOSÉ SÁNCHEZ;PAOLO VINEIS;AURELIO BARRICARTE;MARIE‐CHRISTINE BOUTRON‐RUAULT;JOSÉ MARÍA HUERTA;RUTH C. TRAVIS","48;47;43;43;41;40;40;39;38;36;35;34;29;29;28;27;26;25;24;20","GIUSEPPE DI LORENZO;BRUNO TRIMARCO;GIOVANNI DE SIMONE;PASQUALE PERRONE FILARDI;MARCELLO MOCCIA;LUISA COSTA;FRANCESCO CASO;ROBERTO ERRO;VINCENZO D’ALESSANDRO;CARLO BUONERBA;ELIO RÍBOLI;­ROSARIO ­TUMINO;ANTONIO PISANI;ANTONIO M. RISITANO;LUCA CANTARINI;GIOVANNI TARANTINO;CARMINE FINELLI;ANNE TJØNNELAND;PAOLO BARONE;SALVATORE PANICO","2.96;1.72;1.46;1.46;1.39;1.26;1.26;1.25;1.2;1.19;1.16;1.13;1.11;1.1;1.06;1.06;1.06;1.04;1.04;1.04","­ROSARIO ­TUMINO;SALVATORE PANICO;GIUSEPPE DI LORENZO;AMALIA MATTIELLO;BRUNO TRIMARCO;PASQUALE PERRONE FILARDI;GIOVANNI DE SIMONE;MARCELLO MOCCIA;ROBERTO ERRO;LUISA COSTA;MARINA PICILLO;MAURIZIO GALDERISI;SABINO DE PLACIDO;GIOVANNI ESPOSITO;ARTURO BRUNETTI;GIUSEPPE DE MICHELE;VINCENZO MIRONE;RAFFAELE SCARPA;ALESSANDRO FILLA;RAFFAELE PALLADINO","47;38;35;17;15;13;13;12;11;11;10;10;10;10;10;9;8;8;7;7","GIUSEPPE DI LORENZO;BRUNO TRIMARCO;GIOVANNI DE SIMONE;PASQUALE PERRONE FILARDI;MARCELLO MOCCIA;LUISA COSTA;ROBERTO ERRO;VINCENZO D’ALESSANDRO;CARLO BUONERBA;­ROSARIO ­TUMINO;ANTONIO PISANI;ANTONIO M. RISITANO;GIOVANNI TARANTINO;SALVATORE PANICO;ALESSIA PEDACE;BIANCA GIOIA MARINO;ROCCO PALERMO;LAURA BELLIA;ANTONIO GIUDITTA;LUCA PENNACCHIO","2.96;1.72;1.46;1.46;1.39;1.26;1.25;1.2;1.19;1.13;1.11;1.1;1.06;1.04;1;1;1;1;1;1","ELIO RÍBOLI;­ROSARIO ­TUMINO;KIM OVERVAD;HEINER BOEING;DOMENICO PALLI;ANNE TJØNNELAND;MAURIZIO GALDERISI;PATRIZIO LANCELLOTTI;THOR EDVARDSEN;NICHOLAS J. WAREHAM;KAY‐TEE KHAW;SALVATORE PANICO;MARÍA‐JOSÉ SÁNCHEZ;ROSA SICARI;RUDOLF KAAKS;LUIGI P. BADANO;ANA BARAC;ANDREIA MAGALHÃES;BONNIE KY;BRIAN P. GRIFFIN","3540;3469;3345;3309;3179;2970;2931;2873;2873;2854;2846;2757;2752;2696;2511;2479;2441;2441;2441;2441","MAURIZIO GALDERISI;SALVATORE PANICO;AMALIA MATTIELLO;CHIARA CARLOMAGNO;YOUSSEF ROUPHAEL;LUCIO CATALANO;ALESSANDRO FILLA;ANDREA BALLABIO;ROSARIO CUOMO;CARMINE SETTEMBRE;GIUSEPPE DI LORENZO;CHIARA CRISCUOLO;GIUSEPPE MARTIN;GIUSEPPE DE MICHELE;VALERIA RAIA;LUISA COSTA;MARCELLO MOCCIA;MARIO MUSELLA;ANTONIO PISANI;RICCARDO BONFANTI","2931;2735;1128;1000;878;719;686;681;586;533;494;454;411;374;372;352;339;334;317;308","SALVATORE PANICO;GIUSEPPE DI LORENZO;AMALIA MATTIELLO;BRUNO TRIMARCO;MARCELLO MOCCIA;GIOVANNI DE SIMONE;PASQUALE PERRONE FILARDI;ALESSANDRO FILLA;LUISA COSTA;MAURIZIO GALDERISI;GIUSEPPE DE MICHELE;VINCENZO MIRONE;ARTURO BRUNETTI;GIOVANNI ESPOSITO;RAFFAELE PALLADINO;ROSARIO CUOMO;MARINA PICILLO;RAFFAELE SCARPA;SABINO DE PLACIDO;A. COLANTUONI","37;34;17;12;12;12;11;10;10;10;8;8;7;7;7;7;7;7;7;6","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATERIALS SCIENCE;MATHEMATICS;SOCIOLOGY;ECONOMICS;PHILOSOPHY;ENVIRONMENTAL SCIENCE;POLITICAL SCIENCE;GEOGRAPHY;ART;BUSINESS;GEOLOGY;HISTORY","499;184;84;72;59;51;34;30;30;27;22;18;14;13;12;11;10;8;4","INTERNAL MEDICINE;SURGERY;GENETICS;GASTROENTEROLOGY;PATHOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;ONCOLOGY;CARDIOLOGY;IMMUNOLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;PEDIATRICS;PSYCHIATRY;OPTICS;UROLOGY;CELL BIOLOGY;CANCER RESEARCH;QUANTUM MECHANICS;INTENSIVE CARE MEDICINE","393;114;97;84;79;76;73;72;67;60;52;51;45;35;32;32;30;24;24;23","CANCER;GENE;DISEASE;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;COHORT;POPULATION;OBESITY;PROPORTIONAL HAZARDS MODEL;CHEMOTHERAPY;DIABETES MELLITUS;BODY MASS INDEX;HEART FAILURE;COHORT STUDY;MYOCARDIAL INFARCTION;RECEPTOR;INCIDENCE (GEOMETRY);ANTIBODY;KIDNEY;LUNG;PREGNANCY;RANDOMIZED CONTROLLED TRIAL","109;81;74;46;45;40;40;30;30;28;27;24;24;23;21;20;18;17;17;17;17;17","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HAZARD RATIO;BREAST CANCER;COLORECTAL CANCER;EJECTION FRACTION;MUTATION;PROSTATE CANCER;GENE EXPRESSION;GENOTYPE;ALLELE;CLINICAL ENDPOINT;DOCETAXEL;METABOLIC SYNDROME;PSORIATIC ARTHRITIS;LOWER RISK;PARKINSON'S DISEASE;PHENOTYPE;QUARTILE;RECOMBINANT DNA;SUNITINIB;TYPE 2 DIABETES;WAIST","29;26;25;19;14;13;13;12;12;11;11;11;9;9;8;8;8;8;8;8;8;8","SINGLE-NUCLEOTIDE POLYMORPHISM;ANDROGEN DEPRIVATION THERAPY;DIFFUSING CAPACITY;VECTOR (MOLECULAR BIOLOGY);DISCOVERY AND DEVELOPMENT OF MTOR INHIBITORS;PAZOPANIB;UROTHELIAL CARCINOMA;HAPLOTYPE;MISSENSE MUTATION;ABDOMINAL OBESITY;ACROMEGALY;ANDROGEN RECEPTOR;CARBOPLATIN;CARDIAC RESYNCHRONIZATION THERAPY;DNA METHYLATION;ESTROGEN RECEPTOR;GENE DELIVERY;MACE;NONALCOHOLIC FATTY LIVER DISEASE;PRIMARY CILIARY DYSKINESIA;PROSTATECTOMY;TRANSCRIPTOME;TRASTUZUMAB;TRINUCLEOTIDE REPEAT EXPANSION;UMBILICAL ARTERY;VIRAL VECTOR;WAIST-TO-HEIGHT RATIO","8;6;6;6;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;FEMALE;MALE;MIDDLE AGED;;ADULT;AGED;PROSPECTIVE STUDIES;ITALY;RISK FACTORS;FOLLOW-UP STUDIES;TREATMENT OUTCOME;ADOLESCENT;RETROSPECTIVE STUDIES;YOUNG ADULT;ANIMALS;AGED, 80 AND OVER;EUROPE;OBESITY;CHILD","371;285;279;219;212;173;151;77;72;65;63;57;54;54;52;46;44;43;43;39","RENAL CELL CARCINOMA;DIAGNOSIS AND TREATMENT OF BLADDER CANCER;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT AND TREATMENT OF HEMOPHILIA;MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;BROWN ADIPOSE TISSUE FUNCTION AND PHYSIOLOGY;CHEMOTHERAPY-INDUCED PERIPHERAL NEUROPATHY IN CANCER TREATMENT;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;MANAGEMENT AND DIAGNOSIS OF THYROID CANCER;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;COLORECTAL CANCER RESEARCH AND TREATMENT","13;10;10;10;8;7;7;7;7;6;6;6;6;6;5;5;5;5;5;4","CARDIOVASCULAR RISK ASSESSMENT;CARDIAC IMAGING;HEALTHY EATING INDEX;TREATMENT;ECHOCARDIOGRAPHY;CLINICAL ENDPOINT;CONCOMITANT;LEFT VENTRICULAR FUNCTION;DISCONTINUATION;LOWER RISK;QUARTILE;RENAL CELL CARCINOMA;BREAST CANCER;COMPUTED TOMOGRAPHY ANGIOGRAPHY;DIET QUALITY;DIETARY PATTERNS;CABAZITAXEL;CARDIAC METABOLISM;DIABETES;DIAGNOSIS","18;17;14;14;13;11;11;11;9;8;8;8;7;7;7;7;6;6;6;6","PROSPECTIVE INVESTIGATION;EUROPEAN PROSPECTIVE;BREAST CANCER;CANCER RISK;CELL CARCINOMA;EPIC COHORT;RENAL CELL;COLORECTAL CANCER;UROTHELIAL CARCINOMA;PROSTATE CANCER;PSORIATIC ARTHRITIS;TYPE DIABETES;ADVANCED UROTHELIAL;CASTRATION-RESISTANT PROSTATE;COHORT STUDY;HEART FAILURE;LEFT VENTRICULAR;METABOLIC SYNDROME;METASTATIC RENAL;MYOCARDIAL INFARCTION;RISK FACTORS;CARDIOVASCULAR IMAGING;CLINICAL OUTCOMES;DIABETES MELLITUS;EUROPEAN ASSOCIATION;NUTRITION EPIC;PATIENTS PTS;CARCINOMA UC;CORONARY INTERVENTION;FINE NEEDLE","16;15;14;14;14;12;11;10;10;9;9;9;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;5;5;5","HR CI;CANCER RISK;BREAST CANCER;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;TYPE DIABETES;COLORECTAL CANCER;GENE EXPRESSION;PUBMED GOOGLE;ACADEMIC PUBMED;OXFORD ACADEMIC;CONFIDENCE INTERVAL;PANCREATIC CANCER;HEART FAILURE;ITALY SEARCH;NUTRITION EPIC;BLADDER CANCER;CONFIDENCE INTERVALS;MASS INDEX;RISK FACTORS;STATISTICALLY SIGNIFICANT;BODY MASS;CANCER CELLS;COX PROPORTIONAL;HAZARD RATIOS;HEALTHY CONTROLS;PEDIATRIC GASTROENTEROLOGY;INSULIN RESISTANCE;MYOCARDIAL INFARCTION;PROPORTIONAL HAZARDS","44;35;30;30;30;27;21;20;20;19;19;18;18;17;17;17;15;15;15;15;15;13;13;13;13;13;13;12;12;12",238,0.39,8.15,7,2,1,1,7,3.5,1,1,8,1,1,6,1,1,2,3,5,2,0,0,90,90,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,6.33,373,0.89,3,0.33,69.89,0,0,1,0,3,0,1,4,0,6,3,0,0,0,0,0,0,9,0,0,9,0,0,0,0,0,0,0,0,0,"United States;Belgium;Italy;Japan","3;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3212 OPHTHALMOLOGY AND OPTOMETRY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY","8;4;2;1;1;1;1;1;1","CLINICAL RESEARCH;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;PATIENT SAFETY;PEDIATRIC;CANCER;CARDIOVASCULAR;INFECTIOUS DISEASES;ASSISTIVE TECHNOLOGY;ATHEROSCLEROSIS;AUTOIMMUNE DISEASE;BIOENGINEERING;CHILDHOOD LEUKEMIA;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIABETES;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;EYE DISEASE AND DISORDERS OF VISION;HEART DISEASE","9;4;3;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1","CANCER;BLOOD;CARDIOVASCULAR;INFECTION;RENAL AND UROGENITAL","2;1;1;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","3;2;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;LIVER CANCER;THYROID CANCER","2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;1.4 CANCER PROGRESSION AND METASTASIS;3.3 CHEMOPREVENTION;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","3;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2015,628,12.5589171974522,3.01433121019108,0.423566878980892,0.361464968152866,0.484076433121019,1.7689429373246,1.2258064516129,1.47402597402597,1.216,0.49203821656051,17,324,144,46,54,0.52,0.23,0.07,0.09,35.83,0.961356274433293,5.11422479439536,0.394904458598726,0.856687898089172,0.455,0.428,0.433,0.44,"­ROSARIO ­TUMINO;HEINER BOEING;SALVATORE PANICO;ANNE TJØNNELAND;ELISABETE WEIDERPASS;ELIO RÍBOLI;ANTONIA TRICHOPOULOU;KIM OVERVAD;NICHOLAS J. WAREHAM;KAY‐TEE KHAW;AMALIA MATTIELLO;PETRA H. PEETERS;GIOVANNA MASALA;MARC J. GUNTER;MARÍA‐JOSÉ SÁNCHEZ;ΠΑΓΏΝΑ ΛΆΓΙΟΥ;RUTH C. TRAVIS;RUDOLF KAAKS;GIUSEPPE DI LORENZO;BRUNO TRIMARCO","34;30;29;29;27;26;25;23;23;22;21;20;18;18;18;18;17;17;17;16","MAURIZIO GALDERISI;GIOVANNA DE MINICO;MARIO PETRETTA;YOUSSEF ROUPHAEL;ALBERTO CUOCOLO;PASQUALE PERRONE FILARDI;MATTEO NICOLA DARIO DI MINNO;GIUSEPPE DI LORENZO;BRUNO TRIMARCO;MARIA TRIASSI;GIUSEPPE GALLORO;MADDALENA ILLARIO;FABRIZIO PANE;ALESSANDRO MAGNANI;EMILIANO GRIMALDI;MARCELLO MOCCIA;ANTONIO M. RISITANO;GAETANO SANTULLI;FABRIZIO SCHÖNAUER;GIOVANNI DI MINNO","2.37;2;1.96;1.92;1.91;1.84;1.74;1.64;1.57;1.52;1.44;1.39;1.36;1.33;1.33;1.29;1.26;1.25;1.2;1.18","SALVATORE PANICO;AMALIA MATTIELLO;GIUSEPPE DI LORENZO;BRUNO TRIMARCO;MAURIZIO GALDERISI;MATTEO NICOLA DARIO DI MINNO;MARIA TRIASSI;MARCELLO MOCCIA;MADDALENA ILLARIO;ALBERTO CUOCOLO;GIOVANNI ESPOSITO;ALBERTO AURICCHIO;PASQUALE PERRONE FILARDI;PAOLO BARONE;RAFFAELE PALLADINO;RAFFAELE LIUZZI;ROBERTA LANZILLO;MARCO SALVATORE;GIOVANNI DI MINNO;VINCENZO BRESCIA MORRA","29;21;17;16;15;14;13;13;11;11;11;10;10;9;9;9;9;9;9;9","MAURIZIO GALDERISI;GIOVANNA DE MINICO;MARIO PETRETTA;YOUSSEF ROUPHAEL;ALBERTO CUOCOLO;PASQUALE PERRONE FILARDI;MATTEO NICOLA DARIO DI MINNO;GIUSEPPE DI LORENZO;BRUNO TRIMARCO;MARIA TRIASSI;GIUSEPPE GALLORO;MADDALENA ILLARIO;FABRIZIO PANE;ALESSANDRO MAGNANI;EMILIANO GRIMALDI;MARCELLO MOCCIA;ANTONIO M. RISITANO;GAETANO SANTULLI;FABRIZIO SCHÖNAUER;GIOVANNI DI MINNO","2.37;2;1.96;1.92;1.91;1.84;1.74;1.64;1.57;1.52;1.44;1.39;1.36;1.33;1.33;1.29;1.26;1.25;1.2;1.18","­ROSARIO ­TUMINO;ANTONIA TRICHOPOULOU;SALVATORE PANICO;HEINER BOEING;ANNE TJØNNELAND;ELIO RÍBOLI;NICHOLAS J. WAREHAM;DOMENICO PALLI;KIM OVERVAD;PETRA H. PEETERS;CARMINE SETTEMBRE;PAOLO VINEIS;ELISABETE WEIDERPASS;DIEGO L. MEDINA;ANDREA BALLABIO;KAY‐TEE KHAW;ISABELLE ROMIEU;SANDRO MONTEFUSCO;ALISON FORRESTER;ANDREA ARMANI","2556;2040;1914;1792;1763;1602;1557;1523;1458;1374;1365;1279;1272;1226;1197;1191;1187;1184;1140;1140","SALVATORE PANICO;ANDREA BALLABIO;CHIARA CARLOMAGNO;AMALIA MATTIELLO;GABRIELE RICCARDI;YOUSSEF ROUPHAEL;MARCELLO MOCCIA;G. LONGO;ALBERTO CUOCOLO;ALESSANDRO FILLA;VINCENZO BRESCIA MORRA;MAURIZIO GALDERISI;MARIA SANTUCCI DE MAGISTRIS;ANTONIO M. RISITANO;MARIA TRIASSI;M. PAOLILLO;ROBERTA LANZILLO;BRUNO TRIMARCO;CINZIA VALERIA RUSSO;ANDREA DE BARTOLOMEIS","1914;1197;919;917;823;611;589;530;479;464;443;433;419;382;370;338;336;332;327;325","SALVATORE PANICO;AMALIA MATTIELLO;GIUSEPPE DI LORENZO;MAURIZIO GALDERISI;BRUNO TRIMARCO;MARCELLO MOCCIA;ALBERTO CUOCOLO;MARIA TRIASSI;PASQUALE PERRONE FILARDI;MATTEO NICOLA DARIO DI MINNO;GIOVANNI ESPOSITO;VINCENZO BRESCIA MORRA;ALBERTO AURICCHIO;MADDALENA ILLARIO;CARLO G. TOCCHETTI;GABRIELE RICCARDI;DOMENICO RUSSO;GIOVANNI DI MINNO;FABRIZIO PANE;ANTONIO CAROTENUTO","29;21;17;15;14;13;11;10;10;10;9;9;9;9;8;8;8;8;7;7","MEDICINE;BIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PSYCHOLOGY;MATHEMATICS;MATERIALS SCIENCE;BUSINESS;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;SOCIOLOGY;GEOGRAPHY;GEOLOGY;ART;HISTORY","492;212;79;76;64;58;49;43;23;22;21;21;21;18;18;13;11;7;1","INTERNAL MEDICINE;SURGERY;GENETICS;BIOCHEMISTRY;CARDIOLOGY;PATHOLOGY;GASTROENTEROLOGY;ONCOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PSYCHIATRY;PEDIATRICS;RADIOLOGY;CELL BIOLOGY;OPTICS;CANCER RESEARCH;ORGANIC CHEMISTRY;QUANTUM MECHANICS;NEUROSCIENCE","384;102;98;86;77;77;74;72;68;60;50;42;41;38;34;32;28;28;28;25","GENE;CANCER;DISEASE;POPULATION;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;COHORT;CHEMOTHERAPY;BLOOD PRESSURE;HEART FAILURE;OBESITY;PROPORTIONAL HAZARDS MODEL;COHORT STUDY;BODY MASS INDEX;DIABETES MELLITUS;RECEPTOR;INSULIN;MYOCARDIAL INFARCTION;INCIDENCE (GEOMETRY);ALTERNATIVE MEDICINE;BACTERIA;ENZYME;RANDOMIZED CONTROLLED TRIAL","88;75;68;48;38;36;35;33;30;30;26;25;24;23;23;21;20;20;19;16;16;16;16","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HAZARD RATIO;BREAST CANCER;EJECTION FRACTION;COLORECTAL CANCER;DIASTOLE;MUTATION;CLINICAL ENDPOINT;GENE EXPRESSION;INSULIN RESISTANCE;PARKINSON'S DISEASE;PHENOTYPE;PROSTATE CANCER;GENOTYPE;RECOMBINANT DNA;WEIGHT LOSS;PLACEBO;GENETIC ENHANCEMENT;IMATINIB;OVERWEIGHT","26;22;21;20;15;14;13;12;12;12;12;11;11;10;10;10;9;8;8;8","DNA METHYLATION;GASTRIC BYPASS;KRAS;VECTOR (MOLECULAR BIOLOGY);DASATINIB;DOPPLER ECHOCARDIOGRAPHY;IRINOTECAN;MISSENSE MUTATION;CORONAVIRUS DISEASE 2019 (COVID-19);IMATINIB MESYLATE;SPECKLE TRACKING ECHOCARDIOGRAPHY;ACINETOBACTER BAUMANNII;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;APX;BENDAMUSTINE;CHANDRA DEEP FIELD SOUTH;CROSSOVER STUDY;FRAMINGHAM HEART STUDY;GLYCEMIC INDEX;IL-2 RECEPTOR;NILOTINIB;PARKIN;PHOTOMETRIC REDSHIFT;PROSTATECTOMY;SANGER SEQUENCING;SECONDARY HYPERPARATHYROIDISM;STROKE VOLUME;TFEB;WEIGHT CHANGE","9;6;6;6;5;5;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;YOUNG ADULT;PROSPECTIVE STUDIES;RISK FACTORS;ADOLESCENT;TREATMENT OUTCOME;ANIMALS;FOLLOW-UP STUDIES;RETROSPECTIVE STUDIES;HEART FAILURE;HYPERTENSION;BIOMARKERS;BREAST NEOPLASMS","330;257;238;228;179;156;117;89;57;55;55;52;50;49;48;42;38;37;35;33","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;EFFICACY AND RESISTANCE IN CML TREATMENT;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;EPIGENETIC MODIFICATIONS AND THEIR FUNCTIONAL IMPLICATIONS;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;GENE THERAPY TECHNIQUES AND APPLICATIONS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;EFFECTS OF KETOGENIC DIET ON HEALTH;GALAXY FORMATION AND EVOLUTION IN THE UNIVERSE;GENOMIC STUDIES AND TREATMENT OF OVARIAN CARCINOMA;MAGNETIC RESONANCE IMAGING APPLICATIONS IN MEDICINE;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE","11;11;10;10;7;7;7;6;6;6;6;6;5;5;5;5;5;5;4;4","CARDIAC IMAGING;TREATMENT;CLINICAL ENDPOINT;DIETARY PATTERNS;HEALTHY EATING INDEX;LEFT VENTRICULAR FUNCTION;CARDIOVASCULAR RISK ASSESSMENT;DIET QUALITY;BREAST CANCER;ECHOCARDIOGRAPHY;CARDIOPULMONARY EXERCISE TESTING;DIAGNOSTIC CRITERIA;LOW-CARBOHYDRATE DIET;REGIMEN;CANCER RISK;CONCOMITANT;DIABETES;DNA METHYLATION;EXERCISE CAPACITY;HYPERTENSION","16;15;12;11;10;10;9;9;8;8;7;7;7;7;6;6;6;6;6;6","BREAST CANCER;HEART FAILURE;MULTIPLE SCLEROSIS;LEFT VENTRICULAR;EUROPEAN PROSPECTIVE;GENE THERAPY;MYELOID LEUKEMIA;PARKINSONS DISEASE;PROSPECTIVE INVESTIGATION;CHRONIC MYELOID;COHORT STUDY;EPIC COHORT;PROSTATE CANCER;PATIENTS TREATED;PSORIATIC ARTHRITIS;TYPE DIABETES;UROTHELIAL CARCINOMA;ADVANCED UROTHELIAL;COLORECTAL CANCER;OVARIAN CANCER;SOUTHERN ITALY;CANCER PATIENTS;CANCER RISK;EJECTION FRACTION;HEPATOCELLULAR CARCINOMA;LONG-TERM OUTCOME;PATIENTS RECEIVING;PATIENTS UNDERGOING;SLEEVE GASTRECTOMY;SOMATOSTATIN ANALOGS","17;15;12;11;9;9;9;9;9;8;8;8;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5;5","BREAST CANCER;HR CI;EUROPEAN PROSPECTIVE;RISK FACTORS;PROSPECTIVE INVESTIGATION;GENE EXPRESSION;CANCER RISK;ADVERSE EVENTS;DUAL AAV;GENE THERAPY;CONFIDENCE INTERVAL;DNA METHYLATION;NUTRITION EPIC;MOSAIC VIRUS;COLORECTAL CANCER;LOGISTIC REGRESSION;RECOMBINANT FACTOR;ARTERY DISEASE;MPS VI;MULTIVARIATE ANALYSIS;FATTY ACIDS;HCC RISK;MASS INDEX;ODDS RATIO;TYPE DIABETES;AAV VECTORS;ALCOHOL CONSUMPTION;BODY MASS;CONFIDENCE INTERVALS;EPIC COHORT","39;32;26;26;25;21;19;17;17;17;16;16;16;15;14;14;14;13;13;13;12;12;12;12;12;11;11;11;11;11",275,0.44,7.82,7,2,1,1,4,2,1,1,8,1,1,5,2.25,1.75,1,2.5,5,3,0,0,96.5,96.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,4.54,730.77,1.31,11,0.85,171.31,0,0,2,0,8,0,0,3,0,11,2,0,0,0,0,0,0,12,1,0,13,0,0,0,0,0,0,0,0,0,"United States;Germany;Japan","6;3;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;3207 MEDICAL MICROBIOLOGY;40 ENGINEERING;4003 BIOMEDICAL ENGINEERING;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","12;7;4;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;DIGESTIVE DISEASES;AUTOIMMUNE DISEASE;CANCER;PATIENT SAFETY;RARE DISEASES;AGING;CHRONIC LIVER DISEASE AND CIRRHOSIS;COMPLEMENTARY AND INTEGRATIVE HEALTH;HEPATITIS;INFLAMMATORY BOWEL DISEASE;LIVER DISEASE;NEUROSCIENCES;NUTRITION;PEDIATRIC;ACQUIRED COGNITIVE IMPAIRMENT;ALZHEIMER'S DISEASE;ALZHEIMER'S DISEASE INCLUDING ALZHEIMER'S DISEASE RELATED DEMENTIAS (AD/ADRD);ANTIMICROBIAL RESISTANCE","12;12;6;4;3;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1","ORAL AND GASTROINTESTINAL;CANCER;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;NEUROLOGICAL;RESPIRATORY","3;2;1;1;1;1;1","6.1 PHARMACEUTICALS;6.3 MEDICAL DEVICES","9;1","COLON AND RECTAL CANCER;LIVER CANCER;BREAST CANCER;PANCREATIC CANCER","2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;2.1 EXOGENOUS FACTORS IN THE ORIGIN AND CAUSE OF CANCER;3.3 CHEMOPREVENTION","4;1;1",2,950832,130264.47,3.5,7.5,6.5,1,5,162034.74537037,3.87571195649767,"FEDERICO II UNIVERSITY HOSPITAL;MEDICAL UNIVERSITY OF LODZ;CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE;EUROPEAN REGIONAL AND LOCAL HEALTH AUTHORITIES;FUNDACIÓ CLÍNIC PER A LA RECERCA BIOMÈDICA;HANNOVER MEDICAL SCHOOL;LANDSTINGET I UPPSALA LÄN;ROBERT GORDON UNIVERSITY;SCOTTISH GOVERNMENT;UNIVERSITY HOSPITAL OF MONTPELLIER;UNIVERSITY OF COIMBRA;UNIVERSITY OF DEUSTO;UNIVERSITY OF PELOPONNESE","2;2;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","2","COALITION S;EC & ERC - EUROPEAN UNION","2;2","3RD HEALTH PROGRAMME (PROGRAMME)","2","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR","2;2;1;1","CLINICAL RESEARCH;HEALTH SERVICES;PREVENTION","2;2;1",NA,NA,"8.1 ORGANISATION AND DELIVERY OF SERVICES","1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;C17 BUSINESS AND MANAGEMENT STUDIES","1;1",NA,NA,3,"PUBLIC LIBRARY OF SCIENCE","3","37 EARTH SCIENCES;3705 GEOLOGY;43 HISTORY, HERITAGE AND ARCHAEOLOGY;4301 ARCHAEOLOGY;44 HUMAN SOCIETY;50 PHILOSOPHY AND RELIGIOUS STUDIES","3;2;2;1;1;1",NA,NA,NA,NA,"2.1 BIOLOGICAL AND ENDOGENOUS FACTORS","1",NA,NA,"BASIC SCIENCE","1",NA,NA,NA,NA
"AOUSSN_FEDERICOII",2016,601,12.7554076539101,2.97171381031614,0.40432612312812,0.367720465890183,0.53910149750416,1.74243902439024,1.19704433497537,1.4635761589404,1.29083665338645,0.497504159733777,18,292,140,57,57,0.49,0.23,0.09,0.09,29.51,0.908602465750938,5.10218365061591,0.339434276206323,0.858569051580699,0.486,0.405,0.441,0.444,"­ROSARIO ­TUMINO;ELIO RÍBOLI;ANTONIA TRICHOPOULOU;ANNE TJØNNELAND;KIM OVERVAD;HEINER BOEING;ELISABETE WEIDERPASS;BRUNO TRIMARCO;DOMENICO PALLI;PETRA H. PEETERS;SALVATORE PANICO;RUDOLF KAAKS;KAY‐TEE KHAW;ROBERTA LANZILLO;MARCELLO MOCCIA;NICHOLAS J. WAREHAM;AMALIA MATTIELLO;MARIE‐CHRISTINE BOUTRON‐RUAULT;ΠΑΓΏΝΑ ΛΆΓΙΟΥ;J. RAMÓN QUIRÓS","25;23;22;20;19;19;19;18;17;17;16;15;15;15;15;15;14;14;14;14","VINCENZO D’ALESSANDRO;BRUNO TRIMARCO;BRUNO JOSSA;MARCELLO MOCCIA;ANDREA BALLABIO;ROBERTA LANZILLO;ALESSANDRO MAGNANI;N. RINALDI;MAURIZIO GALDERISI;LIDIA SANTARPIA;LORENZO CODECASA;FRANCESCO VERDE;DONATELLA DARSENA;GIACINTO GELLI;CARMINE FINELLI;RAFFAELE SCARPA;MARIA TRIASSI;RAFFAELE IZZO;GIUSEPPE DE MICHELE;RAFFAELE PALLADINO","2.54;2.17;2;1.92;1.91;1.63;1.54;1.54;1.5;1.38;1.29;1.25;1.25;1.25;1.25;1.24;1.18;1.18;1.18;1.14","BRUNO TRIMARCO;SALVATORE PANICO;ROBERTA LANZILLO;MARCELLO MOCCIA;AMALIA MATTIELLO;RAFFAELE SCARPA;FABRIZIO PANE;MAURIZIO GALDERISI;ARTURO BRUNETTI;VINCENZO BRESCIA MORRA;RAFFAELE IZZO;LUISA COSTA;FRANCESCO CASO;GIUSEPPE DE MICHELE;DARIO BRUZZESE;FRANCESCO SACCÀ;VINCENZO D’ALESSANDRO;ANTONIO RAPACCIUOLO;PAOLO BARONE;FABRIZIO PASANISI","18;16;15;15;14;13;11;11;11;11;10;10;10;10;10;9;9;9;8;8","VINCENZO D’ALESSANDRO;BRUNO TRIMARCO;BRUNO JOSSA;MARCELLO MOCCIA;ANDREA BALLABIO;ROBERTA LANZILLO;ALESSANDRO MAGNANI;N. RINALDI;MAURIZIO GALDERISI;LIDIA SANTARPIA;FRANCESCO VERDE;DONATELLA DARSENA;GIACINTO GELLI;CARMINE FINELLI;RAFFAELE SCARPA;MARIA TRIASSI;RAFFAELE IZZO;GIUSEPPE DE MICHELE;RAFFAELE PALLADINO;FABRIZIO PASANISI","2.54;2.17;2;1.92;1.91;1.63;1.54;1.54;1.5;1.38;1.25;1.25;1.25;1.25;1.24;1.18;1.18;1.18;1.14;1.12","­ROSARIO ­TUMINO;SALVATORE PANICO;ELIO RÍBOLI;VITTORIO KROGH;ANTONIA TRICHOPOULOU;PAOLO VINEIS;ANNE TJØNNELAND;KIM OVERVAD;J. RAMÓN QUIRÓS;HEINER BOEING;PETRA H. PEETERS;DOMENICO PALLI;MARIA TRIASSI;ANDREA BALLABIO;ELISABETE WEIDERPASS;ΠΑΓΏΝΑ ΛΆΓΙΟΥ;RUDOLF KAAKS;RAFFAELE PALLADINO;KAY‐TEE KHAW;CISCA WIJMENGA","2262;1813;1469;1391;1285;1231;1181;1179;1165;1151;1102;1088;1077;1039;1001;947;939;917;899;848","SALVATORE PANICO;ANDREA BALLABIO;MARIA TRIASSI;FRANCESCA SANTAMARIA;AMALIA MATTIELLO;YOUSSEF ROUPHAEL;MAURIZIO GALDERISI;MARCELLO MOCCIA;VINCENZO BRESCIA MORRA;ARTURO BRUNETTI;STEFANIA DE PASCALE;MASSIMO IMBRIACO;SERGIO MONDILLO;FABRIZIO PASANISI;RAFFAELE SCARPA;BRUNO TRIMARCO;PASQUALE PERRONE FILARDI;PAOLO MONTUORI;SIRIO COCOZZA;ANTONIO NARDONE","1813;1039;981;609;608;482;407;393;380;343;333;301;280;274;273;267;242;231;227;219","BRUNO TRIMARCO;SALVATORE PANICO;MARCELLO MOCCIA;AMALIA MATTIELLO;VINCENZO BRESCIA MORRA;ROBERTA LANZILLO;RAFFAELE SCARPA;ARTURO BRUNETTI;DARIO BRUZZESE;MAURIZIO GALDERISI;FABRIZIO PANE;VINCENZO D’ALESSANDRO;MASSIMO IMBRIACO;GIUSEPPE DE MICHELE;RAFFAELE IZZO;ANDREA BALLABIO;ANGELA SALZANO;ANNA DE ROSA;ANTONIO RAPACCIUOLO;B. GASPARRINI","16;16;14;14;13;12;12;11;10;10;9;9;9;9;9;8;8;8;8;8","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;PSYCHOLOGY;MATERIALS SCIENCE;SOCIOLOGY;GEOGRAPHY;ECONOMICS;POLITICAL SCIENCE;BUSINESS;GEOLOGY;ENVIRONMENTAL SCIENCE;PHILOSOPHY;ART;HISTORY","459;205;89;85;84;52;51;48;28;27;26;22;21;19;17;14;12;9;7","INTERNAL MEDICINE;SURGERY;GENETICS;BIOCHEMISTRY;PATHOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;RADIOLOGY;CARDIOLOGY;ONCOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;QUANTUM MECHANICS;CELL BIOLOGY;PEDIATRICS;NEUROSCIENCE;ORGANIC CHEMISTRY;OPTICS;ARCHAEOLOGY;STATISTICS","352;103;96;79;75;61;61;58;56;55;53;47;44;35;34;31;29;29;26;23;23","GENE;CANCER;DISEASE;POPULATION;CHEMOTHERAPY;COHORT;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;HEART FAILURE;BODY MASS INDEX;BLOOD PRESSURE;RECEPTOR;COHORT STUDY;OBESITY;DIABETES MELLITUS;MULTIPLE SCLEROSIS;PROPORTIONAL HAZARDS MODEL;CONTEXT (ARCHAEOLOGY);ODDS RATIO;ADVERSE EFFECT;ENZYME;POWER (PHYSICS);PREGNANCY","82;78;58;41;35;35;34;33;25;24;23;22;19;19;18;18;18;17;17;15;15;15;15","BREAST CANCER;HAZARD RATIO;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;COLORECTAL CANCER;EJECTION FRACTION;GENOME;PHENOTYPE;GENE EXPRESSION;GENOTYPE;METABOLIC SYNDROME;PARKINSON'S DISEASE;PLACEBO;TYPE 2 DIABETES;MUTATION;PSORIATIC ARTHRITIS;WAIST;AUTOPHAGY;FETUS;CARDIOTOXICITY;CRYOPRESERVATION;DIASTOLE","23;19;18;17;16;14;14;13;12;10;10;10;10;9;9;9;8;8;7;7;7","TFEB;DNA METHYLATION;GENOMICS;GENOTYPING;MISSENSE MUTATION;NILOTINIB;COPY-NUMBER VARIATION;DNA-BINDING PROTEIN;FEBRILE NEUTROPENIA;KRAS;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;ALLELE FREQUENCY;COLONOSCOPY;COMPARATIVE GENOMIC HYBRIDIZATION;COMPOUND HETEROZYGOSITY;ELECTROCHEMOTHERAPY;EPIRUBICIN;EXOME SEQUENCING;FLUDARABINE;FRACTIONAL FLOW RESERVE;IMATINIB MESYLATE;LEVODOPA;MASTECTOMY;METASTATIC BREAST CANCER;SEMEN EXTENDER;STROKE VOLUME;TAXANE;TRANSCRIPTOME;TRASTUZUMAB","6;5;5;5;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;RISK FACTORS;YOUNG ADULT;TREATMENT OUTCOME;ADOLESCENT;ANIMALS;HYPERTENSION;PROSPECTIVE STUDIES;PARKINSON DISEASE;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;BIOMARKERS;CHILD","297;267;234;218;168;155;117;69;51;50;48;47;44;44;43;40;37;36;36;32","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;CARDIOTOXICITY OF CANCER TREATMENTS;CLASSIFICATION AND TREATMENT OF SPONDYLOARTHRITIS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;DIAGNOSIS AND MANAGEMENT OF HYPERTROPHIC CARDIOMYOPATHY;EFFICACY AND RESISTANCE IN CML TREATMENT;IMPACT OF OBESITY ON CANCER RISK AND PROGNOSIS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MALE REPRODUCTIVE HEALTH;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;RADIOTHERAPY PHYSICS AND TECHNOLOGY;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ROLE OF AUTOPHAGY IN DISEASE AND HEALTH;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;APPLICATIONS OF ELECTROPORATION IN BIOTECHNOLOGY AND FOOD PROCESSING;BODY COMPOSITION ASSESSMENT AND ANALYSIS;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EATING DISORDERS AND BODY IMAGE CONCERNS","14;8;7;7;6;5;5;5;5;5;5;5;5;5;5;4;4;4;4;4","CARDIAC IMAGING;LEFT VENTRICULAR FUNCTION;REGIMEN;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;HYPERTENSION;DIAGNOSTIC CRITERIA;ECHOCARDIOGRAPHY;CARDIOTOXICITY;PSORIATIC ARTHRITIS;TFEB;BREAST CANCER;CLINICAL ENDPOINT;DISCONTINUATION;ETIOLOGY;HEART RATE VARIABILITY;SALVAGE THERAPY;AGING;BODY MASS INDEX;CARDIOVASCULAR MRI","15;12;12;11;10;10;9;9;7;7;7;6;6;6;6;6;6;5;5;5","MULTIPLE SCLEROSIS;BREAST CANCER;COLORECTAL CANCER;EUROPEAN PROSPECTIVE;LEFT VENTRICULAR;PROSPECTIVE INVESTIGATION;PSORIATIC ARTHRITIS;CANCER PATIENTS;CORONARY ARTERY;EPIC COHORT;MYELOID LEUKEMIA;PARKINSONS DISEASE;COHORT STUDY;HEART FAILURE;NEWLY DIAGNOSED;POOLED ANALYSIS;CANCER RISK;CELL TRANSPLANTATION;HYPERTROPHIC CARDIOMYOPATHY;OBSERVATIONAL STUDY;STEM CELL;TYPE DIABETES;ADULT PATIENTS;CARDIOVASCULAR RISK;CHRONIC MYELOID;COMPACT THERMAL;DYNAMIC COMPACT;FUNCTIONAL CONNECTIVITY;HEMATOPOIETIC STEM;HYPERTENSIVE PATIENTS","16;11;9;9;8;8;8;7;7;7;7;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4","BREAST CANCER;CANCER RISK;RISK FACTORS;STATISTICALLY SIGNIFICANT;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;COLORECTAL CANCER;BODY MASS;MASS INDEX;PANCREATIC CANCER;SODIUM CONCENTRATION;ADVERSE EVENTS;CONFIDENCE INTERVAL;MULTIPLE SCLEROSIS;INTRACELLULAR SODIUM;FOLFOXIRI-BASED REGIMENS;LOGISTIC REGRESSION;NUTRITION EPIC;ODDS RATIO;PERIPHERAL BLOOD;CLINICAL PRACTICE;TYPE DIABETES;CANCER PATIENTS;DNA METHYLATION;EXOME SEQUENCING;GENE EXPRESSION;HR CI;LEFT VENTRICULAR;OVARIAN CANCER;PATIENTS UNDERGOING","34;23;21;21;19;19;18;17;17;15;15;14;14;14;13;12;12;12;12;12;11;11;10;10;10;10;10;10;10;10",266,0.44,8.96,6.75,2,1,1,2,2,1,1,7.75,1.25,1,6,1,1.5,1,2,5,2,0,0,91.75,90.25,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,5.31,727.08,1.35,9,0.69,107.23,0,0,1,0,8,0,1,3,0,11,2,0,0,0,0,0,0,12,0,1,13,0,0,0,0,0,0,0,0,0,"Japan;Italy;United States","4;3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3204 IMMUNOLOGY;3210 NUTRITION AND DIETETICS;42 HEALTH SCIENCES","13;5;5;3;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;AUTOIMMUNE DISEASE;HEMATOLOGY;PATIENT SAFETY;PEDIATRIC;BRAIN DISORDERS;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;NEURODEGENERATIVE;NEUROSCIENCES;ORPHAN DRUG;PARKINSON'S DISEASE;PREVENTION;BEHAVIORAL AND SOCIAL SCIENCE;BIOENGINEERING;BIOMEDICAL IMAGING;BREAST CANCER","13;11;5;4;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL","4;1;1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","10;1","LEUKEMIA / LEUKAEMIA;BLADDER CANCER;BREAST CANCER;KIDNEY CANCER;MYELOMA","2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT","2;1",1,3852677,481584.62,5,8,5,1,2,258351.67037037,2.32628648825228,"EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;FEDERICO II UNIVERSITY HOSPITAL;FUNDACIÓN PARA LA FORMACIÓN E INVESTIGACIÓN SANITARIAS DE LA REGIÓN DE MURCIA;MINISTRY OF HEALTH;SERVICIO MURCIANO DE SALUD;SERVIÇOS PARTILHADOS DO MINISTÉRIO DA SAÚDE;TICBIOMED;UNIVERSITY OF SALERNO","1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-SC1-2016-CNECT (CALL FOR PROPOSAL);PCP - PRE-COMMERCIAL PROCUREMENT (FUNDING SCHEME)","1;1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;46 INFORMATION AND COMPUTING SCIENCES","1;1;1","CLINICAL RESEARCH;DIABETES;HEALTH SERVICES","1;1;1","METABOLIC AND ENDOCRINE","1","7.3 MANAGEMENT AND DECISION MAKING","1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1","3 GOOD HEALTH AND WELL BEING","1",1,"PUBLIC LIBRARY OF SCIENCE","1","34 CHEMICAL SCIENCES;3404 MEDICINAL AND BIOMOLECULAR CHEMISTRY;46 INFORMATION AND COMPUTING SCIENCES","1;1;1",NA,NA,NA,NA,NA,NA,NA,NA,"BASIC SCIENCE","1",NA,NA,NA,NA
"AOUSSN_FEDERICOII",2017,698,12.919770773639,3.28939828080229,0.418338108882521,0.412607449856734,0.531518624641834,1.88423645320197,1.20661157024793,1.54838709677419,1.25337837837838,0.521489971346705,12,349,164,66,58,0.5,0.23,0.09,0.08,34.12,1.15765038619058,4.99592460519613,0.375358166189112,0.863896848137536,0.456,0.447,0.488,0.451,"­ROSARIO ­TUMINO;ANTONIA TRICHOPOULOU;SALVATORE PANICO;FABRIZIO PANE;KIM OVERVAD;BRUNO TRIMARCO;ELISABETE WEIDERPASS;ANNE TJØNNELAND;HEINER BOEING;DOMENICO PALLI;MARIE‐CHRISTINE BOUTRON‐RUAULT;KAY‐TEE KHAW;ELIO RÍBOLI;MAURIZIO GALDERISI;TILMAN KÜHN;RUDOLF KAAKS;PETRA H. PEETERS;ROBERTA LANZILLO;MARÍA‐JOSÉ SÁNCHEZ;GIOVANNI DE SIMONE","27;26;25;25;24;24;24;24;23;23;22;18;18;18;17;17;17;15;15;15","ALESSIO BERNASCONI;YOUSSEF ROUPHAEL;BRUNO TRIMARCO;FABRIZIO PANE;ALESSANDRO MAGNANI;GIOVANNI DE SIMONE;COSTANTINO MANCUSI;VINCENZO D’ALESSANDRO;RAFFAELE IZZO;FRANÇOIS LINTZ;ROBERTA LANZILLO;PAOLO SEVERINO;ROCCO SEVERINO;LORENZO CODECASA;MAURIZIO GALDERISI;MARIO MUSELLA;GIUSEPPE COLLA;N. RINALDI;GIANCARLO TRONCONE;MARCO PICARDI","2.9;2.82;2.57;2.09;2;1.71;1.66;1.63;1.62;1.57;1.56;1.5;1.5;1.46;1.41;1.37;1.37;1.34;1.3;1.29","SALVATORE PANICO;FABRIZIO PANE;BRUNO TRIMARCO;MAURIZIO GALDERISI;ROBERTA LANZILLO;GIOVANNI DE SIMONE;RAFFAELE IZZO;COSTANTINO MANCUSI;GIANCARLO TRONCONE;AMALIA MATTIELLO;MARCO PICARDI;YOUSSEF ROUPHAEL;UMBERTO MALAPELLE;DARIO BRUZZESE;VINCENZO BRESCIA MORRA;ALESSANDRO MAGNANI;ANTONIO RAPACCIUOLO;CLAUDIO CERCHIONE;VINCENZO D’ALESSANDRO;ENRICO TEDESCHI","25;25;24;18;15;15;14;14;13;13;13;13;12;12;12;11;11;11;10;10","ALESSIO BERNASCONI;YOUSSEF ROUPHAEL;BRUNO TRIMARCO;FABRIZIO PANE;ALESSANDRO MAGNANI;GIOVANNI DE SIMONE;COSTANTINO MANCUSI;VINCENZO D’ALESSANDRO;RAFFAELE IZZO;ROBERTA LANZILLO;ROCCO SEVERINO;MAURIZIO GALDERISI;MARIO MUSELLA;GIUSEPPE COLLA;N. RINALDI;GIANCARLO TRONCONE;MARCO PICARDI;UMBERTO MALAPELLE;VINCENZO BRESCIA MORRA;CATERINA ARCIDIACONO","2.9;2.82;2.57;2.09;2;1.71;1.66;1.63;1.62;1.56;1.5;1.41;1.37;1.37;1.34;1.3;1.29;1.28;1.27;1.25","PATRIZIO LANCELLOTTI;JOSÉ LUIS ZAMORANO;EMANUELE BARBATO;MARTIN CZERNY;STEPHAN WINDECKER;PETER JÜNI;MARCO ROFFI;VICTOR ABOYANS;VICTORIA DELGADO;CHARALAMBOS VLACHOPOULOS;HORST SIEVERT;JEAN‐BAPTISTE RICCO;MARCO DE CARLO;MARIANNE BRODMANN;MARTIN BJÖRCK;MICHAŁ TENDERA;CHRISTOPHE LECLERCQ;GERHARD HINDRICKS;MASSIMO PIEPOLI;ANTÓNIO COCA","3580;3166;3104;3060;2985;2973;2948;2948;2945;2925;2925;2925;2925;2925;2925;2925;2922;2922;2907;2902","EMANUELE BARBATO;SALVATORE PANICO;YOUSSEF ROUPHAEL;MAURIZIO GALDERISI;MARCO PICARDI;ANDREA BALLABIO;BRUNO TRIMARCO;CIRO SANTORO;GIOVANNI DE SIMONE;DARIO BRUZZESE;ANTONIO RAPACCIUOLO;COSTANTINO MANCUSI;STEFANIA DE PASCALE;MATTEO NICOLA DARIO DI MINNO;VINCENZO BRESCIA MORRA;ALESSANDRA SCATTEIA;RAFFAELE IZZO;FABRIZIO PANE;MARIO MUSELLA;DANIELA CASO","3104;1426;1286;1098;777;604;574;566;561;482;455;434;404;369;363;362;350;341;336;326","SALVATORE PANICO;BRUNO TRIMARCO;FABRIZIO PANE;MAURIZIO GALDERISI;GIOVANNI DE SIMONE;COSTANTINO MANCUSI;RAFFAELE IZZO;AMALIA MATTIELLO;YOUSSEF ROUPHAEL;MARCO PICARDI;GIANCARLO TRONCONE;VINCENZO BRESCIA MORRA;ALESSANDRO MAGNANI;ANTONIO RAPACCIUOLO;CLAUDIO CERCHIONE;DARIO BRUZZESE;ROBERTA LANZILLO;MARIA ANGELA LOSI;NICOLA BRUNETTI‐PIERRI;UMBERTO MALAPELLE","25;24;24;18;15;14;14;13;13;12;12;12;11;11;11;11;11;10;10;10","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;PSYCHOLOGY;MATHEMATICS;MATERIALS SCIENCE;SOCIOLOGY;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;ENVIRONMENTAL SCIENCE;GEOGRAPHY;BUSINESS;GEOLOGY;ART;HISTORY","534;229;98;82;69;59;50;49;36;35;28;28;27;24;16;14;11;4;4","INTERNAL MEDICINE;SURGERY;PATHOLOGY;BIOCHEMISTRY;CARDIOLOGY;GENETICS;ONCOLOGY;GASTROENTEROLOGY;ENDOCRINOLOGY;RADIOLOGY;IMMUNOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;FOOD SCIENCE;PEDIATRICS;ECOLOGY;CANCER RESEARCH;INTENSIVE CARE MEDICINE;BOTANY;PALEONTOLOGY","414;113;96;93;87;85;73;72;63;63;60;50;46;43;42;38;37;37;35;31","DISEASE;CANCER;GENE;POPULATION;CONFIDENCE INTERVAL;COHORT;CHEMOTHERAPY;PROSPECTIVE COHORT STUDY;OBESITY;BLOOD PRESSURE;DIABETES MELLITUS;HEART FAILURE;BODY MASS INDEX;COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;MAGNETIC RESONANCE IMAGING;MYOCARDIAL INFARCTION;ODDS RATIO;RETROSPECTIVE COHORT STUDY","86;85;81;47;40;37;26;26;25;24;24;24;23;23;22;21;19;18;18;18","GENOTYPE;COLORECTAL CANCER;EJECTION FRACTION;HAZARD RATIO;CLINICAL ENDPOINT;BREAST CANCER;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;GENE EXPRESSION;FABRY DISEASE;TYPE 2 DIABETES;INSULIN RESISTANCE;PHENOTYPE;POLYPHENOL;DOWNREGULATION AND UPREGULATION;RITUXIMAB;WEIGHT LOSS;DIASTOLE;IMATINIB;INFLAMMATORY BOWEL DISEASE;MUTATION;PARKINSON'S DISEASE;UNIVARIATE ANALYSIS","22;21;19;19;17;16;16;11;10;10;9;9;9;8;8;8;7;7;7;7;7;7","KRAS;BENDAMUSTINE;GENOTYPING;BRENTUXIMAB VEDOTIN;SINGLE-NUCLEOTIDE POLYMORPHISM;SPECKLE TRACKING ECHOCARDIOGRAPHY;IMATINIB MESYLATE;PRIMARY CILIARY DYSKINESIA;RELAXOMETRY;TFEB;CARDIAC RESYNCHRONIZATION THERAPY;CONNECTIVE TISSUE DISEASE;DOPPLER ECHOCARDIOGRAPHY;FRACTIONAL FLOW RESERVE;GASTRIC BYPASS;GLUCOSE HOMEOSTASIS;NILOTINIB;OXALIPLATIN;VINCRISTINE;ABDOMINAL OBESITY;ACINETOBACTER BAUMANNII;ADIPONECTIN;ALPHA (FINANCE);ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;ANTHRACYCLINE;ANTIRETROVIRAL THERAPY;APGAR SCORE;BIFIDOBACTERIUM;BIPOLAR JUNCTION TRANSISTOR;BRONCHODILATION;CANCER IMMUNOTHERAPY;COGNITIVE DECLINE;COLONOSCOPY;CONJUGATED LINOLEIC ACID;CYP3A4;CYTOMEGALOVIRUS INFECTION;DASATINIB;DIASTOLIC FUNCTION;DNA METHYLATION;ELLAGIC ACID;ESTROGEN RECEPTOR;EXOME SEQUENCING;FEBRILE NEUTROPENIA;FLAVONOLS;GATED SPECT;GENE FAMILY;GLYCATED HEMOGLOBIN;GLYCEMIC INDEX;HBSAG;HERPESVIRIDAE;ICATIBANT;IMIPENEM;IN SITU HYBRIDIZATION;INDACATEROL;INFLAMMATORY BOWEL DISEASES;INTERFERON BETA-1B;IPILIMUMAB;LDL RECEPTOR;MASTECTOMY;MICROVESICLES;MTORC1;MULTILOCUS SEQUENCE TYPING;MULTIPLEX POLYMERASE CHAIN REACTION;ORGANIC RANKINE CYCLE;PAPILLARY THYROID CANCER;PROMOTER;PULSED-FIELD GEL ELECTROPHORESIS;STROKE VOLUME;SYNOVIAL FLUID;THROMBASTHENIA;THYMOGLOBULIN;VECTOR (MOLECULAR BIOLOGY);VERBAL FLUENCY TEST;WAIST–HIP RATIO","8;6;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;YOUNG ADULT;ADOLESCENT;RISK FACTORS;TREATMENT OUTCOME;PROSPECTIVE STUDIES;RETROSPECTIVE STUDIES;ANIMALS;BIOMARKERS;FOLLOW-UP STUDIES;AGED, 80 AND OVER;CASE-CONTROL STUDIES;PROGNOSIS","337;317;269;253;184;157;136;81;68;61;57;54;53;49;48;44;37;35;33;31","LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;EFFICACY AND RESISTANCE IN CML TREATMENT;LYMPHOID NEOPLASMS;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;MANAGEMENT OF VALVULAR HEART DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND MANAGEMENT OF CELIAC DISEASE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;PREVENTION AND TREATMENT OF VENOUS THROMBOEMBOLISM;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;SARCOPENIA: DEFINITION, DIAGNOSIS, AND IMPLICATIONS;ANKLE INJURIES AND DISORDERS IN SPORTS MEDICINE;CHOLESTEROL-LOWERING TREATMENT;HEPATITIS C INFECTION AND TREATMENT;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES","11;10;10;8;8;7;7;7;6;6;6;6;6;6;6;6;5;5;5;5","CARDIAC IMAGING;CLINICAL ENDPOINT;ECHOCARDIOGRAPHY;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;LEFT VENTRICULAR FUNCTION;HEALTHY EATING INDEX;MEDITERRANEAN DIET;NUTRITIONAL STATUS;BIOMARKER ANALYSIS;HYPERTENSION;REFRACTORY (PLANETARY SCIENCE);STROKE (ENGINE);DIAGNOSIS;DISCONTINUATION;METASTATIC COLORECTAL CANCER;UNIVARIATE ANALYSIS;BENDAMUSTINE;BIOELECTRICAL IMPEDANCE ANALYSIS;CONCOMITANT","20;17;13;13;12;12;10;9;9;8;8;8;8;7;7;7;7;6;6;6","MULTIPLE SCLEROSIS;BREAST CANCER;CANCER RISK;BOWEL DISEASE;INFLAMMATORY BOWEL;LEFT VENTRICULAR;PILOT STUDY;PROSPECTIVE INVESTIGATION;COLORECTAL CANCER;EUROPEAN PROSPECTIVE;CAMPANIA SALUTE;CARDIOVASCULAR RISK;CLINICAL PRACTICE;MEDITERRANEAN DIET;MULTIPLE MYELOMA;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;PATIENTS PTS;SALUTE NETWORK;CHRONIC OBSTRUCTIVE;COMPACT THERMAL;CORONARY ARTERY;FABRY DISEASE;OBSTRUCTIVE PULMONARY;PULMONARY DISEASE;RISK FACTORS;THERMAL MODELS;AORTIC VALVE;CASE-CONTROL STUDY;CHRONIC MYELOID","14;11;10;9;9;9;9;9;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;5;5;5","TFE KO;KO MICE;ONLINE PUBLICATION;PUBLICATION DATE;BREAST CANCER;CANCER RISK;IMMUNE CHECKPOINT;ONLINE NA;RISK FACTORS;HOUSTON TX;TX USA;CELIAC DISEASE;CONFIDENCE INTERVAL;LOGISTIC REGRESSION;CHECKPOINT INHIBITORS;PROSPECTIVE INVESTIGATION;EUROPEAN PROSPECTIVE;SEM STUDENTS;STUDENTS TWO-TAILED;TWO-TAILED T-TEST;HR CI;MASS INDEX;LEFT VENTRICULAR;PATIENTS TREATED;BODY MASS;HEART FAILURE;ADVERSE EVENTS;CANCER PATIENTS;HZ NA;MEDIAN AGE","77;66;43;43;41;32;32;28;28;26;26;25;25;24;23;23;22;22;22;22;21;21;20;20;19;19;16;16;16;16",309,0.44,5.7,7,2,1,2.5,4,4,1,1,8,1,1,5.5,1,1,2,3,5,3,0,0,82,82,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25,4.2,981.79,2.18,16,0.64,140.32,0,0,3,0,13,0,1,8,0,19,6,0,0,0,0,0,0,24,1,0,24,0,0,1,0,0,0,0,0,0,"United States;Italy;Germany;Switzerland","11;8;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3207 MEDICAL MICROBIOLOGY;3213 PAEDIATRICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING;41 ENVIRONMENTAL SCIENCES;4102 ECOLOGICAL APPLICATIONS","23;13;5;4;4;2;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;CANCER;RARE DISEASES;CARDIOVASCULAR;HEART DISEASE;PEDIATRIC;PREVENTION;CHRONIC PAIN;EMERGING INFECTIOUS DISEASES;HEMATOLOGY;NUTRITION;PAIN RESEARCH;ARTHRITIS;BIOTECHNOLOGY;BREAST CANCER;CHILDHOOD LEUKEMIA;COMPARATIVE EFFECTIVENESS RESEARCH;LUNG","22;17;9;6;5;4;4;4;4;3;3;3;3;3;2;2;2;2;2;2","CANCER;CARDIOVASCULAR;ORAL AND GASTROINTESTINAL;CONGENITAL;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;MUSCULOSKELETAL;RENAL AND UROGENITAL;SKIN","4;4;3;1;1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;3.3 NUTRITION AND CHEMOPREVENTION;7.1 INDIVIDUAL CARE NEEDS","20;3;1;1","BREAST CANCER;LEUKEMIA / LEUKAEMIA;MYELOMA;OVARIAN CANCER","2;2;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","4",1,2e+06,250000,4,8,5,1,3,233351.67037037,2.99119350160275,"AGE PLATFORM EUROPE;EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;EUROPEAN HEALTH TELEMATICS ASSOCIATION;EUROPEAN REGIONS RESEARCH AND INNOVATION NETWORK;FEDERICO II UNIVERSITY HOSPITAL;FUNKA NU;OPEN EVIDENCE;TICBIOMED","1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","1","COALITION S;EC & ERC - EUROPEAN UNION","1;1","CSA - COORDINATION AND SUPPORT ACTION (FUNDING SCHEME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME)","1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1",NA,NA,"GENERIC HEALTH RELEVANCE","1",NA,NA,NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY","1",NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2018,738,13.6490514905149,3.0840108401084,0.428184281842818,0.36449864498645,0.560975609756098,1.98603839441536,1.32217573221757,1.59171597633136,1.42758620689655,0.562330623306233,4,389,151,71,65,0.53,0.2,0.1,0.09,40.53,1.32857553755136,4.99345815474847,0.426829268292683,0.865853658536585,0.47,0.43,0.471,0.441,"ANTONIA TRICHOPOULOU;BRUNO TRIMARCO;­ROSARIO ­TUMINO;HEINER BOEING;ELISABETE WEIDERPASS;SALVATORE PANICO;ELIO RÍBOLI;ANNE TJØNNELAND;KIM OVERVAD;RUDOLF KAAKS;EVA ARDANÁZ;MARIE‐CHRISTINE BOUTRON‐RUAULT;TILMAN KÜHN;DOMENICO PALLI;COSTANTINO MANCUSI;GIOVANNI DE SIMONE;MARC J. GUNTER;JOSÉ MARÍA HUERTA;YOUSSEF ROUPHAEL;ROBERTO PACELLI","28;27;26;26;26;24;24;24;23;23;21;17;16;16;16;16;15;15;14;14","LUIGI MANSI;YOUSSEF ROUPHAEL;BRUNO TRIMARCO;COSTANTINO MANCUSI;GIUSEPPE COLLA;MARIA VIVIANA CARLINO;ALFONSO SFORZA;ROBERTO PACELLI;GILDA CENNAMO;GIOVANNI DE SIMONE;MARIOS C. KYRIACOU;FABRIZIO PANE;FRANCO CONTALDO;CLAUDIO CERCHIONE;ANTONIO PISANI;IVO IAVICOLI;VERUSCKA LESO;DAVIDE NAPPI;GIOVANNI CENNAMO;BRUNELLA CAPALDO","4.5;3.29;2.77;2.37;2.12;2.02;2.02;1.9;1.84;1.79;1.77;1.6;1.59;1.56;1.5;1.5;1.5;1.45;1.4;1.37","BRUNO TRIMARCO;SALVATORE PANICO;COSTANTINO MANCUSI;GIOVANNI DE SIMONE;YOUSSEF ROUPHAEL;ROBERTO PACELLI;GILDA CENNAMO;FRANCO CONTALDO;FABRIZIO PANE;ANTONIO PISANI;MAURIZIO GALDERISI;RAFFAELE IZZO;NICOLA DE LUCA;CLAUDIO CERCHIONE;ELEONORA RICCIO;FABRIZIO PASANISI;MARIA VIVIANA CARLINO;ALFONSO SFORZA;GIUSEPPE DE MICHELE;DAVIDE NAPPI","27;24;16;16;14;14;13;13;13;13;13;12;12;12;11;11;11;11;11;11","YOUSSEF ROUPHAEL;BRUNO TRIMARCO;COSTANTINO MANCUSI;MARIA VIVIANA CARLINO;ALFONSO SFORZA;ROBERTO PACELLI;GILDA CENNAMO;GIOVANNI DE SIMONE;FABRIZIO PANE;FRANCO CONTALDO;CLAUDIO CERCHIONE;ANTONIO PISANI;IVO IAVICOLI;VERUSCKA LESO;DAVIDE NAPPI;GIOVANNI CENNAMO;BRUNELLA CAPALDO;UMBERTO MALAPELLE;GIOVANNA MUSCOGIURI;ELEONORA RICCIO","3.29;2.77;2.37;2.02;2.02;1.9;1.84;1.79;1.6;1.59;1.56;1.5;1.5;1.5;1.45;1.4;1.37;1.28;1.28;1.28","VICTOR ABOYANS;STEPHAN WINDECKER;HÉCTOR BUENO;IOAN MIRCEA COMAN;JEAN-PHILIPPE COLLET;STEFAN AGEWALL;VICTORIA DELGADO;EMANUELE BARBATO;PIOTR PONIKOWSKI;MARCO ROFFI;GIOVANNI DE SIMONE;FRANK RUSCHITZKA;JOHN G.F. CLELAND;ANTÓNIO COCA;CHRISTOPHE LECLERCQ;DONNA FITZSIMONS;GERHARD HINDRICKS;ILÉANA DESORMAIS;MARC FERRINI;MASSIMO PIEPOLI","17057;16996;16812;16812;16812;16812;16812;8730;8673;8662;8527;8497;8497;8494;8494;8494;8494;8494;8494;8494","EMANUELE BARBATO;SALVATORE PANICO;YOUSSEF ROUPHAEL;ANDREA BALLABIO;MAURIZIO GALDERISI;ANNAMARIA COLAO;GIOVANNA MUSCOGIURI;LUIGI BARREA;SILVIA SAVASTANO;STEFANIA DE PASCALE;BRUNO TRIMARCO;CARLO G. TOCCHETTI;ANTONIETTA COPPOLA;DANIELA LAUDISIO;ANTONIO M. RISITANO;MARIA GIORDANO;CIRO SANTORO;FRANCESCA DE FILIPPIS;DANILO ERCOLINI;NICOLA DE LUCA","8727;2431;2074;878;826;698;659;605;605;541;439;435;390;366;344;343;321;309;302;285","SALVATORE PANICO;BRUNO TRIMARCO;COSTANTINO MANCUSI;GIOVANNI DE SIMONE;YOUSSEF ROUPHAEL;ANTONIO PISANI;GILDA CENNAMO;FRANCO CONTALDO;CLAUDIO CERCHIONE;MAURIZIO GALDERISI;RAFFAELE IZZO;ELEONORA RICCIO;ROBERTO PACELLI;DAVIDE NAPPI;FABRIZIO PANE;FABRIZIO PASANISI;GIUSEPPE DE MICHELE;NICOLA DE LUCA;LIDIA SANTARPIA;SIRIO COCOZZA","24;24;16;14;14;13;13;13;12;12;12;11;11;11;11;10;10;9;9;9","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;MATHEMATICS;PSYCHOLOGY;MATERIALS SCIENCE;ECONOMICS;PHILOSOPHY;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;GEOLOGY;SOCIOLOGY;ENVIRONMENTAL SCIENCE;ART;HISTORY","554;252;116;100;69;65;61;55;44;39;33;28;24;24;24;24;20;12;5","INTERNAL MEDICINE;GENETICS;BIOCHEMISTRY;PATHOLOGY;SURGERY;CARDIOLOGY;ONCOLOGY;ENDOCRINOLOGY;GASTROENTEROLOGY;RADIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PSYCHIATRY;ECOLOGY;PEDIATRICS;PALEONTOLOGY;FOOD SCIENCE;INTENSIVE CARE MEDICINE;ORGANIC CHEMISTRY;CELL BIOLOGY","418;98;92;92;90;86;78;68;67;64;55;53;50;44;42;39;36;35;35;34","GENE;CANCER;DISEASE;POPULATION;PROSPECTIVE COHORT STUDY;CONFIDENCE INTERVAL;COHORT;CHEMOTHERAPY;HEART FAILURE;DIABETES MELLITUS;MYOCARDIAL INFARCTION;PROPORTIONAL HAZARDS MODEL;BLOOD PRESSURE;BODY MASS INDEX;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;ALTERNATIVE MEDICINE;COHORT STUDY;RETROSPECTIVE COHORT STUDY","86;83;80;41;40;39;38;29;28;26;24;24;23;20;19;19;18;18;18;18","HAZARD RATIO;BREAST CANCER;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;COLORECTAL CANCER;GENOTYPE;EJECTION FRACTION;CLINICAL ENDPOINT;MUTATION;GENE EXPRESSION;PHENOTYPE;PERCUTANEOUS CORONARY INTERVENTION;TYPE 2 DIABETES;AUTOPHAGY;DIASTOLE;INSULIN RESISTANCE;METASTASIS;PI3K/AKT/MTOR PATHWAY;ALLELE;FINGOLIMOD;HEMATOPOIETIC STEM CELL TRANSPLANTATION;PLACEBO;POLYPHENOL","25;22;21;19;16;14;13;12;10;10;9;9;8;8;8;8;8;7;7;7;7;7","SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME;SPECKLE TRACKING ECHOCARDIOGRAPHY;TFEB;FRACTIONAL FLOW RESERVE;GENOTYPING;METASTATIC BREAST CANCER;OXALIPLATIN;POMALIDOMIDE;TERIFLUNOMIDE;BIPOLAR JUNCTION TRANSISTOR;CETUXIMAB;CIRCULATING TUMOR CELL;COLONOSCOPY;DASATINIB;ENTHESITIS;FEBRILE NEUTROPENIA;HEPACIVIRUS;IMATINIB MESYLATE;IN VITRO MATURATION;KRAS;MISSENSE MUTATION;NILOTINIB;STROKE VOLUME;TRASTUZUMAB","7;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;PROSPECTIVE STUDIES;YOUNG ADULT;ANIMALS;RETROSPECTIVE STUDIES;ADOLESCENT;TREATMENT OUTCOME;FOLLOW-UP STUDIES;RISK FACTORS;AGED, 80 AND OVER;CHILD;HYPERTENSION;EUROPE","347;341;277;260;196;171;125;76;68;62;60;54;48;45;36;34;33;32;31;27","MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;RADIOTHERAPY PHYSICS AND TECHNOLOGY;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;ATRIAL FIBRILLATION;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;EFFICACY AND RESISTANCE IN CML TREATMENT;FERTILITY PRESERVATION IN CANCER PATIENTS;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;THERAPEUTIC ADVANCES IN CYSTIC FIBROSIS RESEARCH;ADVANCEMENTS IN LUNG CANCER RESEARCH;CARDIOTOXICITY OF CANCER TREATMENTS;CILIOPATHIES: GENETIC DISORDERS INVOLVING PRIMARY CILIA;EFFECTS OF KETOGENIC DIET ON HEALTH","11;11;10;9;9;8;7;7;7;6;6;6;6;6;6;6;5;5;5;5","CARDIAC IMAGING;ECHOCARDIOGRAPHY;CLINICAL ENDPOINT;TREATMENT;CARDIOVASCULAR RISK ASSESSMENT;LEFT VENTRICULAR FUNCTION;REGIMEN;HYPERTENSION;DISCONTINUATION;HEALTHY EATING INDEX;STROKE (ENGINE);DIAGNOSTIC CRITERIA;DIETARY PATTERNS;LUNG ULTRASOUND;CONCOMITANT;CROSS-SECTIONAL STUDY;ETIOLOGY;HEMATOPOIETIC CELL TRANSPLANTATION;MEDITERRANEAN DIET;METABOLISM","16;16;13;13;11;11;11;10;9;9;9;8;8;7;6;6;6;6;6;6","COLORECTAL CANCER;MULTIPLE SCLEROSIS;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;SOUTHERN ITALY;CANCER PATIENTS;HYPERTENSIVE PATIENTS;TYPE DIABETES;BREAST CANCER;LEFT VENTRICULAR;MULTIPLE MYELOMA;CORONARY ARTERY;EUROPEAN COUNTRIES;HEART FAILURE;LEFT ATRIAL;MYELOID LEUKEMIA;OBSERVATIONAL STUDY;PATIENTS TREATED;CAMPANIA SALUTE;CANCER RISK;COHORT STUDY;CROSS-SECTIONAL STUDY;HODGKIN LYMPHOMA;LUNG CANCER;METASTATIC COLORECTAL;PARENTERAL NUTRITION;PHASE II;SALUTE NETWORK;BODY COMPOSITION;CELL TRANSPLANTATION","13;13;12;12;10;9;9;9;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5","PUBMED SCOPUS;CROSSREF PUBMED;ITALY SEARCH;PRIMARY CILIARY;ITALY DEPARTMENT;PATIENTS TREATED;CANDIOLO ITALY;CILIARY DYSKINESIA;II UNIVERSITY;GLUCAGON RECEPTOR;RISK FACTORS;SPEAKERS BUREAU;TFEBIEC MICE;CONTROL MICE;CYSTIC FIBROSIS;HR CI;ALCOHOL CONSUMPTION;BREAST CANCER;CANCER RISK;EUROPEAN PROSPECTIVE;GENET -ABSTRACT;HUM GENET;LUNG CANCER;PARIS FRANCE;PROSPECTIVE INVESTIGATION;LOGES NT;SAN RAFFAELE;TYPE DIABETES;CV RISK;EUROPEAN COUNTRIES","109;73;58;46;33;31;30;30;29;28;27;27;26;25;25;25;22;22;22;22;22;22;22;22;22;19;19;19;17;17",317,0.43,6.75,9,2,2,1,9,2,1,1,10,2.25,1,8,7,1,2,4,6,4,0,0,77,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24,4.96,1227.88,2.22,18,0.75,130.71,0,0,5,0,12,0,3,4,0,22,2,0,0,0,0,0,0,22,1,1,24,0,0,0,0,0,0,0,0,0,"United States;Italy;Germany;United Kingdom","12;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3206 MEDICAL BIOTECHNOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;3207 MEDICAL MICROBIOLOGY;40 ENGINEERING;4012 FLUID MECHANICS AND THERMAL ENGINEERING","23;9;6;6;5;4;2;2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;RARE DISEASES;PATIENT SAFETY;PEDIATRIC;AUTOIMMUNE DISEASE;AGING;CANCER;HEMATOLOGY;ARTHRITIS;ATHEROSCLEROSIS;BIOTECHNOLOGY;BRAIN DISORDERS;CARDIOVASCULAR;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;GENE THERAPY;GENETICS;HEART DISEASE;HEART DISEASE - CORONARY HEART DISEASE","22;16;8;5;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CANCER;INFECTION;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","3;3;2;2;1;1","6.1 PHARMACEUTICALS;5.2 CELLULAR AND GENE THERAPIES;6.2 CELLULAR AND GENE THERAPIES","17;2;1","LEUKEMIA / LEUKAEMIA;BLADDER CANCER;BREAST CANCER;COLON AND RECTAL CANCER","2;1;1;1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",1,666721,222240.33,3,3,3,1,8,269821.744444444,2.73513908791718,"FEDERICO II UNIVERSITY HOSPITAL;QUEEN'S UNIVERSITY BELFAST;UNIVERSITY OF FLORIDA","1;1;1","MEDICAL RESEARCH COUNCIL","1","COALITION S;ICRP - INTERNATIONAL CANCER RESEARCH PARTNERSHIP;UKRI - UK RESEARCH AND INNOVATION","1;1;1","INTRAMURAL (PROJECT CATEGORY)","1","36 CREATIVE ARTS AND WRITING;3605 SCREEN AND DIGITAL MEDIA","1;1",NA,NA,NA,NA,"2.6 RESOURCES AND INFRASTRUCTURE (AETIOLOGY);5.2 CELLULAR AND GENE THERAPIES;5.3 MEDICAL DEVICES;5.9 RESOURCES AND INFRASTRUCTURE (TREATMENT DEVELOPMENT)","1;1;1;1",NA,NA,NA,NA,"B11 COMPUTER SCIENCE AND INFORMATICS","1",NA,NA,6,"PUBLIC LIBRARY OF SCIENCE","6","37 EARTH SCIENCES;32 BIOMEDICAL AND CLINICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;3507 STRATEGY, MANAGEMENT AND ORGANISATIONAL BEHAVIOUR;3705 GEOLOGY;40 ENGINEERING","3;2;2;2;2;1",NA,NA,NA,NA,"8.5 RESOURCES AND INFRASTRUCTURE (HEALTH SERVICES)","1",NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2019,797,13.1204516938519,3.06775407779172,0.411543287327478,0.351317440401506,0.51693851944793,1.95443645083933,1.29644268774704,1.46596858638743,1.37792642140468,0.572145545796738,18,352,153,78,94,0.44,0.19,0.1,0.12,26.1,1.07339524344765,5.35290544644664,0.400250941028858,0.88456712672522,0.487,0.461,0.438,0.442,"­ROSARIO ­TUMINO;SALVATORE PANICO;ANTONIA TRICHOPOULOU;HEINER BOEING;ANNE TJØNNELAND;YOUSSEF ROUPHAEL;MARC J. GUNTER;ELISABETE WEIDERPASS;FABRIZIO PANE;ANNA KARAKATSANI;TILMAN KÜHN;ELIO RÍBOLI;KIM OVERVAD;CARLOTTA SACERDOTE;DOMENICO PALLI;MARIE‐CHRISTINE BOUTRON‐RUAULT;GIOVANNI MARTINELLI;RUDOLF KAAKS;MARÍA‐JOSÉ SÁNCHEZ;MAURIZIO GALDERISI","33;27;26;25;25;24;24;24;22;21;21;21;20;20;19;18;17;16;16;15","YOUSSEF ROUPHAEL;MAURIZIO SANTOMAURO;VINCENZO D’ALESSANDRO;FABRIZIO PANE;UMBERTO MALAPELLE;LUISA TOSCANO;STEFANIA DE PASCALE;COSTANTINO MANCUSI;GIOVANNI MARTINELLI;MARIOS C. KYRIACOU;CLAUDIO CERCHIONE;LUCIO CATALANO;GIUSEPPE COLLA;MARIA GIORDANO;DAVIDE NAPPI;FRANCESCO SACCÀ;ROSITA DIANA;UGO CARUSO;BARBARA PANUNZI;FRANCESCO GENTILE","3.06;2.43;2.39;2.27;2.11;2;1.88;1.83;1.68;1.63;1.62;1.57;1.57;1.48;1.42;1.41;1.41;1.41;1.41;1.38","SALVATORE PANICO;YOUSSEF ROUPHAEL;FABRIZIO PANE;DOMENICO PALLI;MAURIZIO GALDERISI;CLAUDIO CERCHIONE;STEFANIA DE PASCALE;MARIO PETRETTA;LUCIO CATALANO;DAVIDE NAPPI;COSTANTINO MANCUSI;MARIA GIORDANO;ANTONIO PANNICO;FRANCESCO SACCÀ;CIRO SANTORO;ROBERTA LANZILLO;ALBERTO CUOCOLO;CHRISTOPHE EL‐NAKHEL;MARCELLO MOCCIA;ANNAMARIA COLAO","27;24;22;19;15;15;14;14;14;13;13;13;12;12;12;12;12;12;12;11","YOUSSEF ROUPHAEL;MAURIZIO SANTOMAURO;VINCENZO D’ALESSANDRO;FABRIZIO PANE;UMBERTO MALAPELLE;LUISA TOSCANO;STEFANIA DE PASCALE;COSTANTINO MANCUSI;CLAUDIO CERCHIONE;LUCIO CATALANO;MARIA GIORDANO;DAVIDE NAPPI;FRANCESCO SACCÀ;ROSITA DIANA;BARBARA PANUNZI;FRANCESCO GENTILE;CHRISTOPHE EL‐NAKHEL;GIOVANNI IMPROTA;ANTONIO PANNICO;MAURIZIO GALDERISI","3.06;2.43;2.39;2.27;2.11;2;1.88;1.83;1.62;1.57;1.48;1.42;1.41;1.41;1.41;1.38;1.37;1.37;1.36;1.34","LUISA VERDOLIVA;ANDREAS RÖSSLER;CHRISTIAN RIEß;DAVIDE COZZOLINO;JUSTUS THIES;MATTHIAS NIEßNER;YOUSSEF ROUPHAEL;­ROSARIO ­TUMINO;SALVATORE PANICO;ANTONIA TRICHOPOULOU;MARC J. GUNTER;TILMAN KÜHN;ANNE TJØNNELAND;ELIO RÍBOLI;ELISABETE WEIDERPASS;FRANCESCA DE FILIPPIS;HEINER BOEING;DANILO ERCOLINI;GIUSEPPE COLLA;KIM OVERVAD","1788;1691;1691;1691;1691;1691;1169;1149;1030;983;964;935;885;868;862;858;857;855;835;806","LUISA VERDOLIVA;DAVIDE COZZOLINO;YOUSSEF ROUPHAEL;SALVATORE PANICO;FRANCESCA DE FILIPPIS;DANILO ERCOLINI;CARLO G. TOCCHETTI;MARIA GIORDANO;ANDREA BALLABIO;CHRISTOPHE EL‐NAKHEL;ANNAMARIA COLAO;ANTONIO PANNICO;GIOVANNA MUSCOGIURI;LUIGI BARREA;SILVIA SAVASTANO;DANIELA LAUDISIO;STEFANIA DE PASCALE;CIRO SALZANO;GABRIELLA PUGLIESE;MAURIZIO GALDERISI","1788;1691;1110;1030;858;855;704;661;658;643;600;546;523;523;523;482;476;430;430;401","SALVATORE PANICO;YOUSSEF ROUPHAEL;FABRIZIO PANE;MAURIZIO GALDERISI;COSTANTINO MANCUSI;MARIA GIORDANO;STEFANIA DE PASCALE;DAVIDE NAPPI;MARIO PETRETTA;ANTONIO PANNICO;CHRISTOPHE EL‐NAKHEL;CIRO SANTORO;ALBERTO CUOCOLO;MARCELLO MOCCIA;ANNAMARIA COLAO;FRANCESCO SACCÀ;EMILIA ZAMPELLA;ROBERTA ESPOSITO;ROBERTA LANZILLO;ANNA EMANUELE PARETO","27;23;22;15;14;13;13;13;13;12;12;12;11;11;11;11;10;10;10;10","MEDICINE;BIOLOGY;CHEMISTRY;PHYSICS;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;PHILOSOPHY;ECONOMICS;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;GEOGRAPHY;POLITICAL SCIENCE;BUSINESS;GEOLOGY;ART;HISTORY","576;285;121;108;107;73;61;55;36;33;31;31;29;29;28;24;22;9;5","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;BIOCHEMISTRY;CARDIOLOGY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;IMMUNOLOGY;ONCOLOGY;PSYCHIATRY;RADIOLOGY;ECOLOGY;FOOD SCIENCE;BOTANY;ORGANIC CHEMISTRY;ARTIFICIAL INTELLIGENCE;PEDIATRICS;QUANTUM MECHANICS","448;120;115;101;93;91;82;80;78;72;72;58;54;53;46;43;42;41;41;41","GENE;DISEASE;CANCER;POPULATION;COHORT;CONFIDENCE INTERVAL;PROSPECTIVE COHORT STUDY;HEART FAILURE;CHEMOTHERAPY;DIABETES MELLITUS;BLOOD PRESSURE;MYOCARDIAL INFARCTION;OBESITY;BODY MASS INDEX;RANDOMIZED CONTROLLED TRIAL;RECEPTOR;ALTERNATIVE MEDICINE;BACTERIA;CONTEXT (ARCHAEOLOGY);RETROSPECTIVE COHORT STUDY","93;87;79;76;42;40;40;39;32;28;27;26;26;24;22;21;20;19;19;19","EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;BREAST CANCER;COLORECTAL CANCER;EJECTION FRACTION;HAZARD RATIO;PLACEBO;TYPE 2 DIABETES;PHENOTYPE;CROHN'S DISEASE;MUTATION;NEUTROPENIA;CLINICAL ENDPOINT;INFLAMMATORY BOWEL DISEASE;INSULIN RESISTANCE;PERCUTANEOUS CORONARY INTERVENTION;REVASCULARIZATION;CYCLOPHOSPHAMIDE;HEMATOPOIETIC STEM CELL TRANSPLANTATION;AUTOPHAGY;BORTEZOMIB;GENE EXPRESSION;GENOME;GENOTYPE;LENALIDOMIDE;METASTASIS;RITUXIMAB","26;22;20;20;19;13;13;12;11;11;11;10;10;10;10;10;9;8;7;7;7;7;7;7;7;7","TFEB;FEBRILE NEUTROPENIA;SPECKLE TRACKING ECHOCARDIOGRAPHY;MISSENSE MUTATION;VINCRISTINE;ANDROGEN DEPRIVATION THERAPY;BENDAMUSTINE;DNA METHYLATION;POLY ADP RIBOSE POLYMERASE;POMALIDOMIDE;SINGLE-NUCLEOTIDE POLYMORPHISM;STROKE VOLUME;BRENTUXIMAB VEDOTIN;CARDIAC RESYNCHRONIZATION THERAPY;CARFILZOMIB;CRITICAL LIMB ISCHEMIA;CROSSOVER STUDY;DOUBLE BLIND;ECULIZUMAB;EXHALED NITRIC OXIDE;EXOME SEQUENCING;GENETIC HETEROGENEITY;IMMUNE CHECKPOINT;IRINOTECAN;METASTATIC BREAST CANCER;NIVOLUMAB;OXALIPLATIN;PROBAND;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RNA INTERFERENCE;SUICIDAL IDEATION;TAXANE","7;6;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;YOUNG ADULT;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;ANIMALS;ADOLESCENT;BIOMARKERS;AGED, 80 AND OVER;OBESITY;TREATMENT OUTCOME;RISK FACTORS;CHILD;HYPERTENSION","401;353;254;238;192;157;141;84;64;60;59;55;49;42;41;41;40;38;33;31","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;LYMPHOID NEOPLASMS;PATHOPHYSIOLOGY OF PARKINSON'S DISEASE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;BODY COMPOSITION ASSESSMENT AND ANALYSIS;HEPATOCELLULAR CARCINOMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MOLECULAR MECHANISMS OF NEURODEGENERATIVE DISEASES;3D GEOSPATIAL MODELLING TECHNIQUES;ADVANCEMENTS IN COLORECTAL CANCER RESEARCH;ADVANCEMENTS IN PROSTATE CANCER RESEARCH;CANCER IMMUNOTHERAPY;EFFICACY AND RESISTANCE IN CML TREATMENT;ENDOCANNABINOID SYSTEM AND ITS EFFECTS ON HEALTH","14;13;9;8;8;7;7;7;7;6;6;6;6;6;5;5;5;5;5;5","CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;TREATMENT;LEFT VENTRICULAR FUNCTION;STROKE (ENGINE);ECHOCARDIOGRAPHY;REGIMEN;CLINICAL ENDPOINT;HYPERTENSION;MEDITERRANEAN DIET;PLANT GROWTH;DIAGNOSIS;METASTATIC COLORECTAL CANCER;MYOCARDIAL PERFUSION;REFRACTORY (PLANETARY SCIENCE);DIABETES;DIETARY PATTERNS;INTERNATIONAL MYELOMA WORKING GROUP;INTERQUARTILE RANGE;NEUROIMAGING","21;19;17;14;13;12;12;11;11;9;9;8;8;8;8;7;7;7;7;7","BREAST CANCER;HEART FAILURE;MULTIPLE SCLEROSIS;COLORECTAL CANCER;EUROPEAN PROSPECTIVE;PROSPECTIVE INVESTIGATION;MULTIPLE MYELOMA;TYPE DIABETES;CROHNS DISEASE;SOUTHERN ITALY;DISEASE PATIENTS;MYOCARDIAL PERFUSION;OXIDATIVE STRESS;PILOT STUDY;ARTERY DISEASE;CANCER RISK;CLINICAL PRACTICE;COHORT STUDY;COLON CANCER;COMPUTED TOMOGRAPHY;CORONARY ARTERY;EPIC COHORT;LEFT VENTRICULAR;METASTATIC COLORECTAL;BODY COMPOSITION;BOWEL DISEASE;CAMPANIA REGION;CANCER PATIENTS;CLOSED SOILLESS;COHERENCE TOMOGRAPHY","14;14;14;11;11;11;10;10;9;9;7;7;7;7;6;6;6;6;6;6;6;6;6;6;5;5;5;5;5;5","RESEARCH FUNDING;ADVISORY COMMITTEES;ENTITYS BOARD;SPEAKERS BUREAU;CONSULTANCY HONORARIA;HONORARIA MEMBERSHIP;ITALY SEARCH;HR CI;TELETHON INSTITUTE;RISK FACTORS;CD CD;HOUSTON TX;TX USA;PATIENTS TREATED;HONORARIA RESEARCH;BREAST CANCER;OXIDATIVE STRESS;PUBMED SCOPUS;TRAPP COMPLEX;EUROPEAN PROSPECTIVE;MEDICINE POZZUOLI;PATIENTS UNDERGOING;POZZUOLI NAPLES;PROSPECTIVE INVESTIGATION;HEART FAILURE;COMMITTEES RESEARCH;FUNDING SPEAKERS;THORACIC AORTA;CONFIDENCE INTERVAL;MASS INDEX","200;128;128;106;65;47;36;34;34;33;32;32;32;31;28;26;26;26;26;25;25;25;25;25;24;23;23;23;22;22",351,0.44,8.34,10,2,1,1,6,2,1,1,12,1,1,10,2,1.25,2,4,8,4,0,0,69,69,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,4.2,604.55,1.72,8,0.4,100.85,0,0,3,1,7,0,2,7,0,14,6,0,0,0,0,0,0,20,0,0,20,0,0,0,0,0,0,0,0,0,"United States;Belgium;Germany","13;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3207 MEDICAL MICROBIOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","20;13;4;3;3;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;AUTOIMMUNE DISEASE;BRAIN DISORDERS;RARE DISEASES;PEDIATRIC;ARTHRITIS;HEMATOLOGY;NEURODEGENERATIVE;NEUROSCIENCES;PATIENT SAFETY;PREVENTION;AGING;BEHAVIORAL AND SOCIAL SCIENCE;CANCER;MULTIPLE SCLEROSIS;CHILDHOOD LEUKEMIA;CHRONIC PAIN;CROHN'S DISEASE;DIABETES","18;13;6;5;5;4;3;3;3;3;3;3;2;2;2;2;1;1;1;1","NEUROLOGICAL;BLOOD;CANCER;CARDIOVASCULAR;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;METABOLIC AND ENDOCRINE;ORAL AND GASTROINTESTINAL;SKIN","3;1;1;1;1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS","15;2;2","LEUKEMIA / LEUKAEMIA;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","3;1;1","6.1 PATIENT CARE AND SURVIVORSHIP ISSUES;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.2 SURVEILLANCE","3;1;1",3,8918490,686498.1,5,12.6666666666667,9,1,7,622952.583730159,1.27939111389131,"EMPIRICA - COMMUNICATION AND TECHNOLOGY RESEARCH;FEDERICO II UNIVERSITY HOSPITAL;AGENCIA ESPAÑOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS;AGENCY FOR MEDICINAL PRODUCTS AND MEDICAL DEVICES;ANDALUSIAN HEALTH SERVICE;AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY;BETH ISRAEL DEACONESS MEDICAL CENTER;DEPARTMENT OF HEALTH;EUROPEAN COORDINATION COMMITTEE OF THE RADIOLOGICAL, ELECTROMEDICAL AND HEALTHCARE IT INDUSTRY;EUROPEAN HEALTH TELEMATICS ASSOCIATION;FEDERAL INSTITUTE FOR DRUGS AND MEDICAL DEVICES;HEALTH LEVEL SEVEN INTERNATIONAL;IHE EUROPE;INSTITUT GUTTMANN;ISTITUTO AUXOLOGICO ITALIANO;MEDICAL PRODUCTS AGENCY;MEDICAL UNIVERSITY OF GRAZ;MEDICAL UNIVERSITY OF LODZ;MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY;MEDICINES EVALUATION BOARD","3;3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","EUROPEAN COMMISSION","3","COALITION S;EC & ERC - EUROPEAN UNION","3;3","3RD HEALTH PROGRAMME (PROGRAMME);H2020-EU.3.1. - SOCIETAL CHALLENGES - HEALTH, DEMOGRAPHIC CHANGE AND WELL-BEING (PROGRAMME);H2020-EU.3.1.5.2. - IMPROVING SCIENTIFIC TOOLS AND METHODS TO SUPPORT POLICY MAKING AND REGULATORY NEEDS (PROGRAMME);IA - INNOVATION ACTION (FUNDING SCHEME);PCP - PRE-COMMERCIAL PROCUREMENT (FUNDING SCHEME)","1;1;1;1;1","42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;44 HUMAN SOCIETY;46 INFORMATION AND COMPUTING SCIENCES;4609 INFORMATION SYSTEMS","2;2;1;1;1","CARDIOVASCULAR;CLINICAL RESEARCH;HEALTH SERVICES;HYPERTENSION;SUBSTANCE MISUSE","1;1;1;1;1","GENERIC HEALTH RELEVANCE","2","8.1 ORGANISATION AND DELIVERY OF SERVICES","1",NA,NA,NA,NA,"A03 ALLIED HEALTH PROFESSIONS, DENTISTRY, NURSING AND PHARMACY;B12 ENGINEERING","2;1","3 GOOD HEALTH AND WELL BEING;8 DECENT WORK AND ECONOMIC GROWTH","1;1",0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2020,1087,13.4820607175713,3.11867525298988,0.390984360625575,0.363385464581417,0.471021159153634,2.31895961670089,1.41196013289037,1.87203791469194,1.50146627565982,0.643054277828887,17,451,249,88,87,0.41,0.23,0.08,0.08,22.85,0.906762930227475,6.18788737382684,0.379944802207912,0.873965041398344,0.515,0.502,0.508,0.488,"YOUSSEF ROUPHAEL;MAURIZIO GALDERISI;ELISABETE WEIDERPASS;CIRO SANTORO;­ROSARIO ­TUMINO;ANNE TJØNNELAND;SALVATORE PANICO;FABRIZIO PANE;ROBERTA LANZILLO;ROBERTA ESPOSITO;GILDA CENNAMO;STEFANIA DE PASCALE;ELIO RÍBOLI;MATTHIAS B. SCHULZE;GIUSEPPE COLLA;CHRISTOPHE EL‐NAKHEL;KIM OVERVAD;MAURIZIO MARRA;MARIA TRIASSI;NICOLA BRUNETTI‐PIERRI","46;28;26;25;25;25;24;24;23;22;20;20;20;19;19;19;18;18;18;18","YOUSSEF ROUPHAEL;GIUSEPPE COLLA;GILDA CENNAMO;MAURIZIO GALDERISI;DANIELA MONTORIO;STEFANIA DE PASCALE;ROSARIO NICOLETTI;CIRO SANTORO;MAURIZIO MARRA;MARIOS C. KYRIACOU;MARIA TRIASSI;LUCA SCALFI;VINCENZO D’ALESSANDRO;ROBERTA ESPOSITO;CHRISTOPHE EL‐NAKHEL;FABRIZIO PANE;OLIVIA DI VINCENZO;ANNAMARIA COLAO;GIOVANNI BATTISTA CHIRICO;DANILO ERCOLINI","7.43;3.61;3.27;2.73;2.53;2.5;2.47;2.42;2.33;2.29;2.17;2.17;2.14;2.12;2.11;2.09;2.04;2.03;2.02;1.85","YOUSSEF ROUPHAEL;MAURIZIO GALDERISI;CIRO SANTORO;SALVATORE PANICO;FABRIZIO PANE;ROBERTA LANZILLO;ROBERTA ESPOSITO;GILDA CENNAMO;STEFANIA DE PASCALE;CHRISTOPHE EL‐NAKHEL;MAURIZIO MARRA;MARIA TRIASSI;NICOLA BRUNETTI‐PIERRI;ALBERTO CUOCOLO;MARCELLO MOCCIA;GERARDA CAPPUCCIO;VALENTINA MERCURIO;ANNAMARIA COLAO;LUCA SCALFI;MARIA LEMBO","46;28;25;24;24;23;22;20;20;19;18;18;18;18;18;17;17;16;16;16","YOUSSEF ROUPHAEL;GILDA CENNAMO;MAURIZIO GALDERISI;DANIELA MONTORIO;STEFANIA DE PASCALE;ROSARIO NICOLETTI;CIRO SANTORO;MAURIZIO MARRA;MARIA TRIASSI;LUCA SCALFI;VINCENZO D’ALESSANDRO;ROBERTA ESPOSITO;CHRISTOPHE EL‐NAKHEL;FABRIZIO PANE;OLIVIA DI VINCENZO;ANNAMARIA COLAO;GIOVANNI BATTISTA CHIRICO;DANILO ERCOLINI;ETTORE CAPOLUONGO;ALBERTO CUOCOLO","7.43;3.27;2.73;2.53;2.5;2.47;2.42;2.33;2.17;2.17;2.14;2.12;2.11;2.09;2.04;2.03;2.02;1.85;1.81;1.8","YOUSSEF ROUPHAEL;CARLO G. TOCCHETTI;ALEXANDER R. LYON;ANNE TJØNNELAND;ELISABETE WEIDERPASS;­ROSARIO ­TUMINO;SALVATORE PANICO;PETAR SEFEROVIĆ;ANDREW J.S. COATS;DIMITRIOS FARMAKIS;FRANK RUSCHITZKA;OVIDIU CHIONCEL;RADEK PUDIL;RUDOLF A. DE BOER;STEPHAN VON HAEHLING;JAVID J. MOSLEHI;KIM OVERVAD;ELIO RÍBOLI;NICHOLAS J. WAREHAM;TERESA LÓPEZ‐FERNÁNDEZ","1722;1419;1382;1285;1282;1276;1168;1132;1121;1121;1121;1121;1121;1121;1121;1094;1074;1032;1030;1030","YOUSSEF ROUPHAEL;CARLO G. TOCCHETTI;SALVATORE PANICO;CHRISTOPHE EL‐NAKHEL;MAURIZIO GALDERISI;ANNAMARIA COLAO;LUIGI BARREA;STEFANIA DE PASCALE;GIOVANNA MUSCOGIURI;SILVIA SAVASTANO;GABRIELLA PUGLIESE;FRANCESCA DE FILIPPIS;DANILO ERCOLINI;PAOLO RUBBA;ANTONIO PANNICO;GUIDO IACCARINO;FABRIZIO PANE;VALENTINA MERCURIO;PAOLA VITAGLIONE;CHIARA CARLOMAGNO","1688;1417;1140;846;779;730;678;676;661;642;617;600;595;588;585;583;547;500;495;488","YOUSSEF ROUPHAEL;MAURIZIO GALDERISI;CIRO SANTORO;SALVATORE PANICO;ROBERTA ESPOSITO;FABRIZIO PANE;STEFANIA DE PASCALE;GILDA CENNAMO;CHRISTOPHE EL‐NAKHEL;NICOLA BRUNETTI‐PIERRI;VINCENZO BRESCIA MORRA;GERARDA CAPPUCCIO;VALENTINA MERCURIO;LUCA SCALFI;LUCIO CATALANO;MARIA LEMBO;ANNAMARIA COLAO;ROBERTA LANZILLO;ALBERTO CUOCOLO;MARIA TRIASSI","45;28;23;23;21;21;20;20;19;17;17;16;16;16;16;16;16;16;14;14","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ENGINEERING;PHYSICS;PSYCHOLOGY;MATHEMATICS;ECONOMICS;MATERIALS SCIENCE;POLITICAL SCIENCE;SOCIOLOGY;PHILOSOPHY;ENVIRONMENTAL SCIENCE;BUSINESS;GEOGRAPHY;GEOLOGY;ART;HISTORY","828;363;149;120;101;101;71;66;50;47;46;46;43;42;33;32;19;12;6","INTERNAL MEDICINE;SURGERY;PATHOLOGY;GENETICS;CARDIOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;RADIOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;ECOLOGY;PSYCHIATRY;ONCOLOGY;PEDIATRICS;INTENSIVE CARE MEDICINE;ORGANIC CHEMISTRY;BOTANY;PHYSICAL THERAPY;FOOD SCIENCE","604;198;150;144;132;124;107;98;93;89;79;75;75;69;64;63;59;57;57;52","DISEASE;GENE;POPULATION;CANCER;HEART FAILURE;BLOOD PRESSURE;COHORT;BODY MASS INDEX;CONFIDENCE INTERVAL;DIABETES MELLITUS;OUTBREAK;CHEMOTHERAPY;OBESITY;PROSPECTIVE COHORT STUDY;HEALTH CARE;MYOCARDIAL INFARCTION;BACTERIA;ALTERNATIVE MEDICINE;CONTEXT (ARCHAEOLOGY);MAGNETIC RESONANCE IMAGING;RANDOMIZED CONTROLLED TRIAL","164;119;93;87;59;58;58;54;50;46;42;37;37;35;30;30;29;27;27;27;27","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;2019-20 CORONAVIRUS OUTBREAK;HAZARD RATIO;DIASTOLE;PHENOTYPE;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;BREAST CANCER;COLORECTAL CANCER;MUTATION;OVERWEIGHT;GENE EXPRESSION;LEFT VENTRICULAR HYPERTROPHY;WEIGHT LOSS;CLINICAL ENDPOINT;GENOTYPE;PERCUTANEOUS CORONARY INTERVENTION;POLYPHENOL;TYPE 2 DIABETES;ALLELE;BIOELECTRICAL IMPEDANCE ANALYSIS;INFLAMMATORY BOWEL DISEASE;LENALIDOMIDE;LIPOPROTEIN;LIVER TRANSPLANTATION;PLACEBO;WAIST","69;42;35;31;22;22;21;20;19;18;15;14;13;13;12;11;11;11;11;10;10;10;10;10;10;10;10","CORONAVIRUS DISEASE 2019 (COVID-19);GASTRIC BYPASS;MISSENSE MUTATION;SPECKLE TRACKING ECHOCARDIOGRAPHY;LDL RECEPTOR;SINGLE-NUCLEOTIDE POLYMORPHISM;FEBRILE NEUTROPENIA;BENDAMUSTINE;DNA METHYLATION;FRAMESHIFT MUTATION;POMALIDOMIDE;CANNABINOID RECEPTOR;DOPPLER ECHOCARDIOGRAPHY;MORBID OBESITY;SACUBITRIL;TFEB;VINCRISTINE;APOLIPOPROTEIN A1;CARFILZOMIB;ENTHESITIS;EXOME SEQUENCING;GLOBAL DEVELOPMENTAL DELAY;METHYLTRANSFERASE;MICROSATELLITE;MICROVESICLES;SACUBITRIL, VALSARTAN","69;10;9;9;8;8;7;6;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;COVID-19;PROSPECTIVE STUDIES;RISK FACTORS;RETROSPECTIVE STUDIES;ADOLESCENT;YOUNG ADULT;TREATMENT OUTCOME;PNEUMONIA, VIRAL;CORONAVIRUS INFECTIONS;ANIMALS;HEART FAILURE;CHILD","700;352;223;211;148;130;109;109;61;57;57;56;52;48;47;45;42;40;38;37","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;BODY COMPOSITION ASSESSMENT AND ANALYSIS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;CARDIOTOXICITY OF CANCER TREATMENTS;CHOLESTEROL-LOWERING TREATMENT;CORONAVIRUS DISEASE 2019;LYMPHOID NEOPLASMS;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ARTERIAL STIFFNESS AND CARDIOVASCULAR HEALTH;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;MANAGEMENT OF VALVULAR HEART DISEASE;ROLE OF LUNG ULTRASOUND IN CRITICAL CARE;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;LIGHT SIGNAL TRANSDUCTION IN PLANTS;POWER ELECTRONICS TECHNOLOGY","26;22;16;14;13;13;11;11;10;10;10;10;9;8;8;8;8;7;7;7","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;TREATMENT;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;LEFT VENTRICULAR FUNCTION;ECHOCARDIOGRAPHY;HEALTHY EATING INDEX;HYPERTENSION;STROKE (ENGINE);DIAGNOSTIC CRITERIA;REGIMEN;DIETARY PATTERNS;BIOELECTRICAL IMPEDANCE ANALYSIS;CLINICAL ENDPOINT;PLANT GROWTH;BIOSTIMULANTS;CHOLESTEROL-LOWERING;INTERNATIONAL MYELOMA WORKING GROUP;DIET QUALITY","42;34;27;26;19;19;17;15;15;15;14;14;13;12;12;12;11;11;11;10","MULTIPLE SCLEROSIS;COVID- PANDEMIC;LEFT VENTRICULAR;MULTIPLE MYELOMA;COHORT STUDY;TYPE DIABETES;HEART FAILURE;BREAST CANCER;CANCER PATIENTS;COHERENCE TOMOGRAPHY;COLORECTAL CANCER;FAMILIAL HYPERCHOLESTEROLEMIA;ITALIAN SOCIETY;OPTICAL COHERENCE;TOMOGRAPHY ANGIOGRAPHY;MEDITERRANEAN DIET;ADULT PATIENTS;CORONAVIRUS DISEASE;HYPERTENSIVE PATIENTS;LIVER TRANSPLANTATION;CANCER RISK;CONTROLLED TRIAL;CROP PERFORMANCE;EUROPEAN SOCIETY;FABRY DISEASE;HEAVILY PRETREATED;MYOCARDIAL PERFUSION;PRETREATED MULTIPLE;RANDOMIZED CONTROLLED;RETROSPECTIVE STUDY","26;20;19;16;13;13;11;10;10;10;10;10;10;10;10;9;8;8;8;8;7;7;7;7;7;7;7;7;7;7","SPEAKERS BUREAU;PUBMED SCOPUS;ADVISORY COMMITTEES;ENTITYS BOARD;RESEARCH FUNDING;CONSULTANCY HONORARIA;MASS INDEX;HR CI;BLOOD PRESSURE;RISK FACTORS;COMMITTEES SPEAKERS;HOFFMANN-LA ROCHE;HEART FAILURE;LEFT VENTRICULAR;EJECTION FRACTION;LONGITUDINAL STRAIN;COVID- PANDEMIC;CUSHINGS SYNDROME;BODY MASS;LIVER DISEASE;TYPE DIABETES;HAZARD RATIO;PATIENTS TREATED;OHD LEVELS;ASLNEONEO MICE;CLINICAL PRACTICE;COLORECTAL CANCER;CORONAVIRUS DISEASE;INCREASED RISK;SIGNIFICANTLY LOWER","99;95;87;87;80;56;50;47;42;42;41;40;39;38;37;36;34;31;30;29;29;28;27;26;25;25;25;25;25;25",519,0.48,8.07,8,2,1.25,0,2,1.25,1,1,9,1,1,8,1,2.5,2,5,7,4,0,0,64.5,64.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,31,4.65,657.61,2.31,18,0.58,97.32,0,0,3,1,14,0,2,11,0,23,8,0,0,0,0,0,0,31,0,0,31,0,0,0,0,0,0,0,0,0,"United States;Italy;Japan;France;Germany;Switzerland","12;6;4;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3006 FOOD SCIENCES;3213 PAEDIATRICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","31;18;9;3;3;3;2;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CANCER;RARE DISEASES;HEMATOLOGY;PEDIATRIC;PREVENTION;DIGESTIVE DISEASES;PATIENT SAFETY;AUTOIMMUNE DISEASE;ORPHAN DRUG;BRAIN DISORDERS;CARDIOVASCULAR;COLO-RECTAL CANCER;HEART DISEASE;INFECTIOUS DISEASES;LUNG;LYMPHOMA;NUTRITION;PNEUMONIA & INFLUENZA","29;23;10;9;8;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2","CANCER;CARDIOVASCULAR;INFLAMMATORY AND IMMUNE SYSTEM;INFECTION;METABOLIC AND ENDOCRINE;MENTAL HEALTH;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;SKIN;STROKE","6;3;3;2;2;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;3.3 NUTRITION AND CHEMOPREVENTION;3.4 VACCINES;7.1 INDIVIDUAL CARE NEEDS","24;3;2;2;1;1;1;1","COLON AND RECTAL CANCER;LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BLADDER CANCER;BREAST CANCER;NOT SITE-SPECIFIC CANCER;PANCREATIC CANCER","2;2;2;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.5 COMBINATIONS OF LOCALIZED AND SYSTEMIC THERAPIES","6;2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"AOUSSN_FEDERICOII",2021,1009,13.5401387512388,2.82854311199207,0.35579781962339,0.352824578790882,0.413280475718533,2.03281027104137,1.38076923076923,1.64814814814815,1.52189781021898,0.67195242814668,16,382,201,86,100,0.38,0.2,0.09,0.1,14.92,0.967833289355789,6.49308176100636,0.397423191278494,0.89197224975223,0.505,0.483,0.506,0.481,"YOUSSEF ROUPHAEL;MARIA TRIASSI;MATTHIAS B. SCHULZE;ELISABETE WEIDERPASS;CHRISTOPHE EL‐NAKHEL;SALVATORE PANICO;­ROSARIO ­TUMINO;FABRIZIO PANE;ANNE TJØNNELAND;ANNA BORRELLI;RAFFAELE CAPASSO;ANNAMARIA COLAO;ARIANNA SCALA;MARIOS C. KYRIACOU;TERESA ANGELA TRUNFIO;GABRIELLA FABBROCINI;STEFANIA DE PASCALE;ROBERTA LANZILLO;PILAR AMIANO;GIOVANNI IMPROTA","50;35;24;23;23;22;22;20;20;19;18;17;17;16;15;15;15;15;15;14","YOUSSEF ROUPHAEL;MARIA TRIASSI;ANNA BORRELLI;RAFFAELE CAPASSO;CHRISTOPHE EL‐NAKHEL;ARIANNA SCALA;TERESA ANGELA TRUNFIO;FABRIZIO PANE;MARIOS C. KYRIACOU;STEFANIA DE PASCALE;GABRIELLA FABBROCINI;MARIA GIORDANO;GIOVANNI MARTINELLI;V. K. MUKHOMOROV;ANTONINO DRAGO;ROBERTO TROISI;ANNAMARIA COLAO;LUIGI BARREA;GIOVANNI IMPROTA;CLAUDIO CERCHIONE","7.33;4.58;3.23;2.96;2.91;2.68;2.59;2.51;2.23;2.22;2.2;2.11;2.04;2;2;2;1.98;1.96;1.95;1.88","YOUSSEF ROUPHAEL;MARIA TRIASSI;CHRISTOPHE EL‐NAKHEL;SALVATORE PANICO;FABRIZIO PANE;RAFFAELE CAPASSO;ANNAMARIA COLAO;ARIANNA SCALA;TERESA ANGELA TRUNFIO;GABRIELLA FABBROCINI;STEFANIA DE PASCALE;ROBERTA LANZILLO;GIOVANNI IMPROTA;LUIGI BARREA;GIOVANNI ESPOSITO;MARIA PETRACCA;ALBERTO CUOCOLO;SILVIA SAVASTANO;GUIDO IACCARINO;GIANCARLO TRONCONE","50;35;23;22;20;18;17;17;15;15;15;15;14;14;14;13;13;13;12;12","YOUSSEF ROUPHAEL;MARIA TRIASSI;RAFFAELE CAPASSO;CHRISTOPHE EL‐NAKHEL;ARIANNA SCALA;TERESA ANGELA TRUNFIO;FABRIZIO PANE;STEFANIA DE PASCALE;GABRIELLA FABBROCINI;MARIA GIORDANO;V. K. MUKHOMOROV;ANTONINO DRAGO;ROBERTO TROISI;ANNAMARIA COLAO;LUIGI BARREA;GIOVANNI IMPROTA;CLAUDIO CERCHIONE;LUCIO CATALANO;VINCENZO D’ALESSANDRO;GIOVANNI ESPOSITO","7.33;4.58;2.96;2.91;2.68;2.59;2.51;2.22;2.2;2.11;2;2;2;1.98;1.96;1.95;1.88;1.87;1.8;1.75","YOUSSEF ROUPHAEL;SALVATORE PANICO;RAFFAELE CAPASSO;CARLOTTA SACERDOTE;MATILDE INGLESE;MARCO SALVETTI;ELISABETTA SIGNORIELLO;MARINELLA CLERICO;ALESSIA DI SAPIO;GIAMPAOLO BRICHETTO;MARIA TERESA FERRÒ;MATTHIAS B. SCHULZE;GRAZIELLA CALLARI;DORIANA LANDI;MARIA PIA SORMANI;ELISABETE WEIDERPASS;ANNAMARIA COLAO;CHRISTOPHE EL‐NAKHEL;FRANCESCA CALERI;JESSICA FRAU","1006;727;722;580;556;528;493;479;462;456;456;451;448;446;446;444;443;443;433;433","YOUSSEF ROUPHAEL;SALVATORE PANICO;RAFFAELE CAPASSO;CHRISTOPHE EL‐NAKHEL;ANNAMARIA COLAO;LUIGI ANGRISANI;STEFANIA DE PASCALE;ROBERTO TROISI;GERARDO NARDONE;DAVIDE COZZOLINO;LUISA VERDOLIVA;MARIA TRIASSI;EMILIANO GRIMALDI;ROSA IODICE;MAURIZIO GALDERISI;GIOVANNA MUSCOGIURI;SILVIA SAVASTANO;VERONICA SCUOTTO;EMANUELE BARBATO;CARLO G. TOCCHETTI","1006;727;722;443;426;360;313;305;262;255;255;234;217;211;210;206;206;197;195;190","YOUSSEF ROUPHAEL;MARIA TRIASSI;CHRISTOPHE EL‐NAKHEL;SALVATORE PANICO;ANNAMARIA COLAO;RAFFAELE CAPASSO;STEFANIA DE PASCALE;TERESA ANGELA TRUNFIO;ARIANNA SCALA;FABRIZIO PANE;GIOVANNI ESPOSITO;ROBERTO TROISI;ALBERTO CUOCOLO;GABRIELLA FABBROCINI;GIOVANNI IMPROTA;ILARIA LOPERTO;ROBERTA LANZILLO;VINCENZO BRESCIA MORRA;GILDA CENNAMO;SILVIA SAVASTANO","50;27;23;22;20;18;15;14;14;14;13;13;13;11;11;11;11;11;11;11","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;MATHEMATICS;PSYCHOLOGY;POLITICAL SCIENCE;ECONOMICS;SOCIOLOGY;GEOGRAPHY;ENVIRONMENTAL SCIENCE;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;GEOLOGY;ART;HISTORY","748;359;170;140;105;95;88;83;61;60;56;40;39;38;31;29;17;9;5","INTERNAL MEDICINE;SURGERY;PATHOLOGY;BIOCHEMISTRY;GENETICS;ENDOCRINOLOGY;CARDIOLOGY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PSYCHIATRY;BOTANY;GASTROENTEROLOGY;PEDIATRICS;ECOLOGY;RADIOLOGY;FOOD SCIENCE;ORGANIC CHEMISTRY;LAW;ONCOLOGY;VIROLOGY","522;174;149;143;129;96;95;84;82;82;72;71;66;65;65;64;64;59;56;55","DISEASE;GENE;CANCER;POPULATION;COHORT;OUTBREAK;PROSPECTIVE COHORT STUDY;RETROSPECTIVE COHORT STUDY;OBESITY;CONFIDENCE INTERVAL;HEALTH CARE;HEART FAILURE;RANDOMIZED CONTROLLED TRIAL;MYOCARDIAL INFARCTION;DIABETES MELLITUS;BLOOD PRESSURE;RECEPTOR;ALTERNATIVE MEDICINE;CONTEXT (ARCHAEOLOGY);LOGISTIC REGRESSION","161;116;92;74;55;48;37;37;35;33;33;33;33;32;30;29;29;28;27;26","INFECTIOUS DISEASE (MEDICAL SPECIALTY);2019-20 CORONAVIRUS OUTBREAK;COLORECTAL CANCER;BREAST CANCER;HAZARD RATIO;PHENOTYPE;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;CLINICAL ENDPOINT;EJECTION FRACTION;MUTATION;GENE EXPRESSION;GENOTYPE;TYPE 2 DIABETES;ALLELE;INSULIN RESISTANCE;PERCUTANEOUS CORONARY INTERVENTION;POLYPHENOL;WEIGHT LOSS;CONVENTIONAL PCI;EXPANDED DISABILITY STATUS SCALE","93;40;26;20;19;19;17;16;15;15;14;13;13;12;12;12;12;10;9;9","CORONAVIRUS DISEASE 2019 (COVID-19);GASTRIC BYPASS;TICAGRELOR;EXOME SEQUENCING;FRACTIONAL FLOW RESERVE;P2Y12;POMALIDOMIDE;PRASUGREL;SINGLE-NUCLEOTIDE POLYMORPHISM;TRANSCRIPTOME;ABTS;COLONOSCOPY;MISSENSE MUTATION;APOLIPOPROTEIN A1;BENDAMUSTINE;COMPOUND HETEROZYGOSITY;DIFFUSING CAPACITY;FEBRILE NEUTROPENIA;MACE;MEPOLIZUMAB;MICROSATELLITE;PROSTATECTOMY;RIVAROXABAN;SACUBITRIL;SACUBITRIL, VALSARTAN;USTEKINUMAB","93;9;8;6;6;6;6;6;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4",";HUMANS;MALE;FEMALE;MIDDLE AGED;ADULT;RETROSPECTIVE STUDIES;AGED;ITALY;TREATMENT OUTCOME;COVID-19;PROSPECTIVE STUDIES;ADOLESCENT;CHILD;COLORECTAL NEOPLASMS;ANIMALS;CORONARY ARTERY DISEASE;LIVER NEOPLASMS;RISK FACTORS;YOUNG ADULT","650;330;130;128;86;77;67;62;60;53;44;43;36;35;34;31;31;27;27;26","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;IMPACT OF COVID-19 ON CANCER PATIENTS AND CARE;CORONAVIRUS DISEASE 2019;LIGHT SIGNAL TRANSDUCTION IN PLANTS;IMPACT OF COVID-19 ON MENTAL HEALTH;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;ANTIPLATELET THERAPY IN CARDIOVASCULAR DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;DIAGNOSIS AND MANAGEMENT OF BILIARY TRACT DISORDERS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;HEPATOCELLULAR CARCINOMA;LYMPHOID NEOPLASMS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF DIABETES MELLITUS AND HYPOGLYCEMIA","18;15;14;13;12;11;11;10;9;9;8;8;8;8;7;7;7;7;7;7","PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;CARDIAC IMAGING;TREATMENT;CLINICAL ENDPOINT;CARDIOVASCULAR RISK ASSESSMENT;PLANT GROWTH;ECHOCARDIOGRAPHY;HEALTHY EATING INDEX;DIETARY PATTERNS;PHYTOCHEMICAL;DIABETES;LEFT VENTRICULAR FUNCTION;MEDITERRANEAN DIET;INTERQUARTILE RANGE;CROSS-SECTIONAL STUDY;HYDROPONICS;HYPERTENSION;METABOLISM;PATHOGENESIS","51;35;20;19;17;16;16;15;15;14;14;11;11;11;10;9;9;9;9;9","MULTIPLE SCLEROSIS;COVID- PANDEMIC;COLORECTAL CANCER;HEART FAILURE;COHORT STUDY;BREAST CANCER;MACHINE LEARNING;TYPE DIABETES;CORONARY ARTERY;MULTIPLE MYELOMA;ARTERY DISEASE;EUROPEAN PROSPECTIVE;OBSERVATIONAL STUDY;PROSPECTIVE INVESTIGATION;CANCER RISK;COVID- PATIENTS;MULTICENTER STUDY;NUTRITION EPIC;RETROSPECTIVE STUDY;UNIVERSITY HOSPITAL;CARDIOVASCULAR RISK;HEAVILY PRETREATED;ITALIAN SOCIETY;PATIENTS AFFECTED;PATIENTS UNDERGOING;PRETREATED MULTIPLE;SOUTHERN ITALY;URIC ACID;COVID- LOCKDOWN;COVID- OUTBREAK","20;18;15;15;14;12;11;11;10;10;9;9;9;9;8;8;8;8;8;8;7;7;7;7;7;7;7;7;6;6","SPEAKERS BUREAU;PUBMED SCOPUS;RESEARCH FUNDING;CROSSREF PUBMED;ADVISORY COMMITTEES;ENTITYS BOARD;CONSULTANCY HONORARIA;HR CI;COVID- PANDEMIC;CLINICAL PRACTICE;ITALY SEARCH;RISK FACTORS;PATIENTS TREATED;HEART FAILURE;PLATELET REACTIVITY;UNIVERSITY FEDERICO;II NAPLES;MEDIAN AGE;BREAST CANCER;COVID- PATIENTS;SARS-COV- INFECTION;MICE FED;KO MICE;LIVER DISEASE;SEVERE COVID-;L-TFEB KO;PATIENTS UNDERGOING;STATISTICALLY SIGNIFICANT;INNSBRUCK AUSTRIA;LOGISTIC REGRESSION","65;64;48;46;45;45;39;39;37;35;34;34;33;31;30;30;28;28;27;27;27;26;25;25;25;24;24;24;23;23",477,0.47,7.5,8,2,1,0,2,1,1,1,9,1.75,1,8,1.25,1,2,4,7,4,0,0,36,36,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,33,2.82,791.39,2.57,16,0.48,76.52,0,1,5,3,13,0,2,9,0,27,6,0,0,0,0,0,0,31,2,0,33,0,0,0,0,0,0,0,0,0,"United States;Italy;Netherlands;United Kingdom;France;Switzerland","8;4;3;3;2;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;42 HEALTH SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3215 REPRODUCTIVE MEDICINE;3210 NUTRITION AND DIETETICS;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;35 COMMERCE, MANAGEMENT, TOURISM AND SERVICES;4203 HEALTH SERVICES AND SYSTEMS","33;18;7;7;4;3;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES;HEMATOLOGY;AUTOIMMUNE DISEASE;CARDIOVASCULAR;BRAIN DISORDERS;CANCER;DIGESTIVE DISEASES;HEART DISEASE;NEURODEGENERATIVE;PREVENTION;INFECTIOUS DISEASES;LIVER DISEASE;NEUROSCIENCES;PAIN RESEARCH;CHRONIC LIVER DISEASE AND CIRRHOSIS;DIABETES;GENETICS","31;22;10;8;6;5;5;4;4;4;4;4;4;3;3;3;3;2;2;2","CARDIOVASCULAR;CANCER;NEUROLOGICAL;ORAL AND GASTROINTESTINAL;METABOLIC AND ENDOCRINE;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;RESPIRATORY;SKIN","5;4;3;3;2;1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;7.1 INDIVIDUAL CARE NEEDS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;6.4 SURGERY;7.3 MANAGEMENT AND DECISION MAKING","24;3;3;2;2;1;1;1","LEUKEMIA / LEUKAEMIA;LIVER CANCER;NOT SITE-SPECIFIC CANCER;COLON AND RECTAL CANCER;GASTROINTESTINAL TRACT;LUNG CANCER","2;2;2;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.3 SYSTEMIC THERAPIES - DISCOVERY AND DEVELOPMENT;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"FRONTIERS;MENDELEY DATA;PUBLIC LIBRARY OF SCIENCE","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;42 HEALTH SCIENCES;31 BIOLOGICAL SCIENCES;3103 ECOLOGY;3202 CLINICAL SCIENCES;39 EDUCATION;3904 SPECIALIST STUDIES IN EDUCATION;4201 ALLIED HEALTH AND REHABILITATION SCIENCE;4207 SPORTS SCIENCE AND EXERCISE;49 MATHEMATICAL SCIENCES;52 PSYCHOLOGY","2;2;1;1;1;1;1;1;1;1;1","BRAIN DISORDERS;PEDIATRIC;AGING;ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD);AUTISM;BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD);MENTAL HEALTH;NEURODEGENERATIVE;NEUROSCIENCES;PARKINSON'S DISEASE;PERINATAL PERIOD - CONDITIONS ORIGINATING IN PERINATAL PERIOD;RARE DISEASES","2;2;1;1;1;1;1;1;1;1;1;1;1;1","MENTAL HEALTH;NEUROLOGICAL","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;2.3 PSYCHOLOGICAL, SOCIAL AND ECONOMIC FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1;1","CLINICAL","2","CLINICAL MEDICINE AND SCIENCE","2","SKIN CANCER","1",NA,NA
"AOUSSN_FEDERICOII",2022,1032,13.6744186046512,2.83139534883721,0.373062015503876,0.333333333333333,0.413759689922481,1.96763317599461,1.31849315068493,1.51541850220264,1.40924092409241,0.731589147286822,16,390,186,96,71,0.38,0.18,0.09,0.07,9.05,1.01351795049201,6.15189125295513,0.430232558139535,0.90406976744186,0.491,0.477,0.484,0.457,"YOUSSEF ROUPHAEL;GIOVANNI ESPOSITO;ROBERTO TROISI;MARIA TRIASSI;­ROSARIO ­TUMINO;ELISABETE WEIDERPASS;STEFANIA DE PASCALE;ANNE TJØNNELAND;ROBERTO MONTALTI;MARIANO CESARE GIGLIO;MATTHIAS B. SCHULZE;CIRO INDOLFI;HO‐SEONG HAN;T. PETER KINGHAM;GAETANO SANTULLI;EMANUELE BARBATO;CARMEN SPACCAROTELLA;VINCENZO BRESCIA MORRA;ANNAMARIA COLAO;ADRIAN KAH HENG CHIOW","40;22;21;20;19;18;17;17;16;16;16;16;15;15;14;14;14;14;13;13","YOUSSEF ROUPHAEL;ROBERTO TROISI;GABRIELLA FABBROCINI;STEFANIA DE PASCALE;MARIA TRIASSI;NICOLA BRUNETTI‐PIERRI;NICOLA SERRA;GIOVANNI ESPOSITO;CHRISTOPHE EL‐NAKHEL;ROBERTO MONTALTI;ROSARIO NICOLETTI;SERGIO FAZIO;GIANDOMENICO CORRADO;CIRO COSTAGLIOLA;CIRO INDOLFI;MARIANO CESARE GIGLIO;GIANLUCA ROMPIANESI;GIOVANNI BALATO;ALESSIO BERNASCONI;CARMEN SPACCAROTELLA","6.23;3.57;2.67;2.52;2.42;2.23;2.18;2.17;2.15;2.1;1.8;1.5;1.47;1.46;1.46;1.46;1.45;1.42;1.35;1.33","YOUSSEF ROUPHAEL;GIOVANNI ESPOSITO;ROBERTO TROISI;MARIA TRIASSI;STEFANIA DE PASCALE;ROBERTO MONTALTI;MARIANO CESARE GIGLIO;HO‐SEONG HAN;T. PETER KINGHAM;GAETANO SANTULLI;EMANUELE BARBATO;CARMEN SPACCAROTELLA;VINCENZO BRESCIA MORRA;ANNAMARIA COLAO;ADRIAN KAH HENG CHIOW;GABRIELLA FABBROCINI;CIRO SANTORO;CHARING C. N. CHONG;МИХАИЛ ЕФАНОВ;BRIAN K. P. GOH","40;22;21;20;17;16;16;15;15;14;14;14;14;13;13;13;13;13;13;13","YOUSSEF ROUPHAEL;ROBERTO TROISI;GABRIELLA FABBROCINI;STEFANIA DE PASCALE;MARIA TRIASSI;NICOLA BRUNETTI‐PIERRI;NICOLA SERRA;GIOVANNI ESPOSITO;CHRISTOPHE EL‐NAKHEL;ROBERTO MONTALTI;ROSARIO NICOLETTI;SERGIO FAZIO;GIANDOMENICO CORRADO;CIRO COSTAGLIOLA;MARIANO CESARE GIGLIO;GIANLUCA ROMPIANESI;GIOVANNI BALATO;ALESSIO BERNASCONI;CARMEN SPACCAROTELLA;MICHELE CIRIELLO","6.23;3.57;2.67;2.52;2.42;2.23;2.18;2.17;2.15;2.1;1.8;1.5;1.47;1.46;1.46;1.45;1.42;1.35;1.33;1.25","YOUSSEF ROUPHAEL;GAETANO SANTULLI;EMANUELE BARBATO;NIYA MILEVA;EMANUELE GALLINORO;CELESTINO SARDU;RAFFAELE MARFELLA;PASQUALE PAOLISSO;ROBERTO TROISI;PAOLO CALABRÒ;CIRO MAURO;ALBERTO FOÀ;ANDREA IMPELLIZZERI;ANGELO SANSONETTI;ARTURO CESARO;CARMINE PIZZI;DOBRIN VASSILEV;FELICE GRAGNANO;GIANNI CASELLA;HO‐SEONG HAN","561;475;367;361;302;283;283;277;277;267;254;247;247;247;247;247;247;247;247;247","YOUSSEF ROUPHAEL;GAETANO SANTULLI;EMANUELE BARBATO;ROBERTO TROISI;ANNAMARIA COLAO;STEFANIA DE PASCALE;ELENA CANTONE;RAFFAELE IZZO;VALENTINA TRIMARCO;CARLO G. TOCCHETTI;ANTONIO M. RISITANO;BRUNO TRIMARCO;PASQUALE PAOLISSO;CAMILLA FRIERI;FABIANA CACACE;LUANA MARANO;SERENA MAROTTA;CHRISTOPHE EL‐NAKHEL;CINZIA PERRINO;GABRIELE G. SCHIATTARELLA","561;424;296;273;237;204;196;178;177;175;164;159;157;154;154;154;154;150;148;143","YOUSSEF ROUPHAEL;ROBERTO TROISI;GIOVANNI ESPOSITO;STEFANIA DE PASCALE;ANNAMARIA COLAO;MARIA TRIASSI;CARMEN SPACCAROTELLA;ROBERTO MONTALTI;FABRIZIO PANE;CIRO SANTORO;VINCENZO BRESCIA MORRA;EMANUELE BARBATO;MARIANO CESARE GIGLIO;SALVATORE PANICO;GABRIELLA FABBROCINI;GIANDOMENICO CORRADO;CHRISTOPHE EL‐NAKHEL;NICOLA BRUNETTI‐PIERRI;GIOVANNI BALATO;GAETANO SANTULLI","40;27;22;17;16;15;14;14;13;13;13;12;12;12;12;12;11;11;11;10","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;ECONOMICS;MATERIALS SCIENCE;PHILOSOPHY;ENVIRONMENTAL SCIENCE;POLITICAL SCIENCE;BUSINESS;GEOGRAPHY;GEOLOGY;ART;HISTORY","765;354;158;137;98;79;75;67;58;54;47;41;40;37;33;31;15;14;5","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;CARDIOLOGY;BIOCHEMISTRY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;ONCOLOGY;PSYCHIATRY;ECOLOGY;IMMUNOLOGY;GASTROENTEROLOGY;RADIOLOGY;PEDIATRICS;BOTANY;FOOD SCIENCE;ORGANIC CHEMISTRY;HORTICULTURE;ARTIFICIAL INTELLIGENCE;NEUROSCIENCE","542;200;135;132;121;114;95;88;78;77;76;74;71;67;66;64;64;63;50;49;49","DISEASE;GENE;CANCER;POPULATION;COHORT;HEART FAILURE;RETROSPECTIVE COHORT STUDY;OBESITY;DIABETES MELLITUS;PROSPECTIVE COHORT STUDY;BODY MASS INDEX;BLOOD PRESSURE;CHEMOTHERAPY;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;MYOCARDIAL INFARCTION;ALTERNATIVE MEDICINE;IMMUNE SYSTEM;INCIDENCE (GEOMETRY);PREGNANCY","139;110;98;88;60;57;49;40;39;38;32;30;30;29;28;28;27;26;26;26","INFECTIOUS DISEASE (MEDICAL SPECIALTY);EJECTION FRACTION;BREAST CANCER;COLORECTAL CANCER;2019-20 CORONAVIRUS OUTBREAK;GENE EXPRESSION;PHENOTYPE;CLINICAL ENDPOINT;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HAZARD RATIO;MUTATION;TYPE 2 DIABETES;PLACEBO;RITUXIMAB;WEIGHT LOSS;GENOTYPE;INFLAMMATORY BOWEL DISEASE;OVERWEIGHT;PERCUTANEOUS CORONARY INTERVENTION;POLYPHENOL","63;35;25;20;19;19;19;18;17;16;15;15;14;12;12;11;10;10;10;10","CORONAVIRUS DISEASE 2019 (COVID-19);GASTRIC BYPASS;MISSENSE MUTATION;SACUBITRIL;SACUBITRIL, VALSARTAN;DNA METHYLATION;TRANSCRIPTOME;CARFILZOMIB;FEBRILE NEUTROPENIA;BENDAMUSTINE;COLONOSCOPY;EXOME SEQUENCING;FRACTIONAL FLOW RESERVE;NILOTINIB;POLYCYSTIC OVARY;RESPIRATORY DISTURBANCE INDEX;SINGLE-NUCLEOTIDE POLYMORPHISM;VINCRISTINE;ABTS;ACROMEGALY;DIABETES MANAGEMENT;DIFFUSING CAPACITY;ECULIZUMAB;EPWORTH SLEEPINESS SCALE;FRACTIONAL ANISOTROPY;GENETIC VARIANTS;GRANULOMATOSIS WITH POLYANGIITIS;HEART FAILURE WITH PRESERVED EJECTION FRACTION;ICE CALVING;KRAS;LDL RECEPTOR;MEPOLIZUMAB;METASTATIC BREAST CANCER;NIVOLUMAB;OCRELIZUMAB;PARS PLANA;PROBAND;PROMOTER;PROSTATECTOMY;SPECKLE TRACKING ECHOCARDIOGRAPHY;STROKE VOLUME;TFEB","63;7;7;7;7;6;6;5;5;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;RETROSPECTIVE STUDIES;MALE;COVID-19;POSTOPERATIVE COMPLICATIONS;ADULT;LAPAROSCOPY;ANIMALS;TREATMENT OUTCOME;PROSPECTIVE STUDIES;CHILD;MIDDLE AGED;AGED;CARDIOVASCULAR DISEASES;MULTIPLE SCLEROSIS;HEART FAILURE;LIVER NEOPLASMS;RISK FACTORS","596;378;96;89;66;60;56;50;50;47;47;46;38;37;32;32;32;29;29;29","HEPATOCELLULAR CARCINOMA;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;MANAGEMENT OF VALVULAR HEART DISEASE;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;DIAGNOSIS AND TREATMENT OF MULTIPLE MYELOMA;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;CORONAVIRUS DISEASE 2019;EFFECTS OF KETOGENIC DIET ON HEALTH;LIGHT SIGNAL TRANSDUCTION IN PLANTS;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;NEUROLOGICAL MANIFESTATIONS OF COVID-19 INFECTION;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;CORONAVIRUS DISEASE 2019 RESEARCH;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;DIVERSITY AND FUNCTION OF GUT MICROBIOME;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;IMPACT OF COVID-19 ON MENTAL HEALTH","20;16;15;15;14;11;11;10;10;10;10;9;8;8;8;7;7;7;7;7","PANDEMIC;CLINICAL ENDPOINT;LEFT VENTRICULAR FUNCTION;TREATMENT;2019-20 CORONAVIRUS OUTBREAK;TRANSCATHETER AORTIC-VALVE REPLACEMENT;CARDIAC IMAGING;PLANT DEVELOPMENT;CARDIOVASCULAR RISK ASSESSMENT;ECHOCARDIOGRAPHY;PLANT GROWTH;BIOSTIMULANTS;DIETARY PATTERNS;LIVER RESECTION;PROSTHETIC VALVES EVALUATION;REGIMEN;LONG COVID;LOW-CARBOHYDRATE DIET;DEPRESSION (ECONOMICS);DISCONTINUATION","21;19;18;18;17;16;15;14;13;12;12;11;11;11;11;11;10;10;9;9","MULTIPLE SCLEROSIS;HEART FAILURE;MULTIPLE MYELOMA;BREAST CANCER;MACHINE LEARNING;COVID- PANDEMIC;AORTIC VALVE;COHORT STUDY;MINIMALLY INVASIVE;MULTICENTER STUDY;CLINICAL TRIAL;MYOCARDIAL INFARCTION;CARDIOVASCULAR RISK;COLORECTAL CANCER;EUROPEAN PROSPECTIVE;INTERNATIONAL MULTICENTER;OBSERVATIONAL STUDY;PATIENTS UNDERGOING;PROSPECTIVE INVESTIGATION;SOUTHERN ITALY;TYPE DIABETES;CANCER PATIENTS;COMPARATIVE STUDY;DIABETIC PATIENTS;LUNG CANCER;PILOT STUDY;TRANSCATHETER AORTIC;ACUTE MYOCARDIAL;CANCER RISK;CLINICAL OUTCOMES","23;19;13;12;12;11;10;10;10;10;9;9;8;8;8;8;8;8;8;8;8;7;7;7;7;7;7;6;6;6","ITALY CONTRIBUTION;TELETHON INSTITUTE;RISK FACTORS;MEDICINE TIGEM;POZZUOLI ITALY;TIGEM POZZUOLI;HEART FAILURE;PUBMED SCOPUS;PATIENTS UNDERGOING;EDITING SEARCH;GERMANY CONTRIBUTION;REVIEW EDITING;WRITING REVIEW;DATA CURATION;CONTRIBUTION DATA;EJECTION FRACTION;FORMAL ANALYSIS;HR CI;MUNICH GERMANY;SIGNIFICANT DIFFERENCE;ATRIAL FIBRILLATION;DISEASE PROGRESSION;SIGNIFICANT DIFFERENCES;STATISTICALLY SIGNIFICANT;AORTIC VALVE;CROSSREF PUBMED;LEFT VENTRICULAR;METHODOLOGY SEARCH;PATIENTS UNDERWENT;ADVERSE EVENTS","78;68;61;53;52;52;49;44;43;42;42;42;42;40;36;36;36;35;35;35;31;31;31;31;30;30;30;30;29;28",453,0.44,8,9,1,1,0,4,0,1,1,11,1,0,8,1,2,1,3,6,3,0,0,23,23,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28,3.25,1942.21,2.07,11,0.39,120.25,0,0,5,3,13,0,0,7,0,23,5,0,0,0,0,0,0,28,0,0,28,0,0,0,0,0,0,0,0,0,"United States;Italy;Japan;United Kingdom;Germany;Hungary;Portugal","12;10;4;2;1;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;3211 ONCOLOGY AND CARCINOGENESIS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3208 MEDICAL PHYSIOLOGY;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","27;17;5;5;3;2;2;2;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;RARE DISEASES;CANCER;PEDIATRIC;DIGESTIVE DISEASES;AGING;BRAIN DISORDERS;CARDIOVASCULAR;NEUROSCIENCES;AUTOIMMUNE DISEASE;LUNG;NEURODEGENERATIVE;PREVENTION;ATHEROSCLEROSIS;CHRONIC PAIN;CYSTIC FIBROSIS;GENETICS;HEART DISEASE","28;22;11;9;7;7;5;4;4;4;4;3;3;3;3;2;2;2;2;2","CANCER;ORAL AND GASTROINTESTINAL;CARDIOVASCULAR;CONGENITAL;INFECTION;INFLAMMATORY AND IMMUNE SYSTEM;MENTAL HEALTH;METABOLIC AND ENDOCRINE;MUSCULOSKELETAL;NEUROLOGICAL","3;3;2;2;1;1;1;1;1;1","6.1 PHARMACEUTICALS;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY","23;2;2;1","BREAST CANCER;COLON AND RECTAL CANCER;LIVER CANCER;NON-HODGKIN'S LYMPHOMA","1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS","3;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,"FRONTIERS;FUTURE SCIENCE GROUP","3;2","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3105 GENETICS;3210 NUTRITION AND DIETETICS;3211 ONCOLOGY AND CARCINOGENESIS","10;3;2;1;1;1","CLINICAL RESEARCH;BIOTECHNOLOGY;BREAST CANCER;CANCER;GENETIC TESTING;GENETICS;HUMAN GENOME;NUTRITION;OVARIAN CANCER;PEDIATRIC;RARE DISEASES","3;1;1;1;1;1;1;1;1;1;1","CANCER;METABOLIC AND ENDOCRINE","1;1","2.1 BIOLOGICAL AND ENDOGENOUS FACTORS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1;1","BIOMEDICAL;CLINICAL","1;1","CLINICAL MEDICINE AND SCIENCE","4","PANCREATIC CANCER;BREAST CANCER;OVARIAN CANCER","2;1;1","2 ZERO HUNGER","1"
"AOUSSN_FEDERICOII",2023,953,15.1112277019937,2.96852046169989,0.352570828961175,0.342077649527807,0.397691500524659,2.00995024875622,1.33864541832669,1.58252427184466,1.36823104693141,0.772298006295908,10,394,165,53,69,0.41,0.17,0.06,0.07,4.69,1.07084266350186,5.92088091354001,0.426023084994753,0.923399790136411,0.486,0.462,0.475,0.441,"ROBERTO TROISI;MARIA TRIASSI;YOUSSEF ROUPHAEL;GIOVANNI ESPOSITO;ROBERTO MONTALTI;HO‐SEONG HAN;MATTHIAS B. SCHULZE;COSTANTINO MANCUSI;LUCA ALDRIGHETTI;MOHAMMED ABU HILAL;ANDREA BELLI;FABRIZIO PANE;ANNE TJØNNELAND;GAETANO SANTULLI;GIANCARLO TRONCONE;MARIANO CESARE GIGLIO;BRIAN K. P. GOH;ALICIA K. HEATH;ALESSANDRO FERRERO;RAFFAELE IZZO","25;25;25;24;20;17;17;17;16;16;16;16;16;15;15;15;15;14;14;14","YOUSSEF ROUPHAEL;MARIA TRIASSI;ROBERTO TROISI;GIOVANNI ESPOSITO;ROBERTO MONTALTI;GIULIANO BONANOMI;VINCENZO D’ALESSANDRO;RAFFAELE PALLADINO;COSTANTINO MANCUSI;LUISA VERDOLIVA;UMBERTO MALAPELLE;BORIS BASILE;FRANCESCO GIANNINO;MICHELE CIRIELLO;GIANLUCA CASSESE;DANIELA PACELLA;FRANCESCO D’ANDREA;LUIGI FORMISANO;PAOLO MONTUORI;STEFANIA DE PASCALE","3.68;3.04;2.91;2.16;2.15;1.94;1.89;1.87;1.69;1.47;1.46;1.39;1.34;1.33;1.33;1.3;1.29;1.28;1.26;1.26","ROBERTO TROISI;MARIA TRIASSI;YOUSSEF ROUPHAEL;GIOVANNI ESPOSITO;ROBERTO MONTALTI;COSTANTINO MANCUSI;FABRIZIO PANE;GAETANO SANTULLI;GIANCARLO TRONCONE;MARIANO CESARE GIGLIO;RAFFAELE IZZO;PASQUALE PAOLISSO;ROBERTO TROISI;GUIDO IACCARINO;UMBERTO MALAPELLE;SALVATORE PANICO;FABIANA CASTIGLIONE;PAOLO MONTUORI;EMANUELE BARBATO;GO WAKABAYASHI","25;25;25;24;20;17;16;15;15;15;14;14;14;13;13;12;12;12;12;12","YOUSSEF ROUPHAEL;MARIA TRIASSI;ROBERTO TROISI;GIOVANNI ESPOSITO;ROBERTO MONTALTI;GIULIANO BONANOMI;VINCENZO D’ALESSANDRO;RAFFAELE PALLADINO;COSTANTINO MANCUSI;LUISA VERDOLIVA;UMBERTO MALAPELLE;BORIS BASILE;FRANCESCO GIANNINO;MICHELE CIRIELLO;GIANLUCA CASSESE;DANIELA PACELLA;FRANCESCO D’ANDREA;LUIGI FORMISANO;PAOLO MONTUORI;STEFANIA DE PASCALE","3.68;3.04;2.91;2.16;2.15;1.94;1.89;1.87;1.69;1.47;1.46;1.39;1.34;1.33;1.33;1.3;1.29;1.28;1.26;1.26","EDOARDO PASOLLI;ENRICO DOMENICI;MICHELE FILOSI;ADRIAN TETT;ADRIANA GONÇALVES;AITOR BLANCO‐MÍGUEZ;ALESSIA VISCONTI;ANA G. BINETTI;ANNA LAST;BEI HAN;CLAIRE M. STEVES;DANIEL EIBACH;DAVIDE GOLZATO;ELISA PIPERNI;FABIO CUMBO;FEDERICA ARMANINI;FEDERICA PINTO;FRANCESCO ASNICAR;GIULIA MASETTI;HUANLONG QIN","217;203;203;201;201;201;201;201;201;201;201;201;201;201;201;201;201;201;201;201","EDOARDO PASOLLI;LUISA VERDOLIVA;PASQUALE PAOLISSO;DAVIDE COZZOLINO;CARMINE SETTEMBRE;YOUSSEF ROUPHAEL;ROBERTO TROISI;CARLO G. TOCCHETTI;GAETANO SANTULLI;SALVATORE PANICO;GIOVANNI POGGI;RICCARDO CORVI;RAFFAELE CAPASSO;GIUSEPPE ESPOSITO;PAOLO MONTUORI;MARIA TRIASSI;EMANUELE BARBATO;JESSICA GAMBARDELLA;ANDREA BALLABIO;GIADA ZINGARINI","204;197;179;173;155;155;144;134;130;121;102;100;98;86;86;84;81;80;72;72","ROBERTO TROISI;YOUSSEF ROUPHAEL;ROBERTO MONTALTI;GIOVANNI ESPOSITO;MARIA TRIASSI;COSTANTINO MANCUSI;PASQUALE PAOLISSO;ANNAMARIA COLAO;LUIGI FORMISANO;GIANCARLO TRONCONE;PAOLO MONTUORI;FABRIZIO PANE;SALVATORE PANICO;DANIELA PACELLA;GAETANO SANTULLI;CARLO G. TOCCHETTI;RAFFAELE IZZO;UMBERTO MALAPELLE;GUIDO IACCARINO;LUIGIANA LUCIANO","39;25;20;18;17;15;14;13;12;12;12;12;12;11;11;11;11;11;11;10","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;ENGINEERING;MATHEMATICS;PSYCHOLOGY;SOCIOLOGY;ECONOMICS;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE;GEOGRAPHY;BUSINESS;POLITICAL SCIENCE;PHILOSOPHY;ART;GEOLOGY;HISTORY","731;354;146;116;100;83;73;58;54;53;47;40;34;33;30;26;11;10;5","INTERNAL MEDICINE;SURGERY;GENETICS;PATHOLOGY;BIOCHEMISTRY;CARDIOLOGY;ENVIRONMENTAL HEALTH;ENDOCRINOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;ECOLOGY;ONCOLOGY;PSYCHIATRY;PEDIATRICS;BOTANY;RADIOLOGY;PALEONTOLOGY;PHYSICAL THERAPY;INTENSIVE CARE MEDICINE;FOOD SCIENCE;HORTICULTURE","535;182;122;121;119;108;99;95;82;77;70;70;64;62;61;61;50;46;45;44;44","DISEASE;GENE;CANCER;POPULATION;COHORT;HEART FAILURE;PROSPECTIVE COHORT STUDY;DIABETES MELLITUS;MYOCARDIAL INFARCTION;RETROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;PREGNANCY;CONTEXT (ARCHAEOLOGY);BLOOD PRESSURE;RECEPTOR;BODY MASS INDEX;COHORT STUDY;CHEMOTHERAPY;OBSERVATIONAL STUDY","128;106;97;90;79;52;48;44;43;40;37;36;32;31;29;29;26;26;25;25","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;TYPE 2 DIABETES;CLINICAL ENDPOINT;EJECTION FRACTION;COLORECTAL CANCER;GENOTYPE;PHENOTYPE;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;HAZARD RATIO;CORONARY ANGIOGRAPHY;GENE EXPRESSION;INFLAMMATORY BOWEL DISEASE;ULCERATIVE COLITIS;CONVENTIONAL PCI;IMMUNOTHERAPY;PERCUTANEOUS CORONARY INTERVENTION;2019-20 CORONAVIRUS OUTBREAK;CARDIOMYOPATHY;CROHN'S DISEASE;INFERTILITY;MULTICENTER STUDY;MUTATION;POLYPHENOL;UNIVARIATE ANALYSIS","37;26;25;22;21;18;18;16;15;15;13;13;13;12;11;11;11;10;9;9;9;9;9;9;9","CORONAVIRUS DISEASE 2019 (COVID-19);FRACTIONAL FLOW RESERVE;SINGLE-NUCLEOTIDE POLYMORPHISM;COLONOSCOPY;DNA METHYLATION;MACE;MISSENSE MUTATION;TFEB;MEPOLIZUMAB;NILOTINIB;CARDIAC RESYNCHRONIZATION THERAPY;DASATINIB;DEIODINASE;EXOME SEQUENCING;FAMILY PLANNING;GENETIC VARIANTS;GLYCEMIC INDEX;IMATINIB MESYLATE;PITTSBURGH SLEEP QUALITY INDEX;PRIMARY CILIARY DYSKINESIA;TAMOXIFEN;TRANSCRIPTOME","36;9;7;6;6;6;6;6;5;5;4;4;4;4;4;4;4;4;4;4;4;4",";HUMANS;FEMALE;RETROSPECTIVE STUDIES;MALE;ANIMALS;ITALY;PROSPECTIVE STUDIES;ADULT;TREATMENT OUTCOME;CHILD;COVID-19;MIDDLE AGED;POSTOPERATIVE COMPLICATIONS;AGED;LAPAROSCOPY;HEART FAILURE;LIVER NEOPLASMS;HEPATECTOMY;RISK FACTORS","523;388;109;87;78;51;51;48;43;43;42;39;35;35;33;33;31;31;30;30","HEPATOCELLULAR CARCINOMA;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;DIAGNOSIS AND TREATMENT OF HEART FAILURE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;ADVANCED CARDIAC IMAGING TECHNIQUES AND DIAGNOSTICS;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;ROLE OF MEDITERRANEAN DIET IN HEALTH OUTCOMES;EFFICACY AND RESISTANCE IN CML TREATMENT;MANAGEMENT OF VALVULAR HEART DISEASE;CARDIOTOXICITY OF CANCER TREATMENTS;CHOLESTEROL-LOWERING TREATMENT;CLINICAL STUDIES ON CORONARY STENTS AND REVASCULARIZATION;CORONAVIRUS DISEASE 2019;GENOMIC LANDSCAPE OF CANCER AND MUTATIONAL SIGNATURES;ASTHMA;ATRIAL FIBRILLATION;CHOLANGIOCARCINOMA;DIGITAL IMAGE FORGERY DETECTION AND IDENTIFICATION","19;14;13;12;12;12;11;11;11;10;8;7;7;7;7;7;6;6;6;6","CARDIAC IMAGING;CLINICAL ENDPOINT;TREATMENT;CROSS-SECTIONAL STUDY;ECHOCARDIOGRAPHY;PANDEMIC;CARDIOVASCULAR RISK ASSESSMENT;STROKE (ENGINE);DIETARY PATTERNS;HEALTHY EATING INDEX;2019-20 CORONAVIRUS OUTBREAK;FRACTIONAL FLOW RESERVE;PLANT DEVELOPMENT;BREAST CANCER;DIET QUALITY;DISCONTINUATION;INTERQUARTILE RANGE;LEFT VENTRICULAR FUNCTION;LIVER RESECTION;LIVER TRANSPLANTATION","25;23;19;17;17;16;15;15;14;11;10;10;10;9;9;9;9;9;9;9","TYPE DIABETES;BREAST CANCER;HEART FAILURE;COHORT STUDY;MULTIPLE SCLEROSIS;MINIMALLY INVASIVE;CARDIOVASCULAR RISK;CROSS-SECTIONAL STUDY;RISK FACTORS;SOUTHERN ITALY;CANCER PATIENTS;LIVER RESECTION;MULTICENTER STUDY;PROSPECTIVE STUDY;PATIENTS UNDERGOING;CHRONIC MYELOID;MYELOID LEUKEMIA;CLINICAL TRIAL;COVID- PANDEMIC;DIABETES MELLITUS;FABRY DISEASE;LIVER RESECTIONS;MYOCARDIAL INFARCTION;OBSERVATIONAL STUDY;PATIENTS TREATED;ULCERATIVE COLITIS;CANCER RISK;COLORECTAL CANCER;CONTROLLED TRIAL;CROHNS DISEASE","23;20;20;16;15;12;11;11;11;11;10;10;10;10;9;8;8;7;7;7;7;7;7;7;7;7;6;6;6;6","HEART FAILURE;HR CI;HEALTHY CONTROLS;SIGNIFICANT DIFFERENCES;PATIENTS TREATED;RISK FACTORS;LEFT VENTRICULAR;BREAST CANCER;CV RISK;STATISTICALLY SIGNIFICANT;ADVERSE EVENTS;COVID- PANDEMIC;BLOOD PRESSURE;EJECTION FRACTION;SIGNIFICANT DIFFERENCE;BODY MASS;CARDIOVASCULAR RISK;PATIENTS UNDERGOING;RETROSPECTIVE STUDY;AMINO ACIDS;MASS INDEX;UNIVERSITY HOSPITAL;CROSS-SECTIONAL STUDY;CONFIDENCE INTERVAL;MEDIAN AGE;PRIMARY ENDPOINT;CANCER PATIENTS;CLINICAL PRACTICE;CLINICAL TRIALS;COHORT STUDY","61;49;39;37;33;33;30;29;29;28;27;27;26;26;25;24;24;24;24;23;23;23;22;21;21;21;20;20;20;20",353,0.37,8.65,11,1,1,0,2,1,1,1,12,1.75,1,11,1.75,3.5,2,4,7,5,0,0,10,10,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20,2.7,1529.95,1.53,6,0.3,110.45,0,0,2,0,9,0,1,8,0,16,4,0,0,0,0,0,0,19,0,1,18,0,0,2,0,0,0,0,0,0,"United States;Italy;Denmark;Germany;Ireland","7;6;2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;52 PSYCHOLOGY;5202 BIOLOGICAL PSYCHOLOGY;42 HEALTH SCIENCES;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3204 IMMUNOLOGY;3205 MEDICAL BIOCHEMISTRY AND METABOLOMICS;3212 OPHTHALMOLOGY AND OPTOMETRY;4203 HEALTH SERVICES AND SYSTEMS;4207 SPORTS SCIENCE AND EXERCISE;46 INFORMATION AND COMPUTING SCIENCES;4608 HUMAN-CENTRED COMPUTING","18;8;5;5;4;3;2;1;1;1;1;1;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;CARDIOVASCULAR;PATIENT SAFETY;AGING;CANCER;PREVENTION;BRAIN DISORDERS;DIABETES;HEART DISEASE;HEMATOLOGY;NEURODEGENERATIVE;NEUROSCIENCES;AUTOIMMUNE DISEASE;HEART DISEASE - CORONARY HEART DISEASE;NUTRITION;PARKINSON'S DISEASE;PEDIATRIC;RARE DISEASES;ATHEROSCLEROSIS","20;18;5;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;1","CANCER;CARDIOVASCULAR;METABOLIC AND ENDOCRINE;EYE;INFECTION;MENTAL HEALTH;NEUROLOGICAL;ORAL AND GASTROINTESTINAL","4;4;3;1;1;1;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;7.1 INDIVIDUAL CARE NEEDS;4.1 DISCOVERY AND PRECLINICAL TESTING OF MARKERS AND TECHNOLOGIES;5.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES;6.4 SURGERY;6.7 PHYSICAL","15;2;2;1;1;1;1;1","LIVER CANCER;LUNG CANCER;MELANOMA;NON-HODGKIN'S LYMPHOMA;PROSTATE CANCER","1;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3210 NUTRITION AND DIETETICS","2;1","AUTOIMMUNE DISEASE;CLINICAL RESEARCH;CROHN'S DISEASE;DIGESTIVE DISEASES;INFLAMMATORY BOWEL DISEASE;NUTRITION;PREVENTION","1;1;1;1;1;1;1","INFLAMMATORY AND IMMUNE SYSTEM;ORAL AND GASTROINTESTINAL","1;1",NA,NA,"CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"AOUSSN_FEDERICOII",2024,835,16.0155688622754,2.93892215568862,0.372455089820359,0.319760479041916,0.402395209580838,1.8675799086758,1.2390438247012,1.48333333333333,1.25842696629213,0.707784431137725,8,377,147,47,48,0.45,0.18,0.06,0.06,0.92,0.958630660535494,4.97331284057566,0.426347305389222,0.925748502994012,0.483,0.405,0.448,0.428,"GIOVANNI ESPOSITO;MARIO DAMIANO TORO;YOUSSEF ROUPHAEL;DANIELA PACELLA;ROBERTA LANZILLO;GIANCARLO TRONCONE;MARCELLO MOCCIA;MATTHIAS B. SCHULZE;MARIA TRIASSI;VALENTINA MERCURIO;VERENA KATZKE;ANNE TJØNNELAND;FABRIZIO PASANISI;ALICIA K. HEATH;GIOVANNA MASALA;CARLO G. TOCCHETTI;MICHELE CIRIELLO;VINCENZO BRESCIA MORRA;LUCA ALDRIGHETTI;RAFFAELE IZZO","21;18;17;15;15;14;14;13;13;13;13;13;12;12;12;12;12;12;11;11","YOUSSEF ROUPHAEL;MARIO DAMIANO TORO;OLGA MARIA NARDONE;MICHELE CIRIELLO;GIOVANNI ESPOSITO;ARIANNA SCALA;ALESSANDRA GRAZIOTTIN;IVO IAVICOLI;TERESA ANGELA TRUNFIO;ROBERTO TROISI;NUNZIO D’AGOSTINO;GIOVANNI IMPROTA;MARIA TRIASSI;FABRIZIO PASANISI;GIOVANNI BALATO;GIANCARLO TRONCONE;DANIELA PACELLA;VINCENZO D’ALESSANDRO;CIRO COSTAGLIOLA;COSTANTINO MANCUSI","2.3;1.97;1.75;1.71;1.68;1.68;1.53;1.46;1.37;1.32;1.32;1.31;1.3;1.28;1.27;1.25;1.22;1.21;1.2;1.11","GIOVANNI ESPOSITO;MARIO DAMIANO TORO;YOUSSEF ROUPHAEL;DANIELA PACELLA;ROBERTA LANZILLO;GIANCARLO TRONCONE;MARCELLO MOCCIA;MARIA TRIASSI;VALENTINA MERCURIO;FABRIZIO PASANISI;CARLO G. TOCCHETTI;MICHELE CIRIELLO;VINCENZO BRESCIA MORRA;RAFFAELE IZZO;EDUARDO BOSSONE;ANTONIO CAROTENUTO;FRANCESCO PEPE;COSTANTINO MANCUSI;GAETANO SANTULLI;MARIA ANGELA LOSI","21;18;17;15;15;14;14;13;13;12;12;12;12;11;11;11;11;11;10;10","YOUSSEF ROUPHAEL;MARIO DAMIANO TORO;OLGA MARIA NARDONE;MICHELE CIRIELLO;GIOVANNI ESPOSITO;ARIANNA SCALA;ALESSANDRA GRAZIOTTIN;IVO IAVICOLI;TERESA ANGELA TRUNFIO;ROBERTO TROISI;NUNZIO D’AGOSTINO;GIOVANNI IMPROTA;MARIA TRIASSI;FABRIZIO PASANISI;GIOVANNI BALATO;GIANCARLO TRONCONE;DANIELA PACELLA;VINCENZO D’ALESSANDRO;CIRO COSTAGLIOLA;COSTANTINO MANCUSI","2.3;1.97;1.75;1.71;1.68;1.68;1.53;1.46;1.37;1.32;1.32;1.31;1.3;1.28;1.27;1.25;1.22;1.21;1.2;1.11","BENJAMIN CLAPP;GERHARD PRAGER;SCOTT A. SHIKORA;LILIAN KOW;MEHRAN ANVARI;NASSER SAKRAN;CUNCHUAN WANG;LUIGI ANGRISANI;PAULINA SALMINEN;ALMINO RAMOS;BEKKHAN KHATSIEV;FELIX B. LANGER;JOSÉ G. RODRÍGUEZ VILLARREAL;NIK RITZA KOSAI;PHILIPP BECKERHINN;SANG KUON LEE;SIMON W. NIENHUIJS;TARYEL OMEROV;TESS VAN DER MERWE;WAH YANG","58;57;57;55;52;52;49;44;44;43;41;41;41;41;41;41;41;41;41;41","LUIGI ANGRISANI;ROBERTO TROISI;MARIO MUSELLA;MARTA BELMONTE;YOUSSEF ROUPHAEL;MARIO DAMIANO TORO;MICHELE CIRIELLO;NICOLA ROCCO;VALENTINA MERCURIO;SALVATORE PANICO;CARLO G. TOCCHETTI;GAETANO SANTULLI;GIOVANNI ESPOSITO;MARIA VIRGINIA MANZI;RAFFAELE IZZO;BRUNO TRIMARCO;ANNA DE ROSA;ANNA SANNINO;ANTONIO LUCA SPIEZIA;DANIELA CASO","38;36;30;21;21;17;17;17;17;15;14;14;14;14;14;13;12;12;12;12","ROBERTO TROISI;MARIO DAMIANO TORO;YOUSSEF ROUPHAEL;GIOVANNI ESPOSITO;DANIELA PACELLA;CARLO G. TOCCHETTI;UMBERTO MALAPELLE;VALENTINA MERCURIO;MICHELE CIRIELLO;GIANCARLO TRONCONE;FABRIZIO PASANISI;MARCELLO MOCCIA;SALVATORE PANICO;FRANCESCO PEPE;VINCENZO BRESCIA MORRA;ANTONIO PISANI;ROBERTA LANZILLO;MARIA ANGELA LOSI;UMBERTO MARCELLO BRACALE;EDUARDO BOSSONE","19;18;17;14;13;12;12;12;12;12;11;11;11;10;10;10;10;9;9;9","MEDICINE;BIOLOGY;COMPUTER SCIENCE;CHEMISTRY;PHYSICS;PSYCHOLOGY;ENGINEERING;MATHEMATICS;SOCIOLOGY;MATERIALS SCIENCE;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;ENVIRONMENTAL SCIENCE;GEOGRAPHY;GEOLOGY;BUSINESS;ART;HISTORY","647;285;130;87;82;61;59;50;48;46;44;34;33;28;17;15;14;6;3","INTERNAL MEDICINE;SURGERY;GENETICS;CARDIOLOGY;PATHOLOGY;BIOCHEMISTRY;ENDOCRINOLOGY;PSYCHIATRY;RADIOLOGY;PEDIATRICS;IMMUNOLOGY;ENVIRONMENTAL HEALTH;INTENSIVE CARE MEDICINE;ONCOLOGY;ARTIFICIAL INTELLIGENCE;GENERAL SURGERY;LAW;BIOINFORMATICS;ORGANIC CHEMISTRY;ECOLOGY","431;163;113;104;98;79;72;63;63;62;60;54;52;52;42;42;42;38;38;37","DISEASE;GENE;CANCER;POPULATION;COHORT;HEART FAILURE;DIABETES MELLITUS;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;PROSPECTIVE COHORT STUDY;OBESITY;PREGNANCY;ALTERNATIVE MEDICINE;INCIDENCE (GEOMETRY);OBSERVATIONAL STUDY;MULTIPLE SCLEROSIS;BACTERIA;BLOOD PRESSURE;CLINICAL TRIAL;HEALTH CARE;HORMONE;IMMUNE SYSTEM","106;79;70;45;43;41;31;28;28;27;26;26;25;25;24;22;20;20;18;18;18;18","BREAST CANCER;PHENOTYPE;EJECTION FRACTION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);TYPE 2 DIABETES;COLORECTAL CANCER;INFLAMMATORY BOWEL DISEASE;WEIGHT LOSS;INSULIN RESISTANCE;MULTICENTER STUDY;NEURORADIOLOGY;FABRY DISEASE;GENE EXPRESSION;HAZARD RATIO;CARDIOMYOPATHY;CLINICAL ENDPOINT;EUROPEAN PROSPECTIVE INVESTIGATION INTO CANCER AND NUTRITION;GENOTYPE;HEPATECTOMY;IMMUNOTHERAPY;MUTATION;TRANSCRIPTION FACTOR","28;22;19;18;17;16;12;12;11;11;10;9;9;9;8;8;7;7;7;7;7;7","CORONAVIRUS DISEASE 2019 (COVID-19);GASTRIC BYPASS;TRANSCRIPTOME;ENDOVASCULAR ANEURYSM REPAIR;HEART FAILURE WITH PRESERVED EJECTION FRACTION;METASTATIC BREAST CANCER;MOSFET;TFEB;CARDIAC RESYNCHRONIZATION THERAPY;ESTROGEN RECEPTOR;FRACTIONAL FLOW RESERVE;GLYCEMIC INDEX;HAPLOINSUFFICIENCY;HYPERINSULINEMIA;ICE CALVING;NEOADJUVANT THERAPY;OCRELIZUMAB;SEVERE OBESITY;TRASTUZUMAB;ACROMEGALY;ALTERNATIVE SPLICING;CANCER IMMUNOTHERAPY;CD40;CONTINUOUS GLUCOSE MONITORING;CRIZOTINIB;CYSTECTOMY;DAPAGLIFLOZIN;DEHYDROEPIANDROSTERONE;DIASTOLIC FUNCTION;DIGESTATE;DNA METHYLATION;ECULIZUMAB;ENHANCER;EPITHELIAL–MESENCHYMAL TRANSITION;FABRY'S DISEASE;FAMILY PLANNING;GENE DELIVERY;GENOME EDITING;GERMLINE MUTATION;IL-2 RECEPTOR;INSULIN PUMP;INSULIN SENSITIVITY;KRAS;LIRAGLUTIDE;LOSS FUNCTION;MEPOLIZUMAB;MESODERM;MORBID OBESITY;NILOTINIB;NIVOLUMAB;NONALCOHOLIC FATTY LIVER DISEASE;POLY ADP RIBOSE POLYMERASE;PRENATAL DIAGNOSIS;PRIMARY CILIARY DYSKINESIA;PROCTOCOLECTOMY;RNA SPLICING;SACUBITRIL, VALSARTAN;SENTINEL LYMPH NODE;SINGLE-NUCLEOTIDE POLYMORPHISM;STROKE VOLUME;SYNOVIAL FLUID;SYSTEMIC THERAPY;URETEROLYSIS;UROTHELIAL CARCINOMA;VANCOMYCIN;VARICOCELE","18;9;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",";HUMANS;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;RETROSPECTIVE STUDIES;PROSPECTIVE STUDIES;CHILD;ANIMALS;TREATMENT OUTCOME;AGED, 80 AND OVER;ADOLESCENT;YOUNG ADULT;RISK FACTORS;CHILD, PRESCHOOL;PHENOTYPE;PROGNOSIS","527;274;172;146;109;96;90;47;40;37;36;34;34;31;30;27;24;21;16;16","DIAGNOSIS AND PATHOGENESIS OF MULTIPLE SCLEROSIS;PLANT BIOSTIMULANTS IN AGRICULTURE AND HORTICULTURE;EFFECTS OF BARIATRIC SURGERY ON OBESITY AND DIABETES;EFFECTS OF KETOGENIC DIET ON HEALTH;LYSOSOMAL STORAGE DISORDERS IN HUMAN HEALTH AND DISEASE;MANAGEMENT OF VALVULAR HEART DISEASE;CARDIAC RESYNCHRONIZATION THERAPY IN HEART FAILURE;EPIDEMIOLOGY AND MANAGEMENT OF NAFLD;HEPATOCELLULAR CARCINOMA;RECOMMENDATIONS FOR CARDIAC CHAMBER QUANTIFICATION BY ECHOCARDIOGRAPHY;GENETICS AND TREATMENT OF INFLAMMATORY BOWEL DISEASE;BOTULINUM TOXIN IN NEUROLOGY AND MEDICINE;CORONAVIRUS DISEASE 2019;DIAGNOSIS AND MANAGEMENT OF DRY EYE DISEASE;DIAGNOSIS AND TREATMENT OF HEART FAILURE;DIAGNOSIS AND TREATMENT OF PULMONARY HYPERTENSION;MANAGEMENT OF HYPERTENSION AND CARDIOVASCULAR RISK FACTORS;MOLECULAR RESEARCH ON BREAST CANCER;MYASTHENIA GRAVIS AND THYMIC TUMORS RESEARCH;POTENTIAL OF EDIBLE INSECTS AS FOOD AND FEED","16;14;12;12;12;11;8;8;8;8;7;6;6;6;6;6;6;6;6;6","TREATMENT;CARDIAC IMAGING;CARDIOVASCULAR RISK ASSESSMENT;PLANT GROWTH;DIABETES;LEFT VENTRICULAR FUNCTION;BIOSTIMULANTS;ECHOCARDIOGRAPHY;METABOLIC SYNDROME;NEURORADIOLOGY;SINGLE CENTER;CLINICAL ENDPOINT;DIAGNOSIS;FABRY DISEASE;HEALTHY EATING INDEX;HYPERTENSION;METABOLIC SURGERY;BREAST CANCER;CROSS-SECTIONAL STUDY;DELPHI METHOD","19;16;13;13;11;11;10;10;10;10;10;9;9;9;9;9;9;8;8;8","HEART FAILURE;MULTIPLE SCLEROSIS;BREAST CANCER;TYPE DIABETES;CANCER PATIENTS;CARDIOVASCULAR RISK;RISK FACTORS;ARTERIAL HYPERTENSION;CORONARY ARTERY;INFLAMMATORY BOWEL;LEFT VENTRICULAR;MACHINE LEARNING;ARTERY DISEASE;BARIATRIC SURGERY;COHORT STUDY;COLORECTAL CANCER;ITALIAN SOCIETY;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED;BLACK SOLDIER;BOWEL DISEASE;CARDIOVASCULAR EVENTS;CROHNS DISEASE;EJECTION FRACTION;FABRY DISEASE;LUNG CANCER;MULTICENTER STUDY;PARKINSONS DISEASE;PATIENTS UNDERGOING;PILOT STUDY","25;24;15;10;9;9;9;8;8;8;8;8;7;7;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6","HEART FAILURE;RISK FACTORS;BREAST CANCER;LEFT VENTRICULAR;EJECTION FRACTION;PATIENTS UNDERGOING;PATIENTS TREATED;STATISTICALLY SIGNIFICANT;SIGNIFICANT DIFFERENCES;CLINICAL PRACTICE;HR CI;SCIENCEGOOGLE SCHOLAR;CLINICAL TRIALS;II UNIVERSITY;PUBMEDGOOGLE SCHOLAR;CANCER PATIENTS;GUT MICROBIOTA;HEALTHCARE PROFESSIONALS;LIVER DISEASE;BLOOD GLUCOSE;CORONARY ARTERY;MULTIPLE SCLEROSIS;FATTY LIVER;MAGNETIC RESONANCE;PUBLIC HEALTH;PUBMED SCOPUS;STUDY INCLUDED;TYPE DIABETES;BODY MASS;LIVER RESECTION","49;38;37;33;30;29;28;28;26;21;21;21;20;20;18;17;17;17;17;16;16;16;15;15;15;15;15;15;14;14",5,0.01,10.75,13,1,0,0,1,0,0,0,18,0,0,13,0,0,2.5,3.5,6,3,0,0,6,6,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,190,0.08,0,0,48,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"Switzerland","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEMATOLOGY;LYMPHOMA;RARE DISEASES","1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS;6.5 RADIOTHERAPY AND OTHER NON-INVASIVE THERAPIES","1;1","NON-HODGKIN'S LYMPHOMA","1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,"FRONTIERS","6","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","12;6","ASTHMA;CLINICAL RESEARCH;LUNG","6;6;6","RESPIRATORY","6","5.1 PHARMACEUTICALS","6","CLINICAL","6","CLINICAL MEDICINE AND SCIENCE","6",NA,NA,NA,NA
